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Scope and objectives 
1.1 SCOPE AND OBJECTIVES 
 
 Validation is an important feature in any method of measurement 
because it is closely related to the quality of the results. A method of 
analysis is characterised by its performance parameters, which have 
to be assessed if they are to provide the correct performance values. 
These performance values must be in accordance with previously 
defined requirements that the method of analysis should satisfy. But 
above all, the performance parameters depend on the type of method 
and its intrinsic characteristics. So depending on what is needed, the 
user must choose which method of analysis will best solve the 
analytical problem. 
 
 Of all the different methods of analysis, conventional classification 
differentiates between qualitative and quantitative methods, although 
semi-quantitative methods can also be considered to be a group apart. 
 
 Qualitative methods of analysis provide basic information about 
the composition of a sample and perform quite simple chemical 
reactions to identify the analytes it contains [1, 2]. Quantitative 
methods of analysis provide information not only about the 
composition but also about the concentration of the analytes present 
in the sample and, generally speaking, they often require more 
complex analytical techniques to obtain more accurate and reliable 
information about the sample. Semi-quantitative methods of analysis 
lie between the qualitative and the quantitative methods because they 
assign samples to different classes which delimitate specific ranges 





categories are defined by a particular criterion: concentration of a 
compound, index value, etc. [3, 4]. One example of this sort of 
method is how the acid-base character of a sample is determined by 
means of the pH measurement: different colours mean different pH 
values. These are the semi-quantitative methods of analysis [5]. 
 
 For various reasons ―the need for reliable quantitative results, the 
greater development of instrumental techniques, etc― research effort 
and investment has mainly focused on quantitative methods of 
analysis. As a consequence, validation procedures have been 
developed almost exclusively for quantitative methods of analysis. 
 
 The aim of this doctoral thesis is to study validation processes in 
qualitative methods of analysis. In particular, it reviews the state of 
the art as far as the validation of qualitative methods of analysis is 
concerned. It also proposes classifying these methods of analysis 
according to their characteristics. And, finally, it defines the 
qualitative performance parameters that are so important to the 
establishment of the final validation procedures. 
 
 These procedures are addressed to those analytical methods that 
provide binary results of the type YES/NO, POSITIVE/NEGATIVE or 
ABOVE/BELOW a certain limit. They are often used as screening 
methods of analysis, which separate samples according to one or 
more criteria and then often submit them to the appropriate 
quantitative analytical method. Or, as is becoming increasingly 
common nowadays, they are used as routine methods of analysis in 
fields like environmental, clinical or food analysis. 
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Scope and objectives 
 Considering the applicability of qualitative methods of analysis and 
the importance of the fields in which they are used, method validation 
is fundamental to the quality of the final results. Bearing all this in 
mind, and not forgetting that the area is largely unexplored and that 
many aspects of the validation of qualitative methods of analysis have 
yet to be defined, this thesis has been structured in the following way. 
 
 One of the main focuses is the theoretical part which studies and 
defines the performance parameters of the methods of analysis. 
Several theoretical bases have been discussed and studied in depth, 
and then applied to practical cases. In these cases, the performance 
parameters have been defined and estimated. 
 
 The objectives of the thesis are the following: 
 1)  To review several aspects of the validation of qualitative 
methods of analysis, to revise performance parameters and to define 
more appropriate ones when necessary. These issues are discussed in 
two papers entitled Validation of qualitative analytical methods and 
Validation of qualitative methods of analysis that use control samples. 
Both articles were the starting point of subsequent practical 
applications. 
 2)  To establish the performance parameters of a commercial test 
kit used in food analysis, which provides a sensorial response. This is 
the central theme of the paper Qualitative Method for determ nation of 
Aflatoxin B1 in nuts. The validation procedure is based on the use of 
Performance Characteristic Curves. 
i
 3)  To establish the performance parameters of a commercial test 





instrumental detection but final binary results. This is discussed in the 
paper Validation of qualitative test kits with nstrumental responses. 
Detection of Varicella -Zoster Virus IgG antibodies n human serum. 
The validation procedure uses the statistical characterisation of the 
control sample distribution. 
 i
i
 4)  To establish the performance parameters of a homemade 
autoanalyzer with instrumental response that combines the 
measurement of two analytes using Hypotheses Testing. This topic is 
dealt with in Statistical intervals to validate an autoanalyzer for 
monitoring the exhaustion of alkaline degreasing baths. 
 5)  Robustness is presented separately as a performance 
parameter. Despite its considerable importance, it is generally not 
considered in validation procedures. Robustness in qualitative 
analysis: a practical approach presents practical aspects regarding 
robustness in qualitative methods of analysis. 
 
 
1.2 STRUCTURE OF THE THESIS 
 
 The thesis has been structured in the following chapters: 
 Chapter 1 briefly introduces the framework of the thesis. Then the 
objectives are described and justified, and, finally, the structure is 
outlined. 
 Chapter 2 deals with the concept of method validation in general. 
The aim is to present not only the state of the art but also future 
trends in the field of method validation. This chapter serves as an 
introduction to the in-depth study of the validation of qualitative 
methods of analysis in the following Chapter. 
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Structure of the thesis 
 Chapter 3 discusses the validation of qualitative methods of 
analysis. Several prestigious regulatory bodies have prepared 
validation proposals for these methods, which are summarized 
together with several classifications of qualitative methods of analysis 
and an in depth study of performance parameters. In addition to this 
summary, another paper adds some more general information about 
qualitative methods that use instrumental detection. 
 Chapter 4 describes the main experimental applications carried 
out during this thesis. First, a commercial test kit used in food 
analysis and based on colour development is validated. Secondly, a 
commercial test kit used in clinical analysis is validated. In this case 
the final binary result is obtained by measuring an instrumental 
response. And finally, the validation procedure is performed on a 
homemade autoanalyzer used in the environmental field. This method 
of analysis uses instrumental detection but also gives a final YES/NO 
result. 
 Chapter 5 focuses on robustness. In the framework of method 
validation, both quantitative and qualitative robustness is an important 
performance parameter. Therefore, a brief summary of the state of 
the art of this feature and an application are presented. 
 Chapter 6 presents the general conclusions of the work. Various 
suggestions for future research, in relation to the applications 
presented in this thesis, are also made. 
 The Appendix contains the list of papers and meeting 










[1]  F. Burriel, F. Lucena, S. Arribas and J. Hernández, Química  
 Analítica Cualitativa, Paraninfo, 13rd ed., Madrid, Spain, 1989. 
[2]  Aspectos cualitativos de a Química Analítica, in M. Valcárcel; 
 Principios de Química Analítica, Springer-Verlag, Ibérica, 
 Barcelona, Spain 1999. 
  l
[3]  C. Heiss, M. G. Weller and R. Niessner, Anal. Chim Acta 396, 
 1999, 309. 
[4]  R. W. Gerlach, R. J. White, N. F. D. O'Leary and J. Van Emon, 
 Water Res. 31, 1997, 941. 
[5]  H. F. De Brabander, P. Batjoens, K. De Wasch, D. Courtheyn, G. 









 For several years now, method validation studies, guidelines and 
procedures have focused mainly on quantitative methods of analysis. 
As a result, a large bibliography has grown up which defines 
performance parameters, discusses procedures and describes 
theoretical studies. If the validation of qualitative methods is to be 
analysed appropriately, the concept and main topics must be 
reviewed. The present chapter, then, discusses what method 
validation is and how it can be used. The different aspects of the 
validation process, the types of validation and the usefulness of the 
information gathered are also presented. It should be borne in mind 
that only quantitative methods are dealt with. In the following Chapter, 
we will move on to qualitative methods of analysis. 
 
 
2.2 METHOD VALIDATION 
 
 During method development, analysts establish the most suitable 
steps of the analytical process that will lead to the information 
required: sample pre-treatment, when necessary, separation 
technique and the detection system, among others. The best analytical 
conditions for obtaining good results are also considered. The 
information gathered after the analysis may have several goals: to 
take decisions involving the control of the manufacturing process of a 
product, to assess whether a product complies with regulatory limits, 
to take decisions about legal affairs, international trade, health 





information must be of sufficient quality, which means that it must be 
reliable and match the purposes of the analysis. To meet these 
premises, analysts must define the purposes of the analysis and the 
requirements that the method should fulfil. Therefore, the validation of 
the method of analysis will provide, according to the ISO definition [1] 
the “ confirmation by examination and provision of evidences that the 
particular requirements for a specified intended use are fulfilled” . 
Another definition given in the Handbook for the Quality Assurance of 
Metrological Measurements [2] states that “ method validation 
consists of documenting the quality of an analytical procedure, by 
establishing adequate requirements for performance criteria, such as 
accuracy, precision, detection limit, etc. and by measuring the values 
of these criteria” . In general terms, then, the requirements and 
performance parameters must first be defined for every analytical 
method and purpose of analysis; and second, the value for these 
parameters must be estimated and checked to see if they really meet 
the criteria. This is an essential condition if the results provided are 
to be used. 
 The process of assessing the performance criteria is closely 
related to the concept of ‘ fitness-for-purpose’ , which is defined by 
IUPAC in the Orange Book [3] as the “ degree to which data 
produced by a measurement process enables a user to make 
technically and administratively correct decisions for a stated 
purpose” . Hence, it is important, first, to consider the necessary 
conditions related to the problem at hand, second to choose the 
method of analysis that best fits the necessities, and, finally, to 
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 Figure 1. Fitness for purpose concept. Adapted from the EURACHEM The 
Fitness for Purpose of Analytical Methods [4].  
l
 
 The EURACHEM Guide The Fitness for Purpose of Ana ytical 
Methods [4] also describes how important it is for the analytical 
performance and the analytical problem to be suited. It also describes 
the importance of method validation, and indicates when, how and who 
should perform the validation, among other equally relevant 
statements. Fitness for purpose also involves practicability and 
suitability criteria [5], which entail evaluating operational and time 
constraints, as well as such other parameters as reusability or 
possibilities of automation. 
 
 Although the users of the method of analysis will focus the 





features that all validation procedures must have. The validation 
process must satisfy three requirements [4]: 
1) The whole method must be validated. It is quite usual to focus on 
the detection technique or the instrumental measurement, which often 
means that just this stage is validated. However, the previous steps of 
sample pre-treatment, extraction or pre-concentration also belong to 
the method of analysis and are of utmost importance. So they must all 
be validated. 
2) The whole range of concentrations must be validated. It is difficult 
to comply with this condition because a method may work very well in 
one particular concentration range but not in others. 
3) The whole range of matrices must be validated. It is well known 
that the matrix can have a decisive effect on the analysis. Therefore, 
and for the sake of representativeness, several matrices must be 
submitted to method validation. 
 
 In addition to the conditions mentioned above, it should also be 
pointed out that the method developed, before it is validated, should 
include the various types of equipment and the locations where it will 
be run. That is to say, if the analysis is always to be performed with 
the same equipment and in the same laboratory, then other equipment 
and other laboratories need not be taken into account. Before the 
equipment is used, its performance must be checked with generic 
standards. 
 
 The analytical requirements that the analyst has defined are 
translated to the performance criteria of the method of analysis. So 




values of the quality parameters. In general terms, performance 
criteria can be divided into two main categories [6] although some 
authors may suggest other classifications. The basic parameters 
usually refer to the reliability of the method and are commonly 
derived with statistical procedures. Some examples are trueness, 
precision, selectivity, sensitivity, limit of detection and quantification. 
Criteria such as cost, ease of use, rapidity, etc. are considered to be 
complements of these. 
 
 In the Handbook of Chemometrics and Qualimetrics [7], Massart 
et al. state that there are two types of performance criteria: primary 
and secondary. Precision, bias, accuracy, trueness and the detection 
limit belong to the first group while the other parameters that can 
influence these primary criteria belong to the second (eg. linearity, 
the range of linearity, the quantification limit, selectivity, and 
sensitivity or ruggedness, etc.) 
 
 
2.2.1 Types of method validation 
 
 Because methods of analysis are designed for different uses, not 
all validation procedures are equal. Some examples of factors that can 
influence the definition of these procedures and which must be 
carefully considered are the quality of the final results, the 
consequences in terms of economy and time, whether the method has 
been developed recently or whether it is an adaptation of a previously 
adapted one. Depending on these factors, different method validation 





 A validation procedure cannot be performed if the validation level 
required is not taken into account. The validation level is the degree 
of effort invested in the validation process, so a high validation level 
requires greater effort. On the other hand, if the validation level is 
low, the effort investment will also be low. In both cases, the quality 
of the results obtained by the validated method of analysis will be 
rather different. Figure 2 shows the different levels of method 
validation. 
 So establishing the most suitable validation level is fundamental 
because the definition of the process depends on it and the results 
after the validation will also be of a different quality. To correctly 
choose the most appropriate validation level, operational, economic 
and material resources or the requirements the method must fulfil 
must be considered. The analyst can then choose to perform either an 
internal method validation or an interlaboratory validation [8, 9]. A 
recently accepted alternative is for a third laboratory to make an 






























 Figure 2. The types of method validation that involve different 
 validation levels 
 
 nternal method validation is the lowest validation level [10]. The 
laboratory that incorporates a new method of analysis that has been 
developed internally or externally tests the quality of both the method 
and the results. Internal method validation is mainly carried out in 
three cases: to assess new methods developed in-house, to assess 
methods transferred from other laboratories and, for instance, to 
estimate long-term precision. Routine internal quality control is also 
considered as internal method validation. 
I
 Each of the above mentioned situations requires a particular 
validation scheme because the requirements of every individual case 
are different. As a general philosophy, fitness-for-purpose is also 
applicable here. The main types of internal method validation are 
briefly described below. 
 A full validation process is undertaken when the laboratory 





before carrying out the full validation process, the most appropriate 
performance parameters must be considered. If there is no 
information about the method’ s performance characteristics, it is 
recommended first to check if it is suitable for the intended purpose 
with several samples: for example if the method is selective enough, if 
the sensitivity is tolerable or if the matrix will not interfere 
excessively. If the results are favourable, then the subsequent quality 
parameters are determined. If not, the method itself, the equipment, 
the analysis technique or the acceptance limits should be changed. 
Method development and validation, then, is an iterative process. This 
is so-called prospective validation.  
 Transferring analytical methods from one laboratory to another is 
quite a common situation. Because the transferred method must be 
fully validated in the source laboratory, the receiving laboratory does 
not need to undergo another complete validation process. However, it 
must assess whether the methods of analysis perform correctly under 
the corresponding conditions. This is called suitability checks. 
 Retrospective validation is performed on validated methods that 
are already being used. It may be necessary to examine accumulated 
results to assess whether the method keeps on performing 
appropriately. Likewise, long-term precision can also be assessed by 
collecting data over a long period of time. 
 Once the method is in normal use, a quality control program 
should be run. Control charts [11] are a very useful tool for this 
purpose. 
 
 On the other hand, interlaboratory trials provide the highest 




sample, usually the concentration of one or more analytes. Depending 
on the aim, any one of three main trial types can be used. Method 
performance or collaborative studies are performed on analytical 
methods that will be extensively used and which must provide high 
quality results. In these cases, several laboratories participate in 
validating the analytical method. The participating laboratories have 
been inspected, they are known to perform well and it is assumed that 
their results are highly reliable. They follow the same analytical 
procedure, which is described in detail, and they analyse the same 
samples to establish the performance criteria. After all the results 
have been reviewed, the final values of the quality parameters defined 
are calculated. 
 To perform a collaboratory trial, either the ISO guideline 5725-2 
[8] or the IUPAC technical report [12] are good starting points 
because they define all necessary terms, they specify the optimum 
number of participating laboratories and samples analysed, and they 
describe how the study must be performed and how the data must be 
treated if the method is to be validated. 
 A laboratory proficiency study tests the performance of the 
laboratory itself. Though it is not always possible, it is advisable to 
analyse a material, whose true concentration is known, by using the 
method of analysis that each laboratory considers most suitable for 
the problem at hand. When the results are compared, appropriate 
conclusions about the individual performance of each laboratory can 
be inferred. The ISO/IEC Guide 43-1: 1997 [13] reports a procedure 
for performing proficiency tests. 
 The last objective when performing an interlaboratory trial is to 





proven to be good and reliable, so they analyse a material containing 
one or more analytes using several methods of analysis to determine 
the most probable concentration value/s with the minimum 
uncertainty. Although these studies are not the most commonly used 
ones, there is an ISO guideline that describes the suitable protocol 
[14]. 
 
 Interlaboratory trials are not easy whatever their purpose is. 
Collaborative studies need to find enough laboratories that have been 
proven to perform well. Economical investment is also important so 
that samples and materials can be shipped. And the samples 
themselves can be problematical: despite having the ideal composition 
they are often not stable. And finally, the trials are time-consuming 
for the organizing laboratory. 
 
 Because of these drawbacks in interlaboratory trials, the 
alternative of a third laboratory to test method performance is an 
interesting one. To be more precise, the laboratory which verifies the 
quality parameters of the method under examination belongs to an 
institution or has the competence to assess the quality of other 
laboratories. 
 This option consists of providing the examining laboratory with 
the quality parameters claimed by the method developer. Then, the 
examining laboratory must verify if the values provided are correct or 
if, on the contrary, they must be estimated again. The best example of 
this in operation is the Peer Verified Methods [15] program of the 




(ISTA) [16] also provides a program called Performance Validated 
Method, which has similar characteristics. 
 
 Reporting method validation correctly is also an important issue. 
After the validation procedure, all the actions taken must be clearly 
and orderly documented. In the same way, the values of the 
performance criteria must be documented so that any change or 
variation due to different laboratory conditions can be easily avoided. 
As is usual in these cases, the ISO has a guideline [17] that describes 
how standards should be laid out. Written documents also need to be 
revised: all copies must be up-to-date and any uncontrolled copy 
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 Method validation, as it has been presented in the previous 
chapter, is a step that must be carried out whenever a new method of 
analysis is going to be used in a laboratory or in field analysis. This 
means that before a quantitative, qualitative or semi-quantitative 
method of analysis is to be used, its performance values must be 
estimated and checked. So, there is a higher level of assurance in the 
quality of the results. 
 However, almost all the guidelines discussed in the previous 
chapter are for the validation of quantitative methods of analysis. This 
means that the end user of a quantitative method of analysis has the 
essential tools to perform a proper validation procedure. 
 
 Qualitative methods of analysis have been applied for a long time. 
However, recently they have been arousing increasingly greater 
interest, like quantitative methods. Unfortunately, they have not been 
widely studied yet. Therefore, the end user of a qualitative method of 
analysis does not have the suitable guidance to submit a method to 
complete validation. Recently, some concepts have been clarified and 
some terms defined. This is no more than a starting point but it can be 
a helpful tool to plan a validation procedure. 
 
 Basically, the concepts concerning the reliability of the results 
have been quite well established in recent decades. Reliability 
involves studying other quality parameters such as sensitivity, 
specificity and false results rates. The first article in this chapter 





parameters. They deal mainly with clinical, pharmaceutical and 
microbiological analysis since qualitative methods of analysis (either 
in test kit format or in classical reactions) were largely developed for 
these disciplines. However, these parameters were not estimated as 
part of what nowadays is considered to be a validation procedure: 
they were estimated individually and often not all of them were 
evaluated. 
 
 Considering the growing interest in qualitative methods of 
analysis, the concepts behind the above mentioned parameters have 
recently been summarized in a document published in the Official 
Journal of the European Communities [1]. This document deals with 
the performance of confirmatory analytical and screening methods and 
the interpretation of results. 
 
 Although considerable headway has been made in qualitative 
method validation, there is still some work to do as far as the 
important performance parameters are concerned. In this respect it is 
important that they also be estimated as part of the same validation 
procedure. 
 
 The aim of the present chapter is to review the state of the art in 
the validation of qualitative methods. Several concepts regarding the 
validation of qualitative analysis are presented in two papers: 
 
 1)  Validation of qualitative ana ytical methods published in Trends 
in Analytical Chemistry. This contribution is a general review of 





methods. Then it presents the organizations that deal with qualitative 
method validation and their proposals. Finally, it briefly describes the 
most common quality parameters for qualitative methods and the 
possible alternatives by which they can be estimated. 
 
 2)  Validation of qualitative methods of analysis that use control 
samples published in Trends in Analytical Chemistry. This paper is an 
extension of the first one and describes a particular case of qualitative 
methods. It focuses on the validation of test kits that use control 
samples and, basically, presents the implications of using control 
samples, from two points of view: the experimental one and the 
estimation of the quality parameters. To conclude, it provides a brief 
example of the validation procedure for a test kit that gives 







3.2 VALIDATION OF QUALITATIVE ANALYTICAL METHODS 
 
Trends in Anal. Chem., 23, 2004, 137 
 
E. Trullols, I. Ruisánchez and F. Xavier Rius.  
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This article reviews the state of the art in validating qualitative 
analytical methods. After introducing the scope of these qualitative 
methods, their main characteristics and how they differ from 
quantitative analytical methods, we propose a classification according 
to the detection system. The institutions, programmes and documents 
dealing with the validation of qualitative methods are discussed and 
the performance parameters  false positive and negative, sensitivity 
and specificity rate, cut-off, unreliability region, ruggedness and 
cross-reactivity are presented. The various strategies used to 
validate qualitative analytical methods contingency tables, Bayes’  
theorem, statistical hypothesis tests and performance characteristic 
curves  are also briefly described. 
 





Trends in Anal. Chem. 23, 2004, 137 
1. Introduction 
 
One of the trends in modern analytical chemistry is the development 
of new analytical techniques and methods that can reliably identify 
and quantify the components in complicated samples such as those 
related to environmental problems or food protection. Hyphenated 
techniques such as the combination of chromatography with mass 
spectrometry or various spectroscopic techniques are just some of the 
examples of these developments. These powerful tools have involved 
a considerable investment in expensive instruments and require 
analysts to be properly trained. 
 
 However, from a practical point of view, many users find it 
increasingly important to reconsider whether quantitative results are 
really necessary. In routine laboratories, for example, it is quite usual 
for the first stage to determine whether one or more analytes are 
present/absent in a sample and, if so, for the second step to estimate 
their concentration level. For example, to assess if a sample of 
drinking water is free from pollutants. Therefore, instead of trying to 
quantify the pollutants in the sample as the first goal, it could be 
enough just to assure if they are present above or below the permitted 
concentration level. Qualitative methods are used in these cases. They 
are commonly used as screening techniques before quantification with 
the routine method, which enables both the time and cost of analysis 
to be reduced. 
 
 The quality of the results provided by these qualitative methods is 





make sure that the results obtained in their laboratory are fit for their 
purpose. This means that the analytical requirements must be defined 
and the values of the performance parameters assessed before they 
are used as routine methods in the laboratory. In other words, 
qualitative methods must also be validated [1]. Usually, validation of 
analytical methods has been developed and applied to quantitative 
methods. As a consequence, nowadays there are many validation 
guidelines that are either accepted by regulatory bodies or by 
communities of practitioners in specific fields. There is, however, no 
general validation guideline available for qualitative analytical 
methods. 
 
 This review discusses the state of the art of validation in 
qualitative methods. We try to fill a gap by clarifying the concepts 
related to qualitative analytical methods. First we review the various 
programs provided by the organisms that deal with qualitative method 
validation, and then we define and discuss some terms. Then we go on 
to explain some performance parameters and how they are calculated, 




2. Qualitative Methods of Analysis 
 
The idea of qualitative method is by no means new. In fact, it has been 
defined by the European Community as “ the assessment of the 
presence or absence of one or more analytes in a sample due to its 
physical and chemical properties”  [2]. 
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 Association of Official Analytical Chemists (AOAC) defines 
qualitative methods as a “ method of analysis whose response is 
either the presence or absence of the analyte, detected either directly 
or indirectly in a certain amount of a sample”  [3]. 
 
 It can be concluded from the definitions that a qualitative 
analytical method is used to find out if a sample contains one or more 
specific analytes. In these cases, the result of the analysis can only be 
of the binary type: presence/absence or YES/NO. 
 
 As can be easily inferred, presence/absence is not considered to 
be an absolute measure related to a concentration level of zero but to 
a specific concentration level. Below this limiting level, the 
concentration of analyte is considered not significant. The detection of 
the analyte may require either an instrument or the human senses, but 
whatever the way the response is recorded, it is converted into a 
YES/NO result. 
 
 It is well known that quantitative methods make it possible to 
quantify one or more analytes in a sample by using calibration curves 
that transform the instrumental response into the measurand, often 
expressed as the concentration of analyte. Between qualitative and 
quantitative methods, there is still room for semi-quantitative methods 
of analysis. These methods provide an approximate response that 
enables the analyte to be roughly quantified, and they usually assign 
the test sample to a given class (e.g. the concentration could be high, 
medium, low or very low). This means that the estimate of the true 





useful because quantification does not always have to be accurate. A 
representative example would be the test stripes for pH 
measurements. These methods usually cost less than quantitative 
methodologies, they are easier to handle, and have other practical 
performance parameters. 
 One of the main drawbacks when dealing with qualitative methods 
is the terminology used because there is no internationally accepted 
vocabulary so several names are commonly used in the bibliography. 
Although terms such as screening systems, test kits, field tests or 
immunoassays are traditionally used when referring to qualitative 
methods, they could also be used when dealing with quantitative and 
semi-quantitative methods. Consequently, here we shall try to put into 
context the terms that are usually found in the literature. 
 
 To start with, it is interesting to consider the term “ screening”  
in this regard. In an analytical problem, a screening analysis separates 
or discriminates samples from a large group that contain, e. g., one or 
more analytes above or below a pre-set value (Fig. 1). This value is 
often expressed as a concentration level, and can be set by an official 
agency, internal quality control or a client, among other possibilities. 
This pre-set concentration is also called specification limit, threshold 

















 Figure 1. Scheme for a screening system of samples.  Samples 
 containing more than 2 ng/g of analyte.  Samples containing less than 2 
 ng/g of analyte. 
 
 Nowadays, it is quite usual for the term “ screening method”  to 
be used as a synonym for “ qualitative method”  [4]. However, often 
the term “ screening”  is also used to describe a step that comes 
before the calibration stage in a quantitative method. Therefore, 
screening is not always related to qualitative but also to quantitative 
analysis [5]. 
 
 Another similar term is “ screening test”  that gives a reliable 
indication that the analytes of interest are present/absent in the 
sample at a level that is hazardous or not permitted [6]. Usually, 
screening tests are commercially available in a package containing all 
the reagents and sometimes the instrumentation for the analysis, and 
they are also known as “ test kits”  [7]. These kits are used for 
“ rapid and direct analyses”  because they are easy to handle, cheap 
to purchase and to run, and quick. They also provide results on site. 
 
 Another widely used, synonymous term in some fields is 





molecule as a binding agent to detect and quantify substances in a 
sample. Immunoassays have been shown to detect and to quantify 
many compounds of environmental interest such as pesticides, 
industrial chemicals or drug residues, so some specific forms of 
immunoassay [9] can be considered as quantitative methods. Some of 
the most important advantages of immunoassays are their rapidity, 
sensitivity, specificity and cost-effectiveness; they can be designed 
as rapid field-portable, qualitative methods or as standard quantitative 
laboratory procedures; and, they can also be used as screening 
methods to identify samples that need to be analyzed further by 
classical analytical methods. 
 
2.1 Classification of qualitative methods. 
As often happens in many disciplines, there is no generally accepted 
classification of qualitative methods, although several schemes with a 
diversity of criteria have been proposed by various authors. 
 
 Valcárcel [4] et al. suggest quite a broad classification based on a 
variety of criteria: the physical state of the sample (i. e., whether it is 
solid or liquid); the detection system (either sensorial or 
instrumental); etc. The authors discuss the integration of the 
chromatographic techniques and the qualitative methods, so the 
resulting analytical systems can be classified as sensors, as systems 
that use separate laboratory steps or as methods that integrate the 
body of operations. 
 
 More intuitive sorting exists, e. g., Unger-Heumann [7] considers 
test kits as adaptations of well-known analytical methods, so the 
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classification takes into account if test kits are based on chemical, 
physical-chemical, biochemical or biological methods.  
 
 Throughout this article, we have classified qualitative methods of 
analysis according to the type of detection system so as to 
differentiate between sensorial and instrumental detection. 
 
2.2 Qualitative methods based on sensorial detect on  i .
The main feature of these qualitative methods is that human senses 
are used to record and interpret the response. As might be expected, 
vision is the sense that is most used (e. g., the response can be a 
signal, such as a coloured solution, a spot on a test strip or the 
appearance of turbidity). In order to obtain this response, these 
methods are based on the reaction between the analyte of interest in 
the sample and specific reagents involved in the procedure. The 
magnitude of this response can be either directly or indirectly related 
to the concentration of the analyte. The reaction follows different 
principles, mainly chemical and immunological. The most commonly 
used chemical reactions are complexation and precipitation. However, 
in immunological methods, in particular those of the ELISA (enzyme-
linked immunosorbent assay) type, the appearance of the coloured 
spot requires the addition of an enzyme that recognizes the analyte-
antibody binding. 
 
 In addition to visual inspection, colour development can be 
measured and colour intensity related to analyte concentration. One 





with a predefined correspondence between colour intensity, either in 
solution [10] or test strip [11], and concentration. 
 
2.3 Qualitative methods based on instrumental detection. 
These methods provide an instrumental response, which, in many 
cases, measures absorbance, although in principle any instrument can 
be used. There are considerable differences between the way 
instruments are used in qualitative and quantitative analysis. The final 
decision is made by comparing the response of a test sample and the 
response of a sample containing the target analyte at the specification 
level. We call this the reference sample. Instead of working in the 
concentration domain, these methods work in the response domain. 
They can also be used to quantify the analyte in the sample if 
necessary. 
 
 Their basis is that an instrumental response is used to decide 
whether the analyte is above or below a specific concentration level. 
No calibration curve is prepared, however; the test-sample response 
is simply compared to the response provided by the reference sample, 
so this reference sample, which should ideally be a reference 
material, is measured and its response (rSL) recorded. Subsequently, 
the recorded test sample response (ri) is compared to rSL. If ri is 
larger than rSL, it can be concluded that the test sample contains the 
analyte at a concentration level higher than the reference sample. 
However, if ri is lower than rSL, then the conclusion is that the test 
sample contains less analyte than the reference. Thus the 




Trends in Anal. Chem. 23, 2004, 137 
 Using this procedure, Waters et al. [12] compared the test-
sample response with the reference-sample response but did not 
consider either probabilities of type α  or type β  errors. These 
probabilities of error are used by Pulido et al. [13] to calculate the 
so-called cut-off value, a limiting value in the response domain, at 
which the decision about whether the analyte is above or below the 
specific concentration level must be taken. 
 
 As in the previous case (sensorial detection), chemical and 
immunological based reactions are commonly used. ELISA-based 
methods can be considered to be special cases because a specific 
detection tool is sometimes required (e. g., when a 96-microtiter-
plate format is used). This tool enables the calibration standards and 
some samples to be measured simultaneously. Although the calibration 
curve can be computed, it need not be used if the only thing required 
is a comparison between the response of the reference sample and 
the test sample. 
 
 
3. Method Validation in Qualitative Analysis 
 
As is well known, before any analytical method is applied to test 
samples on a routine basis, it should be validated, so its performance 
characteristics should be defined and properly assessed. The ISO/IEC 
17025 standard [14] describes the importance of method validation 






 There is general agreement about the concept of method 
validation. The ISO defines method validation as a “ confirmation with 
an examination and provision of objective evidences that particular 
requirements for a specified use are met”  [1], so the first thing to be 
done is to define these particular requirements that depend on the 
specific determination ahead and are, therefore, particular to each 
case. This is very much related to the concept of “ fitness-for-
purpose”  [15] and can also be applied to qualitative analytical 
methods. 
 
 The validation of these methods must follow the same philosophy 
as that of quantitative methods, although there are some differences 
in the methodology, as described below. In recent years, some 
organizations have published guidelines or documents about the 
validation of qualitative analytical methods. The aim of the next 
section is to give an overall view of the institutions involved in this 
subject. 
 
3.1 Organisms that deal with qualitative method validation 
All organizations that deal with qualitative method validation focus on 
the concept of fitness for purpose, and therefore on evaluating the 
relevant performance parameters. Among the different possibilities, 
the general recommendation is that participation in collaborative 
studies is the preferred way of validating methods. The strongest 
exponent of this idea is AOAC International [16]. Like the “ Peer-
Verified Methods Program”  for quantitative in-house methods [17, 
18], AOAC International has the “ Performance Tested Methods 
Program”  [19] specifically addressing test kits. This validation 
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program makes it possible for the quality parameters claimed by the 
manufacturer or end user to be assessed by a third laboratory. 
Similarly, the “ International Seed Testing Association”  (ISTA) [20] 
has a program called “ Performance Validated Method”  in which a 
third laboratory proves the quality parameters of the test kits based 
on immunological reactions. 
 
 The US Environmental Protection Agency (EPA) [21] also has a 
specific document called “ Guidance for Methods Development and 
Methods Validation for the RCRA Program”  [22]. This ensures that 
established, validated immunoassays are available for measuring and 
monitoring needed for the RCRA (Resource Conservation and 
Recovery Act) Program and it is addressed to developers of 
qualitative and quantitative methods in general. 
 
 In “ The Fitness for Purpose of Analytical Methods”  document 
[15], EURACHEM specifies that the qualitative performance 
parameters that should be evaluated are: confirmation of identity; 
sensitivity; selectivity/specificity; and precision. Precision may be 
expressed as true and false positive (and negative) rates and it has to 
be taken into account that these rates are related to sensitivity and 
specificity. To avoid problems of nomenclature, the same guide 
clarifies the meaning of these two parameters in chemical usage. 
AOAC International also proposes and defines what it calls the four 
performance indicators: sensitivity, specificity, false negative and 






 Similarly, in its official bulletin [2], the European Union (EU) 
defines and proposes the evaluation of the following qualitative 
parameters: limit of detection (CCβ ); selectivity/specificity; stability; 
applicability; and robustness. The EU also states that screening 
methods can be used as long as they are properly validated and the 
percentage of false complaints (probability of β  error) is lower than 
5% at the concentration level of interest.  
 Finally, the European Cooperation for Accreditation of 
Laboratories (EAL) has a guide entitled “ Validation of test methods”  
[23], which emphasizes that the uncertainty associated with the 
method is the most important quality parameter. This guide also 
makes specific reference to qualitative methods that deal with 
sensorial responses, in the sense that not all known validation 
procedures are applicable. It has to be clarified that, in this guide, 
“ test methods”  refers to any analytical method (quantitative and 
qualitative). 
 
 According to the above, the definition of method validation is 
applicable to both quantitative and qualitative methods of analysis, 
although there are differences in the validation process. The different 
meanings of the performance parameters used in qualitative and 
quantitative methods and the disparity in their definitions require 
changes in the ways that they are calculated. 
 
3.2 Use of references 
References are essential in method validation, as trueness has to be 
assessed, so, if we try to use references from quantitative analysis in 
a qualitative method, we can follow an established hierarchical order. 
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The hierarchy ranges from primary methods to recovery studies, and 
it includes certified reference materials (CRM), participation in 
collaborative studies and the use of confirmatory methods. 
 
 Unfortunately, there are considerably fewer possibilities for 
qualitative analytical methods. For these cases, there is still no 
primary method. Moreover, CRMs are rather complicated to use. It 
should be emphasized that any qualitative method claimed to work at 
the specification level will provide positive and negative results about 
the test samples. But, as a result of experimental or random error, 
false rates (either positive or negative) are obtained close to this 
concentration level, so the CRM should contain the analyte at a 
concentration level that is near to the specification limit. If the 
concentration level is either far below or far above the specification 
limit, we will be able to check only if the method correctly classifies 
the samples as negative or positive. For CRM concentrations close to 
this concentration level, we have to compute the probabilities of false 
positive and negative responses, so the comparison with a CRM has to 
be in terms of probabilities, and cannot be in terms of concentration. 
 
 As a result, whenever possible, comparison with a reference 
method is the best option. The analysis must be made using both the 
reference method (usually quantitative) and the qualitative method 
[24, 25]. To assess whether the qualitative method is performing 
well, the proportions of positive results obtained by both methods 
have to be compared by means of a suitable hypothesis test such as 






 Participation in collaborative studies is also recommended. 
However, as with CRMs, basic statistics, such as mean and standard 
deviation, cannot be computed. Each laboratory will report its own 
results (positive and negative test samples). The positive or negative 
rates can be computed both individually, for each participating 
laboratory, and globally, for the study as a whole [26, 27]. Again the 
probabilities obtained by each laboratory can be compared by means 
of the Chi-square test. If any one of these possibilities is 
impracticable, spiked samples can be used as a first approximation for 
the validation process. 
 
3.3 Qualitative performance parameters 
The definition of the performance parameters is an important aspect 
to consider when dealing with qualitative analysis. Table 1 shows 
some of the most common parameters according to whether the type 
of analytical method chosen is quantitative or qualitative. 
 
 Table 1. Quality parameters for both quantitative and qualitative 
 analytical methods 
Quantitative method Qualitative method 
Accuracy: trueness, precision Sensitivity and specificity 
Uncertainty Unreliability region 
Sensitivity and specificity False positive and negative rates 
Selectivity: interferences Selectivity: interferences 
Range and linearity Cut-off limit 
Detection limit Detection limit 
Ruggedness or robustness Ruggedness or robustness 
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 Although some performance parameters have the same name, the 
concepts attached to them and their evaluation can be different, e. g., 
sensitivity can be differently considered depending on the analytical 
method. If a quantitative method is used, sensitivity should be a 
numerical value that indicates how the response changes whenever 
there is a variation in the concentration of the analyte. However, this 
parameter will be evaluated in a different way if a qualitative method 
is used. The same occurs with the specificity, detection limit, cut-off 
value and uncertainty or unreliability region. 
 
 The following parameters have to be considered when dealing 
with qualitative responses. 
 
3.3.1. False positive and negative rates. The false positive rate is 
“ the probability that a test sample is a known negative, given that the 




=        (1) 
where fp are false positive test samples and tn are known true 
negative test samples. 
 
 Similarly, the false negative rate is “ the probability that a test 
sample is a known positive, given that the test sample has been 










where fn are false negatives samples and tp known true positive test 
samples. 
 
3.3.2. Sensitivity and specificity. Generally speaking, when dealing 
with qualitative methods, sensitivity is “ the ability of a method to 
detect truly positive samples as positive”  [6], so the sensitivity rate 
“ is the probability, for a given concentration, that the method will 
classify the test sample as positive, given that the test sample is a 






==    (3) 
 
where tp are truly positive test samples and fn are false negative test 
samples. 
 
 The same occurs with specificity, which is defined as “ the ability 
of a method to detect truly negative samples as negative”  [6]. In the 
same way, the specificity rate “ is the probability, for a given 
concentration, that the method will classify the test sample as 
negative, given that the test sample is a ‘ known’  negative”  [28], 






==    (4) 
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3.3.3. Unreliability region. In quantitative analysis, the uncertainty is 
the numerical value related to the interval in which the measurand 
may be found with a given probability. However, for qualitative 
methods, having binary responses of the YES/NO type, there is no 
meaning for a number associated with the result and expressed as a 
semi-interval that is attached to it, so uncertainty is expressed not as 
a numerical value but as a region of probabilities of committing error. 
Moreover, following the nomenclature used until now, it corresponds 
to the region in which false responses are obtained (either false 
positive or negative). 
 
 As we are dealing with a region where there are certain 
probabilities of error, some authors prefer to call it an unreliability 
region rather than an uncertainty region [29]. This region is defined 
by an upper and a lower concentration limit [30], between which the 
qualitative method can provide false responses. As these false 
responses can be either positive or negative, the upper and lower 
limits that define this unreliability region depend on the probability of 
obtaining these false responses, which is fixed by the analyst. 
 
3.3.4. Detection limit and cut-off value. The term detection limit was 
defined by the IUPAC [31] in 1995 for quantitative analysis. 
According to this definition, it can be calculated when the response is 
a numerical value and when a value is assigned to the two 
probabilities of α -and β -type errors. When the response is of the 
binary-sensorial type, however, the standard deviation of the blank 
samples cannot be calculated, and the probabilities of α -and β -type 





set by the analyst. Depending on the interest of the analyst and the 
problem in hand, either the probability of committing an α  type error 
or that of committing a β -type error will be considered. 
 
 The detection limit has also been defined as “ the lowest 
concentration of the analyte which the test can reliably detect as 
positive in the given matrix”  [6]. This implies that we should 
consider only the probability of a β -type error or false negative rate, 
usually at 5%. This definition is presented in the context of assessing 
a maximum permitted concentration level, but, if it is extrapolated to 
the case of assessing a minimum concentration level, we should 
consider only the probability of an α -type error or false positive rate, 
also at 5%. Therefore, both probabilities of committing error cannot 
be considered simultaneously. In the first case, the limit of detection 
coincides with the upper limit of the unreliability region, where the 
sensitivity rate is 95% and it also coincides with the cut-off value. 
However, in the second case, the limit of detection coincides with the 
lower limit of the unreliability region. 
 
 The cut-off value is a special performance parameter, since it has 
been widely studied and used in qualitative analytical methods that 
use instrumental responses [13]. Regarding the qualitative methods 
with sensorial responses, this value means the concentration level 
where the qualitative method differentiates the samples with a certain 
probability of error, usually of 5%. In the particular case of problems 
related to the maximum permitted level, the cut-off value is related to 
the sensitivity, as it corresponds to the concentration level at which 
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the sensitivity rate is 95%, when the β -type error probability has 
been set at 5%. 
 
 Other parameters should also be considered. Ruggedness is an 
important parameter related to how the method performs under 
variations in the operational, environmental, etc. conditions. In 
quantitative methods, it must be evaluated [2, 15], but in qualitative 
methods it need not be. According to some authors [3], it is not a 
“ formal part of the validation protocol” , and “ it is not a submission 
requirement”  when submitting a method for evaluation. 
 
 Another parameter to be considered is cross-reactivity or the 
presence of interferences. For test kits, in particular, it is 
recommended to check whether the presence of analytes of the same 
family as the one under study might modify the result of the analysis. 
These checks are mandatory for manufacturers of the test kits. 
 
3 4 Evaluation of the qualitative performance parameters .   
There are various ways of evaluating the performance parameters in 
qualitative analysis. Recently, Pulido et al. [32] showed that 
Contingency Tables [33], Bayes’  Theorem [34], Statistical 
Hypothesis tests [13] and Performance Characteristic Curves [35] 
are the four main ones, each of which has advantages and drawbacks. 
However, depending on whether or not the type of response obtained 
is instrumental and on the number of analyses that the analyst wants 






3.4.1. Contingency tables. Contingency tables have been widely used 
in bioassays [36, 37]. They are based on the calculation of 
probability. Although other formats are possible, the simplest and 
most commonly used are those that give a two-category 
classification: positive or negative, above or below a regulatory 
concentration level, etc. Then, the qualitative method result is 
compared with the results obtained using the confirmatory method 
(see Fig. 2). From this table, it is possible to calculate only four 
performance parameters (false positive, false negative, sensitivity and 
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 Figure 2. Example of a 2x2 contingency table. ‘ tp’  are true positive 
 samples, ‘ fp’  are false positive samples, ‘ fn’  are false negative 
 samples and ‘ tn’  are true negative samples. 
 
 One of the main features of this approach is that it gives an overall 
vision of how the qualitative method performs, but it does not give 
individual information, as a probability of error for each sample is not 
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computed. This means that it is assumed that the unknown sample has 
the same statistical behaviour as the samples used to build the 
Contingency Table. One of the drawbacks is that the capacity of the 
Contingency Table depends on the total number of analyzed samples 
used to build it and the experimental design. It should also be pointed 
out that all samples must be analysed using both the qualitative and 
confirmatory methods. 
 
3.4.2. Bayes’  Theorem. This methodology is based on the well-
known Bayes’  Theory of Probability. Several intermediate 
probabilities must be computed and evaluated. Bayes’  Theorem 
calculates the probability of giving a correct result (either positive or 
negative) when it is indeed correct, P(a/p). This probability is called 
conditional probability, so many analyses are required in order to 
achieve a good uncertainty estimation or a better error probability. 
The main feature of this methodology is that, unlike Contingency 
Tables, the probability of giving a wrong result is estimated 
individually, because the conditional probability is calculated for each 
analysed sample. And, again, only the same four parameters can be 
calculated: false positive, false negative, sensitivity and specificity 
rates. 
 
3.4.3 Statistical Hypothesis Tests. These Hypothesis Tests compare 
the response of the sample with that of a pre-set reference [13] (Fig. 
3). As was said above, this reference sample contains the analyte at a 













offcutr − screeningr  
 Figure 3. Statistical hypothesis tests for qualitative analytical methods 
 providing instrumental response 
 
 The main advantages of these Hypothesis Tests derive from the 
use of the well-known probability of an α -type error (the probability 
of committing false positives) and the increasingly used probability of 
a β -type error (the probability of committing false negatives). This 
method makes it easy to evaluate uncertainty when using qualitative 
methods that provide an instrumental response. Traceability can also 
be verified and the detection limit computed. However, if the test kit 
does not provide an instrumental response, or if the response is based 
on a visual observation that cannot be quantified, Hypothesis Tests 
cannot be used. 
 
3 4 4. Performance characteristic curves. Performance Characteristic 
Curves are a plot of the probability of having a positive result versus 
the concentration level of the analyte. The result is a sigmoidal type 
of curve the slope and the amplitude of which are particular for each 











































 Figure 4. Performance Characteristic Curve. Probability of positive 
 responses, P(x), and probability of positive plus inconclusive responses, 
 P(x)+I(x), were plotted versus concentration levels tested. (1) FP=P(x); 
 (2) X0,05 where specificity=N(x)=100-(P(x)+I(x)), (3) X0,95, Cut-off limit, 
 detection limit; (4) FN=100-(P(x)+I(x)), (5) Sensitivity =P(x)=100-β  
 
 The main advantage is that considerable information is provided. 
In addition to false positive and negative rates, these Curves make it 
possible to calculate sensitivity and specificity rates and other 
performance characteristics of qualitative methods, such as the 
detection limit and the cut-off limit or the unreliability region. The 
main drawback is that it is necessary to perform several analyses for 












Demand for qualitative analytical methods is increasing and they are 
becoming more and more important. However, some aspects still need 
to be developed and clarified. For users, one of the most confusing is 
the nomenclature used to refer to qualitative analysis, since there are 
many different terms that often have different meanings. Similar 
confusion occurs with the classification of qualitative methods, where 
there are several possibilities, according to different authors. 
Although this may be of no practical importance for many users, some 
work should be done to structure the criteria for classification. 
 
 Validation of qualitative analytical methods is an important issue to 
consider so as to provide confidence to the analysts. Although several 
organizations are working on this task, very few of them have defined 
validation protocols and their own validation programs for method 
developers. It has to be said that there is still confusion regarding how 
this validation process should be generally performed. Performance 
parameters are quite well defined, but, even so, a way of evaluating 
them has yet to be established. In this article, we have briefly 
described some possibilities. As far as the use of references in 
qualitative analytical methods is concerned, the possibilities are 
considerably fewer compared with quantitative analytical methods. 
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Qualitative methods of analysis that use control samples 
3.3 QUALITATIVE METHODS OF ANALYSIS THAT USE 
CONTROL SAMPLES 
 
 Now that a general overview has been given of qualitative 
methods of analysis validation, it must be stressed that every 
qualitative method has special features that must be taken into 
account before the validation process is designed. One example is the 
case of qualitative methods that use control samples. 
 
 Some qualitative analytical methods provide the final result by 
recording the signal obtained from the sample measurement after the 
necessary pre-treatment steps. This final result is obtained by 
comparing the response or decision value, among other possibilities, 
of the analyte with an accepted reference. Depending on the response 
of this reference or the previously established decision value (using 
this reference or not), the sample can be classified (YES/NO) 
appropriately. 
 
 The reference mentioned above can be either external or internal. 
External references are usually well-characterized samples (e. g. 
Certified Reference Materials, working reference materials or spiked 
samples). In some situations a suitable Certified Reference Material 
cannot be obtained (e. g. the matrix is not stable enough or it is too 
complicated) or spiking a sample is not viable. In such cases, the 
analytical method often uses internal references. 
 Internal references are well-characterized samples, as well, but 
they are intrinsic to the qualitative method, which usually has a 





they are supplied with each specific unit of the test kit. So they must 
be used as long as the specific unit of the test kit is in use. 
 
 The analytical methods which provide internal references or 
control samples are mainly used in the field of clinical analysis, where 
the sample response is usually compared to a cut-off control or 
calibrator. 
 
 In the next section, a review of these methods of analysis is 
presented. The main groups, their characteristics and performance 
are described. A validation procedure is also briefly described. The 
example given is for a method of analysis used in the clinical context. 
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Qualitative methods are frequently used for screening. In some 
applications, the resulting positive samples are subsequently analyzed 
by a suitable quantitative confirmatory method, so it is important that 
the qualitative assay provides reliable results. Although some 
validation procedures have been reported in this area, much work is 
still required because there are many different qualitative methods 
with many different characteristics. In this report, we examine the 
different types of control samples used in qualitative analysis that 
provide instrumental responses, we review the most important quality 
parameter in the validation process, we propose a procedure for 
estimating the selected quality parameters-traceability, the 





and negative rates- and we show how their values can be calculated 
in a case study: an ELISA method used in a clinical context. 
 
Keywords: Binary results; Control samples; Performance quality 
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1. Introduction 
 
During the last decade, qualitative methods have been widely 
developed and, as a result, some of them are now used as routine 
laboratory methods. However, the range of applications is not as wide 
as in quantitative analysis. They are mainly used as screening 
methods, selecting the positive samples and considerably reducing the 
time and cost of the confirmatory analyses. 
 
 As is well known, a key point when dealing with either quantitative 
or qualitative analytical methods is their validation. Method validation 
was defined some time ago by ISO [1] and, from the practical point of 
view, it can be considered as the definition and the estimation of the 
performance parameters necessary to match the analytical 
requirements. The validation procedure should always take into 
account the intended use of the analytical method. The validation of 
qualitative methods is not as developed as the validation of 
quantitative methods, which have been the subject of numerous 
studies [2-4]. Some guidelines are therefore already available and 
accepted by either regulatory bodies or practitioners in specific fields. 
At present, the situation is changing, because recent studies have 
focused on the validation of qualitative methods. This means that 
some documents and guidelines are available, although they are still 
not generally accepted [2, 3, 5-7]. 
 
 There are numerous qualitative methods and their validation 
methodology depends on their specific nature. In this article, we focus 





absorbance, current intensity, and peak area) to classify the test 
sample into two different categories: positive/yes and negative/no. 
More specifically, we focus on those methods that use control 
samples. Controls are commonly used to establish a limit value known 
as a “ cut-off value”  (COV) (i. e., the limit at which the samples can 
be assigned to one of the two different categories). 
 
 As a case study, we discuss the validation of an immunoassay-
based test kit that measures immunoglobulin G class antibodies to 
Varicella-Zoster Virus in human serum (i. e., it is used in the clinical 
context). On the one hand, the kit uses controls to establish the COV 
and, on the other, it provides a final YES/NO result based on 
absorbance measurements as the instrumental response. The test 
samples are therefore classified according to the established COV. 
The test kit is an enzyme-linked immunosorbent assay (ELISA) [8], 
based on the antigen-antibody reaction. Some ELISA methods use 
control samples to calculate a reference value that is necessary for 
classifying the samples into different categories according to the 
property measured, whereas other test kits use different types of 
calibration samples [9]. 
 
 First, we briefly describe the different types of test kits that use 
control samples, either in the same way as the kit selected for the 
case study or not. Then, we propose and define the quality 
parameters for such test kits, and, finally we report the validation of 
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2. Qualitative methods that use control samples 
 
Numerous test kits use control samples, supplied by the manufacturer, 
as part of their methodology for classifying test samples. Within this 
format, there is a wide variety of possibilities. Some test kits just use 
positive and negative controls, which are usually used to establish the 
COV and to validate the analysis internally. Others provide the end 
user with a solution at the activity level of the COV. And yet others, in 
addition to the positive and the negative controls and to the cut-off 
control sample, also require intermediate levels of positive controls. 
 
 Because the key point of this paper is the validation of test kits 
that use controls, let us first define the various controls used: 
 
• Negative control is a blank sample (i. e., a sample that is 
known to be free of the target analyte). In the framework 
of clinical chemistry, it is a real serum sample from a 
patient (or a pool of patients) that it is proved not to have 
the antibodies against a specific antigen. 
• Positive control is a sample containing a perfectly known 
amount of the target analyte. In the framework of clinical 
chemistry, it is a pool of positive real serum samples (i. e., 
samples from patients that have been proved beyond all 
doubt to have the antibodies against a specific antigen). 
• Cut-off control or cut-off calibrator is a sample containing 
the amount of analyte corresponding to the cut-off level. 
For clinical chemistry, it is a sample of human serum that 





• Intermediate controls can be used depending on the 
application and the test kit (e. g., samples that are positive 
even though they do not contain a considerable amount of 
the target analyte and are considered as low positive 
controls). In some cases, they provide an inconclusive 
result. Some samples are high positive samples, which 
mean that they contain a considerable amount of the target 
analyte (antibodies). 
 
 In most cases, these controls are required for estimating the COV. 
Generally speaking, the COV is the value from which the decision 
about the test sample must be taken and it refers either to the 
response domain or to the concentration or activity domain. This 
value can be set by legislation when dealing with the maximum 
contents of some contaminants in food, as is the case of Aflatoxin B1 
in nuts, the maximum content of which is regulated by the European 
Commission [10] or when dealing with drinking water pollutants [11], 
which are strictly controlled by several regulation bodies [12]. 
 It is quite common, mainly in the context of clinical analysis, to 
estimate this COV using a mathematical expression provided by the 
manufacturer’ s test kits [13]. Alternatively, it is recorded as an 
instrumental response, when measuring a specific sample (‘ cut-off 
control or calibrator’ ), also provided with the test kit [14]. 
 
 Although attempting to classify the different test kits is always 
risky, for the sake of clarity we have decided to differentiate between 
them by the presence or absence of a cut-off control sample and 
specially those cases where the COV refers to the response domain. 
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2 1  Test kits without a cut-off control sample . .
. .
These test kits measure only the positive and the negative control 
samples to estimate the COV that is usually calculated by means of a 
mathematical expression that combines the response values from both 
control samples. Once the cut-off has been obtained, and, always in 
terms of instrumental response, it is compared to the value obtained 
for the test sample. 
 
 In some cases, the control samples are measured every day, so 
the COV is also obtained daily. Additional information about the day-
to-day variation in the COV is therefore also possible. These control 
values can also be used as internal validation for the assay; since they 
are different every day, they must comply with some requirements. 
Usually, it must be ensured that the positive and negative controls fall 
into a specific range of instrumental response values. 
 
2 2  Test kits with a cut-off control sample 
As well as the positive and negative control samples in their test kits, 
some manufacturers provide an extra sample named the “ cut-off 
control”  or “ cut-off calibrator” . In these cases, the measured 
responses from the test samples are directly compared with the 
measured response from the cut-off control. This can be done by 
directly comparing instrumental responses or sometimes by 
establishing a function between both responses and comparing this 
value with a preset range of values. In addition to the cut-off control 
calibrator, other manufacturers provide a low and a high positive 





can be controlled. This does not affect the way the COV is established 
and subsequently compared to the test sample value. 
 
 We would like to emphasize the importance of the COV, although it 
is not considered a quality parameter in the validation process. This 
importance is illustrated by the fact that the COV directly defines the 
regions where actual negative and positive responses are obtained. 
Moreover, the limits that define the region where inconclusive sample 
results are obtained depend on the error associated to this COV. 
Significant information about the performance of the test kit can 
therefore be inferred from the COV. 
 
 
3. Identification of the relevant Quality Parameters 
 
The quality parameters must be carefully identified and estimated 
according to the requirements that the analysis should fulfil [15]. 
These requirements normally involve a wide variety of items related 
to the information we want to obtain: verification of traceability, 
estimation of the uncertainty associated to the results, cost and time 
constraints, and practical parameters, such as reusability or 
possibilities of automation, to give just a few examples. The “ fitness-
for-purpose”  [16] approach is used to identify, estimate and finally 
validate the quality parameters depending on the requirements to be 
fulfilled. 
 
 Concerning the quality parameters that have a statistical 
character, as in any qualitative method, in addition to the traceability 
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and to the estimation of the uncertainty of the results, it is important 
to consider the probabilities of providing false positive and false 
negative results. It is also important to properly define the region that 
provides inconclusive results. This region is around the COV so, as 
we will see later on, most of the quality parameters are related to the 
lack of precision associated to the COV. The most important quality 
parameters are described below. 
 
3.1. Traceability 
According to a recent definition of traceability [17] and from the 
practical point of view, we assume that there is an unbroken chain of 
calibrations of a measuring system or comparisons. Among other 
possibilities, traceability can be assessed by comparing the results 
obtained from the method to be validated with those obtained by a 
reference method, or by using a certified reference material [18]. 
 The control samples provided by the manufacturer can be 
considered as secondary references, since there is a formal statement 
that they have been compared to an in-house serum preparation and 
that the whole test kit has been compared to another commercially 
available ELISA [19]. 
 
3 2  Sensitiv ty and specificity rates . . i
In the framework of qualitative analysis, sensitivity and specificity 
refer to the ability of the test kit to classify positive samples 
(sensitivity) or negative samples (specificity) when indeed they are 
positive or negative [20]. Both parameters therefore give an idea of 
how good the test kit classifies positive and negative samples. They 





importance to assess that the test kit has a high sensitivity and a high 
specificity in order to avoid any false result. 
 Closely related to the occurrence of interferences, to specificity 
and to false positive rate, selectivity [21] must be also taken into 
account. A test kit lacks selectivity if a set of substances, or the 
matrix as a whole, has an effect on the signal of the analyte measured. 
The manufacturer assesses the general absence of cross reactivity 
[19]. However, in the cases where the test kit is used as a routine 
method, the manufacturer also suggests ruling out some infections 
before interpreting the result of the Varicella-Zoster Virus (VZV) test, 
due to expected cross reactivity, since the VZV is related to other 
viruses of herpes viridae family. 
 
3.3. Unreliability region 
When dealing with binary responses (YES/NO), it is not meaningful to 
consider the classical definition of the uncertainty of the final results 
[22]. The term unreliability region better describes the idea of a 
region in which there is a certain probability of error, and therefore a 
region in which false results may be obtained [6, 23]. In the particular 
case of test kits that provide an instrumental response (numerical 
value), the unreliability region can be defined by the range of 
instrumental responses that provide inconclusive results. The 
unreliability region is a key point in the validation process because of 
the considerable amount of information that it provides. 
 
 If the measurement of control samples to establish the COV is 
needed, the definition of the unreliability region takes into account the 
precision associated with this COV. When a mathematical expression 
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is used to calculate the COV, its precision is easily determined by 
using the error-propagation law. The unreliability region is defined by 
an upper and a lower limit, which make it possible to estimate the 
sensitivity and the specificity, and the false positive and false negative 
rates (see Fig. 1). 
Unreliability region
Negative results Positive results
Cut-off value--COV
Inconclusive results
False negative rateFalse positive rate
 
 Figure 1. Definition of the unreliability region and the information that it 
 provides: region of positive, negative and inconclusive results, false 
 positive and negative rates in the response domain 
 
 Test-kit manufacturers usually provide an error associated with 
the COV (e. g., as a percentage in terms of relative standard 
deviation). This means that the samples with response values higher 
than the COV plus the specific percentage of this COV will be positive 
and the probability of error will theoretically be very small. However, 
the manufacturer does not provide this information. The same occurs 
with the samples that give rise to response values smaller than the 
COV minus the specific percentage of this COV: they will be negative 
with a very small probability of error. The samples that give rise to 





The information related to the error associated to the COV, which is 
provided by the manufacturer, should be validated by comparison with 
the experimental results. This means that the error of the cut-off 
should be experimentally evaluated, the unreliability region should be 
defined and they should then be compared with the values claimed by 
the manufacturer. 
 
3.4. False positive and false negative rates 
False positive and false negative are the probability that the test kit 
will classify the samples as positive when they are in fact negative 
(false positives), or as negative when they are positive (false 
negative) [3].  Closely related to sensitivity and specificity, these 
false rates also give an idea of how well the test kit classifies, 
although in the sense that it estimates the probability of giving results 
that are false. The false rates are closely related to the unreliability 
region because they are inferred from its lower (false positive) and 
upper limits (false negative). 
 
 In many cases it is a challenge to keep both rates (probabilities of 
error) to nearly zero. In such situations, one should evaluate the 
consequences of either providing false positive results or false 
negative results. Depending on that, the approach would be either 
setting the probability of committing: 
• α  type error (false positives) as small as possible, if the 
consequences of considering a not immunized patient 
(without the antibodies) as immunized are worse than 
considering an immunized patient as not immunized; or, 
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• β  type error (false negatives) as small as possible, if the 
consequences of considering an immunized patient as not 
immunized are worse than considering a not immunized 
patient as immunized. 
 Though it is not a rule, in a wide range of clinical analysis, false 
negative results are more critical since positive results are checked 
using other analytical methods, either test kits or not. In these cases, 
and particularly if the test kit is used as a routine method in the 
laboratory, deeper studies concerning the occurrence of false 
negative results using different matrixes and involving a wider range 
of possible cross-reactants should be carried out. 
 When the test kit also provides inconclusive results, the lower 
limit of the unreliability region is related to the false results, but in the 
sense that it gives the percentage of negative samples that will give 
an inconclusive result. The percentage of negative samples that give a 
positive result will be always much lower (or nearly zero) than those 
that give an inconclusive result. For the upper limit of the unreliability 
region, the situation is very similar. The upper limit is related to the 
probability of giving false results but in the sense that it provides the 
rate of positive samples that will give an inconclusive result. 
 
 Quality parameters other than those defined in this article can also 
characterize a test kit. Parameters such as robustness may be 
important when the same assay is to be used in different conditions 
(e. g., in different laboratories). The detection limit is also an 
important quality parameter because, in some qualitative assays, it is 
given by the lowest concentration of the analyte that the kit can 





to the unreliability region, prediction intervals for future samples can 
be estimated, as they are directly related to the error associated with 
the COV. 
 
 To improve the characterization of the test kit, statistical tools, 
such as control charts, can also provide valuable information (e. g., 
whether the instrumental responses of the control samples are within 
or beyond the accepted range of values). These control charts and the 
information they provide, discussed in another contribution in the 
present issue, together with the last mentioned quality parameters, 
will be studied in a future paper. 
 
 
4. Estimation of the Quality Parameters: a case study 
 
Once the main quality parameters required to validate a test kit have 
been defined, we show how they can be estimated in practice with the 
validation procedure of a particular test kit. We have used a test kit 
that measures IgG antibodies to Varicella-Zoster Virus in human 
serum, so the context is a clinical one. First, we will describe the test 
kit and the experimental work carried out to estimate the quality 
parameters. 
 
4.1. Test k t performance i
The test kit used, VZV IgG [13], is an indirect ELISA that detects the 
IgG antibodies to Varicella-Zoster Virus in human serum. The 
microtiter wells are coated with a Varicella-Zoster Virus antigen from 
a cell culture. After an incubation period, the antibodies in the test 
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sample or the control sample are linked to the antigen coating the 
microtiter. In a second incubation period, a conjugate anti-IgG (anti-
human IgG antibodies traced with peroxidase) binds to the IgG 
antibodies. When the substrate 3, 3’ , 5, 5’ -tetramethylbenzidine 
with hydrogen peroxide is added, it turns blue and finally yellow when 
the stop solution is added. The intensity of this colour, measured by 
means of a spectrophotometer at 450nm, is proportional to the 
concentration of antibodies in the sample. 
 Once the absorbance value of the test sample (or a related index) 
has been recorded, it is compared with the absorbance value of the 
cut-off (or cut-off index, which is always equal to one). As a 
consequence of this comparison, the test-kit result is transformed into 
a YES/NO result for the presence or absence of IgG antibodies to 
Varicella-Zoster Virus. 
 
 In the test kit we used, the COV was obtained by combining the 
absorbance values of the negative and positive controls with a 
mathematical transformation specified by the manufacturer. This 
transformation involves two steps: the first is to calculate the COV 
(Equation (1)), using the mean absorbance value for the control 
samples (negative and positive) that are measured in the same 
microtiter plate as the samples: 
+− ×+= AACOV 1.0 ,       (1) 
where −A  is the mean value of the absorbance for the negative 






 According to the manufacturer, the COV has an associated 
variation of 15%. Although this value is provided without units and 
without information of how it is calculated, we have assumed that it is 
a coefficient of variation. The following results are therefore derived 
from the test: 
 
1. If the absorbance measured at 450 nm (serum test sample) 
is higher than the COV + 15%, the sample is given as 
positive. This means that the sample serum is considered 
to have IgG antibodies to Varicella-Zoster Virus. 
2. If the absorbance measured at 450 nm (serum test sample) 
is lower than the COV - 15%, the sample is given as 
negative. In this case, the sample is considered not to have 
IgG antibodies to Varicella-Zoster Virus. 
3. If the absorbance measured at 450 nm (serum sample) lies 
between the COV plus and minus 15%, the sample is given 
as inconclusive. This value is given according to the 
intrinsic characteristics of the samples and, in addition, 
because the manufacturers must provide the end users 
with a range of values that refer to inconclusive samples. 
 
 From the practical point of view, it may be more convenient to 
work with indexes than with raw absorbance values, because all 
response values refer to the COV. So, the second step is to calculate 
the sample indexes (Equation (2)): 
COV
absorbanceSampleIndex =        (2) 
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With these indexes, it is even easier to apply the criteria described 
above to take the decision about the sample. The cut-off index will be 
always equal to 1 by definition and, if the 15% is taken into account, 
the criteria can be stated as: 
 
1. If the sample index is higher than 1.15, the sample is 
considered positive. 
2. If the sample index is lower than 0.85, the sample is 
considered negative. 
3. If the sample index is between 1.15 and 0.85, the sample is 
considered inconclusive. 
 
 According to this description, it can be seen that the COV for this 
test kit is compared to the sample in the response domain, as no 
relation is established between the response and the activity of the 
sample. 
 
4.2. Experimental work 
There are several ways of establishing the quality parameters of a 
test kit [6, 24]. Depending on the option chosen, the experimentation 
to be carried out should be carefully designed. In the present study, 
the experimental work is based on characterizing the distribution of 
the control samples, as we are dealing with an instrumental response 
(numerical values). The control samples must therefore be analyzed a 
sufficient number of times for their distributions to be characterized. 
One of the possible experimental designs considered is the one shown 





replicates of the controls are measured by the same analyst under the 







X2,1 X2,2 X30,1 X30,2…  
 
 Figure 2. Experimental design used to measure controls (positive and 
 negative) and estimate the cut-off value 
 
4.3. Results and discussion 
4.3.1. Traceability In order to assess the traceability of the results, a 
reference material [18] is measured simultaneously with the control 
samples for 30 days. The aim is to compare the responses of the 
reference material and the positive control sample, both of which have 
the same activity. This reference material is an ampoule containing 
lyophilized Varicella-Zoster IgG antibodies. If these antibodies are 
diluted in 1 mL of distilled water, the activity is 4 UI/mL. Once we 
have this solution with the antibodies, we need to further dilute it by a 
factor of 1/200 for the activity to be equivalent to the activity of the 
positive control sample. 
 
 The data obtained with the reference material follow a t-Student 
probability-distribution function (Fig. 3). The mean value from the 
data of the positive control and the mean value of the reference 
material can therefore be compared using the t-Student test. Table 1 
shows that the traceability is assessed because the mean values of 
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both distributions do not differ significantly (tcal = 1.89 is lower than 































 Figure 3. Index distribution obtained for the positive control sample 
 (dotted line) and for the reference material (solid line) 
 
 Table 1. Mean values and standard deviations from the positive control 
 sample and the reference material measurements 
Comparison of the mean value using a t-Student test
tcalc < ttab no significant differences are detected at α = 5%
ttab = 1.99
tcalc = 1.89
n= 60Standard deviation =0.57Mean value = 5.98Reference material sample
n= 60Standard deviation =0.24Mean value = 5.83Positive control sample
 
 
4.3.2. Sensitivity and spec fic ty. According to the manufacturer’ s 
instructions, a negative and a positive control sample, both of which 
are provided with the kit, must be measured twice every day so that 






estimate the sensitivity and the specificity of the test kit by assessing 
that positive control sample measurements give positive results and 
that negative control samples provide negative results. Fig. 4 shows 
the t-Student probability-distribution function for both controls and 
the COV with the upper and lower limit of the unreliability region. As 
can be clearly seen, all the negative samples measured provide 
negative results as they are below the lower limit of the unreliability 
region (0.85) and all the positive results are above the upper limit of 


































 Figure 4. Index distribution obtained for the negative control sample (solid 
 line) and for the positive control sample (dotted line). The variation of 15 
 % in the cut-off value (0.85 and 1.15) is also plotted 
 
 It can therefore be concluded that this test kit is specific because 
it provides negative results for all the negative control samples 
measured and that it is also sensitive because it provides positive 
results for all the positive control samples measured. In this particular 
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case, it is logical, as the positive and negative control distributions are 
far from the cut-off or unreliability limits. 
 
4.3.3. Unreliability region. The estimation of this region is directly 
related to the lack of precision associated with the (COV). Indeed, the 
cut-off precision can be used for two purposes: 
1. To estimate the cut-off variation over time. Once this 
region has been established, future COVs that may be 
suspected of being wrong can be evaluated by checking 
whether they belong to this unreliability region or not. 
2. To estimate the unreliability region and, therefore, to 
predict test sample compliance. 
 
 In order to estimate the precision of the COV, we can use the 
information gathered during the analysis of the control samples and 
apply the error-propagation law to Equation (1). For this particular 
case, the variables are the mean absorbance value of the negative 
control measurements ( −A ) and the mean absorbance value of the 
positive control measurements ( +A ). The final expression is depicted 




























COV .     (3) 
 
When both variables are partially derived, the result is as expressed 
in Equation (4): 
22222222 1.01.01
+−+−






The mean values −A  and +A  correspond to a set of measurements 
that were made over 49 days. They also show a t-Student 
probability-distribution function with a mean of 0.145 and a standard 
deviation of 0.032 for the negative control sample; and a mean of 
1.431 and a standard deviation of 0.081 for the positive control 
sample. The average value for the COV is 0.28. 
 
Finally,  = 0.033, which is a relative standard deviation of 12% 
with respect to the COV. It can therefore be concluded that there is no 
significant difference between the 12% estimated experimentally and 
the value given by the manufacturer of 15%. If necessary, a shorter 
unreliability region could be defined in which results would be 
inconclusive between the indexes 0.88 and 1.12. 
COVs
 
4.3.4. False positive and negative rates. As has been shown in the 
assessment of sensitivity and specificity, this test kit classifies 
negative samples and positive samples correctly when control 
samples are used. The α and β  probabilities of error (false positive 
and negative rates) are therefore nearly zero in the region where 
these control samples provide their indexes. However, it is advisable 
to have information in the proximity of the unreliability region, where 
the probability of obtaining false results is high. The easiest way to 
obtain samples that elicit indexes close to this region is to dilute the 
positive control. 
 
 Theoretically, the relation between the instrumental response and 
the activity or the concentration of the analyte when ELISA methods 
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are used is not linear. This relation can be established using such 
models as the 4-parameter, the logit-log or the cubic spline, among 
others [9]. In this application, an in-depth study of several dilution 
factors showed that the relation between the index value and the 
dilution factor follows a quadratic function (Fig. 5). However, it also 
shows that the dilution factors that give rise to samples within the 

































 Figure 5. Quadratic relation (solid line) of the indexes ( ) obtained when 
 the positive control sample is diluted by several dilution factors 
 
 The diluted positive control samples at 1/8 and at 1/12 were 
analyzed using the same experimental design described at the end of 
section 4.2. The results depicted in Fig. 6 show that they also follow a 




































 Figure 6. Index distribution obtained for the positive control sample 
 diluted at 1/12 (solid line) and 1/8 (dotted line). The cut-off value and its 
 variation (0.85 and 1.15) are also plotted 
 
 The results for the 1/8 dilution factor of the positive control 
sample have a mean distribution of 1.3 and a standard deviation of 
0.10 and the results of the 1/12 dilution factor have a mean 
distribution and standard deviation of 0.91 and 0.09, respectively. 
These distributions of the results are used to estimate the theoretical 
false positive and false negative rates according to the well-known t-
Student probability-distribution function (Equation (5)). 
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where −I  is the mean value of the indexes for the negative control 
sample;  is the standard deviation of the indexes for the negative 
control sample; 
−s
+I  is the mean value of the indexes for the positive 
control sample, and  is the standard deviation of the indexes for the 
positive control sample. 
+s
 
 These theoretical probabilities of committing errors were 
compared to the experimental probabilities, which were calculated 
using the experimental data. To estimate the false positive rate, we 
consider as false positives those results whose experimental index 
after the analysis of the positive control sample diluted by a factor of 
1/12 was equal to or higher than 1.15. In our case, there was just one 
measurement out of 60, so the probability of committing a type α  






resultspositiveFalse       (6) 
 
 The difference between the theoretical probability (0.48%) and 
experimental probability (1.6%) is probably due to the relatively small 
number of samples analyzed. 
 
 The experimental probability of committing false negatives (type 
β  error) is calculated in a similar way. In this case, to estimate the 
false negative rate, we consider false negatives to be those results 
whose experimental indexes after the analysis of the positive control 





this group of indexes, we have not obtained a single measurement 
with these characteristics. The probability is therefore 0%. In this 
case, there is a good agreement between the theoretical false 





Without any doubt, qualitative methods should also be validated. 
Method validation depends on the characteristics of the qualitative 
methods being used and should be designed according to their 
particularities. We have identified and defined the most important 
quality parameters for the different qualitative methods that use 
control samples and obtain the responses by instrumental analysis. 
Control samples are mainly used to establish the COV. Because they 
are standards of a certain metrological level, they can also be used in 
the validation process. The instrumental responses are transformed to 
obtain the final binary result (YES/NO) or, as in the case study, 
inconclusive. 
 The range of values considered as inconclusive is a key point in 
the definition of quality parameters, such as the unreliability region 
around the COV, and the false positive and false negative rates. 
 We have also estimated other important quality parameters, such 
as traceability, sensitivity and specificity rates. 
 
 As a case study, we validated a commercial test kit that uses 
control samples and provides instrumental responses with a final 
result of the positive/yes and negative/no type. The quality 
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parameters - sensitivity, specificity, and rate of false results - are 
defined and estimated using the statistical distributions of the control 
samples. Traceability is assessed by using a reference material and 
the definition of the unreliability region takes into account the 
precision associated to the COV. This precision is estimated by 
applying the error-propagation law to the response measurements, 
which, in this case, were the absorbance values. 
 The validation process has revealed that the cut-off provided by 
the manufacturer was accurate but that its associated standard 
deviation was wider than the experimental value. This meant that the 
manufacturer had chosen a conservative option when providing the 
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Trends in qualitative methods of analysis 
3.4 TRENDS IN QUALITATIVE METHODS OF ANALYSIS 
 
 As is only to be expected, there is considerable agreement among 
the scientific community about the importance of developing and 
applying qualitative method validation. This increasing agreement is 
largely due to the performance characteristics of qualitative methods, 
particularly those of rapidity and easiness of handling. Therefore, new 
progress is necessary to satisfy the demand. 
 
 In this respect, the European project ‘ MEQUALAN’  focused on 
the quality assurance of qualitative analysis. The working group 
reported the main issues that affected the quality principles of 
qualitative analysis [2]. Such important topics as traceability, 
reliability or validation were examined to assess the quality of the 
results and, finally, to incorporate qualitative methods in the 
laboratory routine with a high degree of confidence. 
 
 Recently, a special issue of the journal Trends in Analytical 
Chemistry focused on modern qualitative analysis. The aim was not 
only to review the main features of qualitative analysis but also to 
present the new approach to qualitative analysis. This new approach 
was first developed in the above mentioned European Project. Such 
aspects as the reliability of binary analytical responses [3], the 
identification of chemical compounds [4] or quality control [5] were 
discussed. 
 
 The starting point in this issue was a discussion of the current 





describes several problems which can affect qualitative analysis and 
defines some important quality parameters.  
 
 The section on statistics is divided into several parts. Current 
practice in interlaboratory studies is examined quite intensively. 
Calculation of error rates, the concepts of accordance and 
concordance and contingency tables are all used to analyze the data 
and to extract the maximum amount of information. The modeling of 
qualitative responses is also discussed and some examples given. 
 
 The special issue provides an in-depth definition of analytical 
features in qualitative analysis [7]. These qualitative methods of 
analysis and their binary type responses must first be characterized if 
the analytical properties are then to be defined. On the basis of the 
classical analytical characteristics in quantitative analysis, relevant 
performance parameters such as reliability, representativeness and 
robustness are carefully defined and discussed. Finally, it is stressed 
that method validation is fundamental to the conjunction of fitness for 
purpose and the performance parameters (derived from the analytical 
properties). Validation procedures for qualitative methods of analysis 
are divided into two groups: methods of identification and methods of 
classification. The validation procedures presented vary according to 
the intended use, the quality of the results required and the inherent 
characteristics of each qualitative method of analysis. 
 
 Reliability is one of the most important analytical features [3]. 
The basic descriptors of reliability are traceability and uncertainty, 
even when dealing with analytical methods that provide binary 
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responses. This article deals with the problem of defining and 
applying uncertainty and traceability in qualitative analysis. 
 
 The identification of chemical compounds is also discussed [4]. 
Concepts such as testing hypotheses, the so-called false response 
rates or the prevalence of the analyte are described. They link 
qualitative analysis with the identification of chemical compounds. 
 
 Once the performance parameters have been well-established and 
the method of analysis has been validated, the performance of the 
method needs to be supervised. This point is discussed thoroughly in 
the paper by Simonet [5]. Once the distinction between Quality 
Assurance and Quality Control has been made, the concepts related to 
quality control in qualitative analysis are systematized. Several 
proposals to establish an internal quality control are also discussed. 
 
 
 In this special issue there is also a place for an approach involving 
multivariate-based methods for qualitative analysis [8]. In particular, 
it focuses on the difficulties that must be faced when the unreliability 
region is defined in the multivariate analysis methods. 
 
 Two articles deal with different practical aspects. Barceló et al. 
[9] focus on the screening of pollutants in water, sludge and sediment 
samples. The biological methods used with screening responses are 
classified according to the technical principles involved and the 






 The field of clinical analysis is also approached [10]. The authors 
present a review of the terminology from laboratory medicine which is 
related to qualitative analysis but not in a classical way. 
 
 As well as this special issue, some validation strategies for 
specific applications other than the ones presented in this doctoral 
thesis have recently appeared in the bibliography. Nitrite control in 
water, for example, has been chosen as a case study [11]. The 
development of a qualitative spot test and its validation involves 
several steps. First, the preparation of the spot test means that the 
qualitative method, which is thoroughly described, must be optimized. 
Second, the reliability of the spot test is determined. Then, the 
validation is carried out by analyzing synthetic standard samples and 
screening real samples. A very interesting novelty is that the 
validation process is integrated with an internal quality control, which 
is based on qualitative control charts and Youden plots in this case. 
 
 There is also another example of the screening of toxic metal ions 
in water samples [12]. A spectrofluorometric method measures the 
spectra of the complex resulting from the reaction of 6-
mercaptopurine with toxic metal ions (e. g. Pb (II), Hg (II) or Cd (II)). 
The performance parameters are also evaluated considering the 
legislation limits for the toxic metal ions under study. 
 
 As has been stated, qualitative analysis is becoming an important 
issue in several fields. The subjects involved are heterogeneous (e. g. 
performance parameters, statistics, quality control) and method 
validation is also important. Although there is still room for greater 
 
108 
Trends in qualitative methods of analysis 
effort, interest in defining flexible and applicable validation 
procedures is growing [7]. These should be adapted by the end user 
to the problem at hand, always bearing in mind the requirements that 








[1]  Decision from the Commission. Implementing Council Directive 
96/23/EC concerning the performance of analytical methods and 
the interpretation of results. CO (2002) 3044 final (12.08.02). 
[2]  A. Ríos, D. Barceló, L. Buydens, S. Cárdenas, K. Heydorn, B. 
Karlberg, K. Klemm, B. Lendl, B. Milman, B. Neidhardt, R.W. 
Stephany, A. Townshend, A. Zschunke, M. Valcárcel, Accred. 
Qual. Assur. 8, 2003, 68. 
[3]  A. Ríos and H. Téllez, Trends in Anal. Chem. 24, 2005, 509. 
[4]  B. L. Milman, Trends in Anal. Chem. 24, 2005, 493. 
[5]  B. M. Simonet, Trends in Anal. Chem. 24, 2005, 525. 
[6]  S. L. R. Ellison and T. Fearn, Trends in Anal. Chem. 24, 2005, 
468. 




[8]  B. Lendl and B. Karlberg, Trends in Anal. Chem. 24, 2005, 488. 
[9]  M. Ferré, R. Brix and D. Barceló, Trends n Anal. Chem. 24, 
2005, 532. 
[10]  U. Forsum, H. O. Hallander, A. Kallner and D. Karlsson, Trends 
in Anal. Chem. 24, 2005, 546. 
[11]  M. R. Plata, N. Pérez-Cejuela, J. Rodríguez and A. Ríos. Anal. 
Chim. Acta 537, 2005, 223. 
[12]  A. Sanz-Medel, B. San Vicente de la Riva, J. M. Costa-












 Validation should be the last step in the development of a method 
before it is applied to actual samples in qualitative analytical methods. 
However, the only support the end user has in qualitative analysis are 
the documents summarised in the previous chapter. 
 The aim of the present chapter is to compensate for this lack of 
validation procedures by describing the tools required to validate 
some qualitative analytical methods. 
 The validation procedures presented have been designed in 
accordance with the intrinsic characteristics of the qualitative 
analytical method, and in particular the detection system. Thus, the 
cases studied were two commercial test kits, one of which provides a 
sensorial response and the other an instrumental response, and a 
home-made autoanalyzer with an instrumental outcome, although the 
final result is also binary. These validation procedures have been 
published and submitted as articles. They are presented below.  
 The first contribution describes the validation scheme designed 
for a commercially available test kit used in the field of food analysis. 
The test kit detects the presence of aflatoxin B1 above a certain 
concentration level in nuts. The detection is visual, so the appearance 
of a coloured spot on the analysis card means that the analyte does 
not exceed a particular concentration level and the sample can be said 
not to contain the analyte. If the spot does not appear, however, then 
the analyte exceeds a certain concentration and the sample can be 
said to contain it. 
 Before the article there is an introduction to aflatoxins: the 





conditions in which they can be produced, etc. After the paper there 
are some extended practical aspects that are not included in the 
article. 
 
 The second article describes the procedure for validating a test kit 
that is also available commercially but which is used in the field of 
clinical chemistry. The test kit detects the presence of IgG antibodies 
to Varicella-Zoster Virus in human serum. The response is obtained 
using a UV-Vis spectrophotometer for 96-well microtiter plates and 
the instrumental value is transformed into an index value. The final 
result is a comparison between the index value of the sample and a 
reference index value.  
 
 Finally, the third paper focuses on the validation procedure of a 
home-made autoanalyzer. The device was designed to analyse 
samples from the degreasing baths used in the automotive industry. 
So the field of application is industry although it also has 
environmental effects. 
 
 There is a wealth of qualitative analytical methods, all of which 
have their intrinsic characteristics. The validation procedures should 
be designed with these features in mind. The three validation case 
studies reported here might serve as a guide to validating new 
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4.2 AFLACARD B1 : A VISUAL DETECTION TEST KIT 
 
 This study was planned and performed in collaboration with the 
Laboratory of Public Health in Tarragona. The aim was to validate a 
qualitative method of analysis for detecting the presence of aflatoxin 
B1 in nuts. The analysis of aflatoxin B1 in nut and spice matrixes 
belongs to the Surveillance Program of Foodstuffs in Catalonia which 
also includes the detection of Sudan I colouring in spices, the analysis 
of heavy metals in processed baby food, apple juice and fishing 
products, or the investigation of Lysteria Monocytogenes in processed 
salads and milk derivates, among other determinations. The aim of 
these analyses is to appraise the quality of particular foods because 
they may contain hazardous substances. 
 
 The routine method of analysis for the application chosen is based 
on chromatography and requires a tedious sample pre-treatment and 
pre-column derivatization of the analyte. On the other hand, the 
qualitative method of analysis requires a simple sample pre-treatment 
and the response is obtained rapidly. Therefore, because of the 
advantages of the operational performance, the qualitative method of 
analysis is an excellent candidate to be used as the routine method. 
Then it needs to be validated so that the basic performance 












 Aflatoxins are secondary metabolites that belong to the group of 
mycotoxins, which are toxic metabolites produced by a fungus under 
special conditions of moisture and temperature. They are potential 
pathogens for animals and humans as they can cause kidney and liver 
diseases as well as immunodeficiency and damage to the nervous 
system.  
 
 They are generated by various species of fungi during the 
biosynthesis of fatty acids. During this process, the reduction of the 
keto functional groups may be interrupted. If this occurs, condensation 
reactions can take place and give rise to poliketonic compounds. 
 Not all fungi can produce mycotoxins. They usually need special 
conditions such as specific levels of moisture, pH and the correct 
temperature to produce mycotoxins. However, they might not be 
produced continuously. The absence of mycotoxins does not 
necessarily mean the absence of fungal spores, so fungi may be 
produced when the temperature and humidity are right. In addition to 
this, mycotoxins are very resistant to temperature treatments and to 
conventional food processes such as cooking, freezing etc. 
 
 Although almost 200 different mycotoxins have been 
characterised, only a few are often found in food and feed, although 
they are rather hazardous. These are aflatoxins, trichothecenes, 
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 Mycotoxins can naturally contaminate a wide variety of foodstuff. 
Table 1 summarizes the most common products that can be 
contaminated with mycotoxins. 
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 The fungi Aspergillus Flavus and Aspergillus Parasitivus produce 
aflatoxins, which are difuran-cumarin derivatives. Aflatoxin B1, B2, G1, 
G2, M1 and M2 (Figure 1) are the most common. Nevertheless, up to 20 
different classes of aflatoxins have been found. Although aflatoxin B1 
is clearly the most toxic, aflatoxins B2, G1 and G2 have considerable 
carcinogenic, teratogenic and mutagenic activity which mainly affects 
kidney, liver and brain [1], in the following order: G1, B2 and G2. The 
term B and G refer to their fluorescent colour (blue and green), when 
they are exposed to UV-light. 
 Aflatoxins M1 and M2 are hydroxyl derivatives of aflatoxin B1 and 
B2 which are usually found in milk and its derivatives. Although they 
are not as toxic as the other aflatoxins, their presence in dairy food 





 For all these reasons, toxicological studies of aflatoxins tend to 
deal only with the ones mentioned above. In the 90’ s, 
immunochemical methods for analysing mycotoxins were introduced 
[2]. These immunochemical methods have rapidly evolved and are 
nowadays the basis of many other methods of analysis for mycotoxin 
determination [3], where method validation is also an important 


































Figure 1. Chemical structure of aflatoxins B1, B2, M1, G1, and G2. As can 
be seen, they are structurally related. 
 
 The production of aflatoxins is affected by physical, chemical and 
biological factors. The main physical factors are humidity (> 16%), 
temperature (25-30°C) and healthiness of the grains (broken seeds 
encourage fungi to develop). The chemical factors are pH (2.5-7.5), 
substrate composition (greasy seeds undergo more intensive fungi 
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attack) and mineral nutrients in the seeds (iron, zinc and copper). And 
finally, one of the principal biological factors is that insects can spread 
the spores, which leads to the rapid development and multiplication of 
the fungi. 
 
 These optimal conditions are met mainly in the tropical and sub-
tropical areas because of the considerable amount of humidity stored 
in the seeds before they are gathered. Therefore, aflatoxins have 
been proved to cause extensive health damage and important 
economic losses because of the international trade in products such as 
nuts, coffee and spices. 
 
 Several countries have legislation on the maximum permitted 
levels of aflatoxins in various foodstuffs. For example, the European 
Community establishes that the maximum concentrations of aflatoxin 
B1, B2, G1 and G2 in several food matrices [6, 7] should range between 
2 ng/g for aflatoxin B1 and 4 ng/g for the total content of aflatoxins. 
Likewise, the U. S. Food and Drug Administration sets the so-called 
action level at 20 ng/g for aflatoxin B1 in several food matrices [8]. 
 
 The distribution of aflatoxins in the sample is rather 
heterogeneous. Decontamination and food processing do not eliminate 
them efficiently. Therefore, sampling techniques must be used to 
provide quite homogeneous sub-samples [9, 10], and strictly accurate 
analytical procedures in order to provide high quality and healthy 
foodstuffs. If the sub-samples analysed are not homogeneous enough, 
the analytical results may not be representative of the contamination 





 Nowadays, modern analytical techniques, which are based on 
monoclonal antibodies and high performance liquid chromatography, 
can reliably determine and quantify aflatoxins at rather low detection 
limits and with excellent specificity. The main drawbacks are the 
expense and the time of the analysis because it requires rather 
expensive material, such as immunoaffinity columns for the clean-up, 
extremely pure solvents and derivatization agents. The analysis also 
requires a rather tedious procedure, involving an extraction, sample 
clean-up and pre-column derivatization. 
 
 Thin-layer chromatography performs the analyses quicker and 
simpler but does not provide detection limits as low as the previous 
one. Moreover, the large volume of solvents used increases the 
expense. 
 
 The number of samples to be analysed and the drawbacks of the 
quantitative methods have meant that immunochemical techniques are 
increasingly being used either as qualitative methods of analysis or 
combined with more sophisticated analytical techniques. This is the 
case of Aflacard B1 which is used to discriminate samples of nuts 
contaminated with 2 ng/g of aflatoxin B1 from non-contaminated nuts. 
The contaminated samples are subsequently submitted to 
confirmatory methods, which are quantitative methods of analysis, and 
will provide the concentration of aflatoxin B1. The most commonly 
used confirmatory method is High Performance Liquid 
Chromatography with Fluorescence Detection. It is based on the 
AOAC International Methods of Analysis (see references in the 
following paper). The sample requires a clean-up step with an 
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immunoaffinity column and aflatoxin B1 must be derivatized. The 
derivatization reaction can occur either before or after the separation, 
depending on the method of analysis used. Non-contaminated samples 
do not require any special processing. 
 
 The validation procedure of Aflacard B1 is presented in the 
following paper, but the other relevant, practical aspects not included 






4.2.2 QUALITATIVE METHOD FOR DETERMINATION OF 
AFLATOXIN B1 IN NUTS 
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The proper characterization of a commercial qualitative method for 
determining aflatoxin B1 in some nuts is described. A qualitative 
method that provides binary responses of the yes/no type means that 
the performance parameters have been properly adapted and defined. 
Performance characteristics such as the cut-off limit, the detection 
limit, sensitivity, specificity, the false-positive and negative rates, and 
the unreliability or uncertainty region are defined and then estimated 
by means of the performance characteristics curves. The commercial 
test kit showed the cut-off limit at 1.6 ng/g, with a sensitivity rate of 
95% and a false-negative rate of zero. A modification can be 
performed to shift the cut-off to 2.0 ng/g, keeping the same values for 
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 In recent years, analytical developments have tended towards fast 
screening methods, efficient cleanup procedures, and precise but 
easily applied techniques. Screening test kits, commercial packages 
containing all the reagents and sometimes the instrumentation for the 
analysis, are now widely available (1). The main reason for this is 
that, rather than aiming to quantify a particular concentration, we are 
often more interested in knowing whether the concentration of a 
specific analyte is above or below a regulatory value or a threshold 
value. This value is mostly referred to as a specification limit, 
although other names, e. g., threshold value, are quite common. The 
current legislation, a client with specific needs, or even an internal 
quality control standard may fix that value. Therefore, qualitative 
methods have been developed to provide binary responses of the 
‘ yes/no’  or ‘ positive/negative’  type that are used for making 
immediate decisions, for instance, of whether the sample complies 
with a specific regulation. 
 In order to provide confidence to end users, the test requirements 
and performance characteristics of any analytical method must be 
defined and properly validated. Although much work has been done on 
the definition of the requirements and the validation of quantitative 
analytical methods (e.g., by the European Committee for 
Standardization (2) AOAC INTERNATIONAL), less work has been 
done on qualitative methods. 
 The present study discusses the characterisation of a commercial 
test kit, Aflacard B1 (3). The determination of aflatoxins in some nuts 
(pistachios, peanuts) is used as a case study. This characterization 
has meant the definition and, subsequently, the establishment of 





and negative rates, unreliability or uncertainty region. Although there 
are several ways of characterizing a qualitative method, we propose 
to use performance characteristics curves (4). 
 Aflatoxins are organic compounds that belong to the mycotoxins 
family and are produced by some fungi. At certain concentrations, 
they are proven to be toxic compounds. Though there are a wide 
variety of them, just a few are present in food products like cereals, 
nuts, or milk. We will focus on aflatoxin B1 because it is found in daily 
food and is potentially carcinogenic. According to European Union 
(EU) legislation (5), the maximum level of aflatoxin B1 permitted in 
nuts is 2.0 ng/g. Therefore, samples of nuts whose concentration of 
aflatoxin B1 is above this EU regulation limit are considered to be 
contaminated. 
 The most common quantitative methods used for determination of 
aflatoxin B1 in nut samples are based on liquid chromatography (LC) 
and thin layer chromatography. However, some new methods are 
based on an immunoaffinity reaction such as the enzyme-linked 
immunosorbent assay (ELISA). AOAC (6) proposes a method based on 
a derivatization of the aflatoxin B1 and LC with fluorescence detection. 
We used this confirmatory technique in addition to the qualitative 






 The raw material used consisted of fried ready salted peanuts 
sampled according to a European Directive (7). Once the material was 
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homogenized and the absence of aflatoxin B1 was confirmed by LC, 
subsample portions of it were spiked with aflatoxin B1 at different 
concentration levels. These samples were analyzed with both the test 
kit and the confirmatory LC method. 
 
day: j=1,2,...,12
replicate: l=1 and 2
analyst: i= 1 and 2
sample: k=1...42
1 2
X1,1,1,1      X1,1,1,2 X1,1,2,1        X1,1,2,2
1 2
21 1 2
1 12... 1 12...
41 42
21 1 2
X2,12,41,1    X2,12,41,2 X2,12,42,1    X2,12,42,2
 
Figure 1. Experimental design followed. Each experiment is represented by 
Xi,j,k,l where i corresponds to the analyst (1 and 2); j, the day (12 days); k, the 
sample (42 samples); and l, the 2 replicates 
 
 Basis of the Test Kit 
 
 The assay is based on a competitive ELISA format, i. e., on the 
immobilization of monoclonal antibodies attached to a card’ s 
membrane. This monoclonal antibody retains the aflatoxin B1 present 
in the sample. The antibody sites that are free because of the absence 
of enough analyte are then covered by the addition of an aflatoxin 
B1– enzyme conjugate. As the amount of aflatoxin B1 in the sample 
increases, the number of free antibody sites decreases. The 
membrane is then washed to remove any unbound conjugate. When 
substrate is added, the spot on the port’ s membrane where the 





sample port indicates a negative result, which means that the sample 
contains <2.0 ng/g of aflatoxin B1. On the other hand, if the sample 
port shows no colour change, the assay is positive, as all the antibody 
sites are occupied by the analyte. 
Table 1. Concentration levels of aflatoxin B1 tested, with each sample’ s 
replicate and probabilities of positive, P(X), negative, N(X), and inconclusive, 
I(X), results calculated for each concentration level 
Conc. (ng/g) Analyst 1 Analyst 2 P(X) N(X) I(X) P(X)+I(X) 
       
0.6 −a − −  − 0 100 0 0 
0.6 −  − −  −     
0.8 −  − −  −     
0.8 −  − −  Ib 0 90 10 10 
0.8 −  − NSc     
1.0 −  − −  −     
1.0 − +d −  + 14,3 50 35,7 50 
1.0 −  I I  I     
1.0 I  I NS     
1.2 −  − I  I 0 66,7 33,3 33,3 
1.2 NS −  −     
1.4 +  + I  I     
1.4 +   I +  + 50 0 50 100 
1.4 I   I +   I     
1.6 +  + +  + 100 0 0 100 
1.8 +  + +  +     
1.8 +  + +  + 100 0 0 100 
1.8 +  + +  +     
2.0 +  + +  +     
2.0 +  + +  + 100 0 0 100 
2.0 NS +  +     
2.2 +  + NS 100 0 0 100 
2.4 +  + +  + 100 0 0 100 
2.4 NS +  +     
a Negative sample   b Inconclusive sample 
c No sample analysed   d Positive sample 
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M g. homogeneous sample with 5 g. NaCl
add aflatoxin B1
add 25 mL n-Hexane and 100 mL MeOH/water (80:20) 
blend 2 minutes at 13000 rpm 
filtrate 
all 10 mL through the immunoaffinity column
elute with 1 mL MeOH
derivatization with TFA
evaporate with N2
test kit analysis 2 mL of the filtrate in 8 mL Tween 20 10%
LC quantification  
Figure 2. Scheme of the intended parallel analysis for screening and 
confirmatory methods 
 
 In the present study, the sample was considered not to be 
contaminated if the sample port had a clearly visible colour 
development. On the other hand, the sample was considered to be 
contaminated when the sample’ s port failed to develop a readily 
detectable color. Some samples were inconclusive when it was not 










 Experimental Design 
 
 The experiments were undertaken following a predefined nested 
design (Figure 1) in which the main sources of variation considered 
were analyst, day, sample and replicate. Each of the two analysts 
prepared and analyzed 2 independent samples per day over a period 
of several days, in repeatability conditions. Some days, only one 
sample was analyzed, and the final number of analyses was 84. Blank 
samples of peanut butter were spiked at concentration levels ranging 
from 0.6 to 2.6 ng/g (Table 1). 
 
 Sample Preparation and Analysis by the Screening Test Kit   
 
 The analysis was performed according to the manufacturer’ s 
instructions: 100 ml methanol-water (80+20, v/v) solution was added 
to a 50 g portion of ready-salted peanuts containing 5 g of NaCl and 
the right amount of aflatoxin B1 standard. This mixture was blended in 
an UltraTurrax (IKA-WERKE GmbH & Co. KG., Staufen, Germany) for 
2 min. The blended extract was filtered through a 2V Whatman 
(Clifton, NJ) filter paper. Briefly, 1 ml filtrate was added to the tube 
provided with the kit containing 3 ml of sample solvent. A 4 ml portion 
of mixture was filtered through the cleanup column, also provided with 
the kit. And 500 μ l sample was applied to the card’ s port and 
allowed to pass through the membrane. Then, 100 μ l conjugate and 
100 μ l wash solution, in this order, were applied to the port. The 
colour developed after the substrate had been added and after 5 min 
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 As one of our main interests was to make parallel analysis 
possible (screening method and confirmatory method), we modified 
the LC Official Method [6] to ensure the concentration of the spiked 
samples. We mixed 2 ml of MeOH-water (80+20, v/v) with 8 ml 10% 
Tween 20 (figure 2). This quantity (10 ml) was then used in the 
immunoaffinity columns. 
 
 Performance Characteristic Curves 
 
 To build the performance characteristic curves (4), we spiked 
several blank samples with aflatoxin B1 at different concentration 
levels. The highest level should provide only positive results (i.e., the 
samples are contaminated) while the lowest level should provide only 
negative responses. At each concentration level, the number of 
positive results is computed and the positive’ s percentage, P(x), is 
calculated. In the same way, the negative’ s percentages, N(x), and 
the inconclusive ones, I(x), are calculated. With these data, a graph of 
positive’ s percentage versus the concentration levels tested is 
plotted. As inconclusive results are also obtained, the P(x) + I(x) 
curve is depicted as well as the P(x) curve. The shape of these 
performance curves is sigmoidal, the position and the slope being 
characteristic of each particular qualitative method. Once the curves 
are drawn, it is reasonably straightforward to calculate the 
performance parameters of the qualitative method by setting the 








 Definition of performance parameters 
 
 Performance parameters are perfectly defined for quantitative 
analytical methods (8), but not for qualitative analytical methods. 
Table 2 shows some of the most common parameters for both 
quantitative and qualitative analysis. In this section, we report the 
definitions of the most usual parameters, some of which have already 
been defined by the AOAC (9). 
 
Table 2. Some of the most common quality parameters for quantitative and 
qualitative analysis 
Quantitative Qualitative 
Accuracy: trueness, precision False positive and negative rates 
Uncertainty Sensitivity and Specificity 
Sensitivity and Specificity Selectivity: Interferences 
Selectivity: Interferences Limit of Detection 
Range and Linearity Cut-off limit 
Limit of Detection Unreliability region 
Ruggedness or Robustness Ruggedness or Robustness 
 
 As a result of a qualitative method analysis, a positive or negative 
result is obtained. The positive result that the test kit gives for a 
sample is considered to be true-positive if a reference method has 
given the same sample a concentration level higher than a predefined 
value. Likewise, a true negative is the negative result provided by the 
test kit for a sample that, according to a reference method, has a 
concentration level lower than a predefined value. Two related 
parameters should be defined: a false positive is a positive test kit 
 
130 
J. AOAC Int. 87, 2004, 417 
response to a sample that is a true negative. An associated parameter 
is the false-positive rate: the ratio between the number of false 
positive results and the total number of true negatives. The same 
occurs when the test kit provides negative responses when the 
samples are true positive. In this latter case, these responses are 
called false negatives, and the false negative rate is the ratio between 



































Figure 3. Experimental performance characteristic curves. Probability of 
positive responses, P(X), and probability of positive plus inconclusive 
responses, P(X)+I(X), were plotted versus concentration levels tested. (1) 
FP=P(X); (2) X0.05 where specificity=N(X)=100-(P(X)+I(X)); (3) X0,95, cut-off 
limit, detection limit; (4) FN=100-(P(X)+I(X)); (5) sensitivity =P(X)=100-β  
 
 When handling samples providing true positive or negative 
responses, 2 other parameters must be taken into account: sensitivity 





ability of an assay to detect true positive samples as positive. An 
associated parameter is the sensitivity rate (10), which is defined as 
the probability, for a given concentration, that the method will classify 
the test samples as positive given that the test sample is true positive. 
Specificity (10), again in the context of qualitative analysis, is also 
defined as the ability of an assay to detect true negative samples as 
negatives. Again, an associated parameter is the specificity rate, 
which is the probability, for a given concentration, that the method 
will classify a test sample as negative given that this test sample is 
true negative. 
 A very informative performance parameter is the uncertainty 
associated to any measurement due to the presence of random errors. 
In the case of a binary response, the statement of uncertainty of a 
result cannot be expressed as a standard deviation-related statistical 
parameter but should be expressed as a probability of obtaining false 
responses. Therefore, rather than talking about uncertainty, we will 
talk about unreliability. As false responses can be either positive or 
negative, this unreliability (11, 12) becomes a region whose limits are 
the concentration levels where these probabilities of having false 
responses are set by the analyst. As the aim of a qualitative method is 
mainly to detect positive samples (that subsequently are usually 
submitted to quantitative confirmatory analysis), it is important that 
the unreliability region be placed below the established specification 
limit or threshold value. The upper limit appears when a given 
probability of having a positive result is set when it is indeed true 
positive. Usually, this probability is fixed at 95% and corresponds to a 
false-negative rate of 5% (β =5%, the probability of calling a positive 
assay negative). This upper limit corresponds to an analyte 
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concentration symbolized by X0,95 and is directly related to the 
sensitivity rate. 
 On the other hand, the lower limit is usually set at a given 
probability of having a negative result when it is indeed true negative. 
Usually, this probability is fixed at 95% and corresponds to a 5% 
probability of committing a false positive. Like the previous limit, it 
corresponds to the concentration X0.05 and is directly related to the 
specificity rate because it indicates the concentration where 5% of the 
responses are false positive. Another concentration value arises from 
the middle point of the unreliability region, the X0,5, where the 
probability of a negative result is equal to 50%. Song et al. (13) 
denotes this point as the ‘ identification limit’ . 
 Two additional parameters should be defined: the cut-off value 
and the detection limit. These 2 parameters have different 
connotations; depending on the type of qualitative analysis, the kit can 
provide either a numerical continuous value or a binary response. The 
treatment of the cut-off values for instrumental responses consisting 
of continuous values has been explained elsewhere (14). 
 When the qualitative method provides binary responses, such as 
the one we are using, the cut-off value is defined as the concentration 
value at which the test kit screens. Any test kit that performs well 
should ensure that any sample that contains a concentration of the 
analyte above the cut-off value will provide positive results with a 
certain and low probability of error. In this particular case, it is much 
more important to have no false-negative responses, because a 
contaminated sample must not be falsely considered non-
contaminated. In well validated qualitative methods, the cut-off should 





corresponds to 95% probability of detecting true positives as 
positives. 
 The detection limit was defined by the International Union of Pure 
and Applied Chemistry in 1995 for quantitative analysis (15), but this 
definition is not equally applicable to qualitative methods that provide 
binary responses because this response type prevents the statistical 
parameters from being calculated by the well established procedure 
(14). Although, the concept of detection limit as the minimum 
concentration or amount that can be detected by a chemical procedure 
considering the 2 probabilities of committing α  type and β  type 
errors should be maintained, it is particular from binary responses the 
possibility to maintain just one probability depending on what one is 
interested in controlling, either the α  or β  probability of committing 
error. 
 The detection limit has also been defined as “ the lowest 
concentration of the analyte which the test can reliably detect as 
positive in the given matrix”  [10]. Like the quantitative approach, 
reliably usually means 5% of false-negative (probability of β -error) 
responses. Therefore, this parameter is the upper limit of the 
unreliability interval. It must be stressed, however, that in this case, 
the false-positive error (probability of α -error) cannot be considered 
because, at the concentration level of the upper limit, all samples 
should provide a positive response. If this approach is adopted, it can 
be concluded that, for a binary response, the cut-off value and the 
limit of detection coincide with the upper limit which, as stated above, 
should be placed at the specification limit. Other authors consider the 
detection limit as the identification limit (13) in the sense that, in 
quantitative measurement, the detection limit corresponds “ to the 
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values of analyte concentration at which one has a 50% chance of a 
negative result” . Therefore, the detection limit would now be placed 
at the centre of the unreliability region, at X0,5. 
 
Results and Discussion 
 
 The performance characteristic curve is obtained by fitting the 
experimental results from Table 1 to a sigmoidal function that 
minimizes the root mean square of the residuals (Figure 3). To obtain 
the performance parameters discussed in the previous section, the 
analyst has to fix the probabilities of committing false-positive (α ) 
and false-negative (β ) errors that can be accepted. Usually, these 
values are fixed at 5%, and correspond to the horizontal lines plotted 
on Figure 3, α =5% and 100-β =95%. Once the probabilities of error 
are fixed, all performance parameters are calculated. The first is the 
unreliability region, defined by its upper and lower limits. The upper 
limit corresponds to the concentration at which the 100-β  line 
crosses the P(X) curve [in our case it is at 1.6 ng/g (dotted vertical 
line)]. Therefore, 1.6 ng/g is also the cut-off and the detection limit of 
the test kit under study. Similarly, the lower limit corresponds to the 
concentration at which the α  line crosses the P(X) +I(x) curve [in our 
case, it is placed at 0.8 ng/g (dotted vertical line)]. Therefore, the 
unreliability region is between 0.8 and 1.6 ng/g. The sensitivity rate at 
1.6 ng/g is equal to 95% as it corresponds to the point where: 
     P(x) =100-β  
 
 Also, the false-negative rate at 1.6 ng/g must be known and, in 





    FN=100-(P(x) +I(x)) = 0 
 
 Similarly, the specificity rate at 0.8 ng/g is equal to 95%, as it 
corresponds to the point where: 
    N(x) =100-(P(x) +I(x)) 
 
 The false-positive rate at this concentration level is also zero 
because 
     FP=P(x) = 0 
 
 These values show that the test kit tends to give a positive result, 
not a negative one, to any sample containing between 1.6 ng/g and 1,9 
ng/g of aflatoxin B1; this corresponds to a region where only false-
positive results occur. In order to minimize this tendency, we propose 
a modification based on the cut-off’ s shift from 1.6 to 2.0 ng/g, and 
maintaining no false negatives at 2.0 ng/g. This involves varying the 
amount of sample. Working with 40 g instead of 50 g of sample shifts 
the performance curves to the right by 0.4 ng/g. The experimental 
design was the same as above (Figure 1), but considering the results 
obtained in the previous experimentation, fewer samples were 
analyzed (Table 3). The parallel analysis using the test kit and the LC 
method was also done. The performance characteristic curves plotted 
from these experimental results are shown in Figure 4. This curve 
shows that the unreliability region appears between 1.2 and 2.0 ng/g. 
As inconclusive results are considered, the sensitivity rate at 2.0 ng/g 
is equal to 95%, and there is no false-negative response. Similarly, 
the specificity rate at 1.2 ng/g is equal to 95% and, at this level, there 
is no false-positive response. 
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Table 3. Concentration levels of aflatoxin B1 tested, with each sample’ s 
replicate and probabilities of positive, P(X), negative, N(X), and inconclusive, 
I(X), results calculated for each concentration level when using 40 g of the 
sample 
Conc. (ng/g) Analyst 1 Analyst 2 P(X) N(X) I(X) P(X)+I(X) 
       
0.6 −a  − −   − 
0.6 −   − −   − 
0.6 −   − n.  s.b
0 100 0 0 
       
0.8 −   − −   − 
0.8 −   − −   − 
0.8 n.  s. −   − 
0 100 0 0 
       
1.0 −   − −   − 
1.0 −   − n.  s. 
0 100 0 0 
       
1.2 −   − −   − 
1.2 −   − −   − 
1.2 n.  s. −   Ic
0 90 10 10 
       
1.4 −   I −   I 0 50 50 50 
       
1.8 +  +d +   I 
1.8 I   I I   + 
1.8 +   + +   I 
1.8 I   I +   + 
56,3 0 43,7 100 
       
2.0 +   + +   + 
2.0 n.  s. +   + 
100 0 0 100 
       
2.2 +   + +   + 
2.2 +   + +   + 
100 0 0 100 
a Negative sample   c Inconclusive sample 










































Figure 4. New performance characteristic curve and recalculation of the 
performance parameters using 40g of raw sample in the experimental 
procedure. (1) FP=P(x), (2) X0.05 where Specificity=N(x)=100-(P(x)+I(x)), (3) 
X0,95, Cut-off limit, detection limit, (4) FN=100-(P(x)+I(x)), (5) Sensitivity 
=P(x)=100-β  
 
 It is important to state that this modification must take the 
requirements of the end user into account. This means that in some 
cases, obtaining a positive sample at 1.6 ng/g is not a hitch: the 
laboratory can assume the cost (mainly in time and economical terms) 
of quantifying by the confirmatory LC method all samples containing 
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Conclusions 
 
 A commercial test kit that gives binary responses of the 
positive/negative type was validated and its performance 
parameters’  sensitivity rate, specificity rate, and limit of detection 
were defined and established by means of performance characteristic 
curves. When qualitative methods are used, performance parameters 
are expressed in terms of probability, whereas in the quantitative 
approach some of them are expressed as quantities having the same 
dimension as the obtained result. The validation process has shown a 
tendency towards false-positive samples, as the cut-off value 
appeared at 1.6 instead of at 2.0 ng/g, which was the value claimed by 
the kit’ s manufacturer. These cannot be considered an 
inconvenience because, in case of hazardous substances, the false-
negative rate must be controlled and, in many cases, minimized. In 
that sense, the users of test kits should take into account that 
manufacturers tend to provide procedures that reassure the absence 
of false negatives. This can be acceptable when the cost of this 
assurance is known; a number of unnecessary confirmatory analyses 
should be made because of the high number of false-positives 
reported. Nevertheless, some modification in the Aflacard B1 analysis 
procedure can be performed, but always assessing that the false 
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4.2.3. Practical aspects not discussed in the previous article 
 
 The validation process of the qualitative method of analysis has 
been described. However, one practical aspect requires further 
consideration: the results obtained with the test kit must be traceable 
to a validated confirmatory method. 
 For this particular case, and according to the statement in section 
4.2.1, the confirmatory method is based on High Performance Liquid 
Chromatography with fluorescence detection and pre-column 
derivatization. There are two official methods of analysis included in 
the AOAC INTERNATIONAL 17th Official Methods of Analysis (2000) 
[11]. They both propose a derivatization reaction but at different 
stages of the procedure: the 990.33 method describes a pre-column 
derivatization reaction, while the 991.31 method includes a clean-up 
procedure using an immunoaffinity column and post-column 
derivatization step. Liquid Chromatography and fluorescence detection 
is used in both cases. 
 Considering the current instrumentation and the characteristics 
that the confirmatory method of analysis should have, the Public 
Health Laboratory has modified both official methods of analysis. As a 
result, its confirmation method involves a clean-up procedure that 
uses an immunoaffinity column but a pre-column derivatization step. 
Since the new procedure was developed and validated by this 
laboratory, the only thing we had to do was perform suitability checks 




Aflacard B1: a visual test kit 
 These checks involve such steps as peak identification, and 
studies of reproducibility, the calibration line (which includes the 
detection limit) and traceability. 
 Spiked samples were analysed to verify the results provided by 
Aflacard B1 (see the corresponding article). 
 
The confirmatory method of analysis 
 
 The quantitative method based on HPLC has been used for years 
in the Public Health Laboratory to quantify the aflatoxin B1 present in 
the supposedly contaminated samples. Depending on the matrix 
(spices or different kinds of dried fruits), the quantity of sample used 
may range between 10 and 15 g. (for spices) and between 40 and 60 
g. (for dried fruits). In the present application, the matrices are dried 
fruits: ready-salted fried peanut butter and ready salted roasted 
pistachio butter. These two matrices are used because of the 
availability of blank sample that can be spiked with aflatoxin B1 
standard. 
 
 In general terms, this method of analysis consists of several steps: 
first, the extraction of the analyte with n-hexane and methanol/water; 
then, the sample clean-up using an immunoaffinity column in order to 
specifically retain the analyte and the following elution with methanol. 
Finally, the derivatization with trifluoroacetic acid (TFA) provides the 
appropriate fluorescent signal. 
 
 The instrumental components used are a Liquid Chromatograph 





7725i six-port injection valve and a sample loop of 100 µl. The 
column is a Hypersil-ODS (4.6x200 mm), 5 micron and the mobile 
phase used is Milli-Q water/acetonitrile/methanol (55:30:15). Both 
solvents are of HPLC Grade and provided by SDS (Peypin, France). 
The flow rate is 0.7 ml/min, which provides a working pressure of 62-
65 bar. The detector is an FLD G1321A from Agilent Technologies 
and it is set at an excitation wavelength of 365 nm and an emission 
wavelength of 430 nm. However, excitation spectra for a specific 
emission wavelength or emission spectra for a specific excitation 
wavelength are also possible. 
 
 Depending on the type of sample to be analysed (standard or 
spiked), the preparation process can vary. Unlike spiked samples, 
standard aflatoxin B1 samples do not require the analyte to be 
extracted or the sample to be cleaned up. 
 
 Peaks are identified and the reproducibility studied with 10 ml 
standards of aflatoxin B1 which are prepared per duplicate at a 
concentration level of 2.0 ng/g. The calibration line is also designed 
with duplicated standards in the concentration range between 0.4 and 
5.0 ng/g. 
 
 The preparation is a rather tedious process because it involves 
such complicated steps as evaporating the stock solution solvent and 
derivatizing with trifluoroacetic acid. In addition to this, the dark glass 
material used must be kept in sulphuric acid 2 N for 24 hours and later 
rinsed out with Millipore water and acetone. 
 
144 
Aflacard B1: a visual test kit 
 The stock standard solutions of aflatoxin B1 are kindly supplied by 
the Public Health Laboratory. They consist of small, frozen, sealed 
vials with approximately 2 ml of a solution containing aflatoxin B1 in 
chloroform (0.4 µl/ml). A register of the weight of each vial is also 
supplied with the vials. Every time a standard solution or the 
standards of the calibration line are prepared, a new vial is used. 
Before it is unsealed, its weight at room temperature is recorded. 
Whenever the mass measured varies by more than 0.0009 grams, the 
vial is discarded. 
 Once the appropriate volume of stock solution is placed in the 10 
ml dark vials, and the chloroform is evaporated under a nitrogen 
stream, 200 µl of n-hexane is rapidly added to prevent the analyte 
from oxidizing. After mixing for 30 seconds, 50 µl of trifluoroacetic 
acid (min. 99%, spectrophotometric grade) is added to carry out the 
derivatization according to Figure 2. Finally, 10 ml of an 
acetonitrile/water (10:90) solution is added after 5 minutes of waiting 
time. These standards must be kept in the freezer and protected from 












 Figure 2. Derivatization reaction of the aflatoxin B1
 
 Once the standards are ready, the analysis should be performed as 






 The information above shows that only two peaks should appear in 
the chromatograms. They correspond to the trifluoroacetic acid 
excess at minute 3, which has a characteristic shape, and to the 
derivatized aflatoxin B1 at minute 4.75, approximately. Nevertheless, 
the first analyses show a third peak at minute 8, the fluorescent 
intensity of which depends on which duplicate of the standard is being 
measured (Figure 3). There are various reasons why this third peak 
should appear (e. g. contamination of the vial containing the stock 
solution of aflatoxin B1, an impurity from the trifluoroacetic acid or 
from the acetonitrile/water (10:90) solution). However, the most 
probable reason is an inaccuracy during the derivatization. Therefore, 
the emission spectra of the derivatized aflatoxin B1 and of the peak at 
eight minutes are recorded at 365 nm of excitation wavelength (Figure 
3). Figure 4 shows the emission spectra of the non-derivatized 
aflatoxin B1 (40 ng/g) recorded in the same conditions as the previous 
two. As is assumed, the peak at minute 8 approximately corresponds 
to the non-derivatized aflatoxin B1. Even though there is an excess of 
trifluoroacetic acid, it must be at room temperature if the reaction is 




























































 Figure 3. Chromatogram and emission spectra at 365 nm excitation 
 wavelength corresponding to a) the derivatized aflatoxin B1 and b) to the 

































 Figure 4. Chromatogram (red solid line) and spectrum (blue solid line) 
 corresponding to a 40 ng/g standard of non-derivatized aflatoxin B1
 
 The residues from the standards must be placed in a special 
container because the remaining aflatoxins are submitted to the 
appropriate waste management. The re-usable glass material must be 
decontaminated by immersion in a 10%-sodium hypochlorite solution 
for twenty four hours.  
 
 The 2 ng/g aflatoxin B1 replicated standards are also used in a 
reproducibility study. The aim is to check the comparability of the 
results when the analyst or the day of the analysis is changed. To 
assess any variation in the results, we studied the peak areas obtained 
when two different analysts measure the standards for four days. On 
each day, each analyst performed five measurements. 
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 The theoretical approach used is the well-known two-way 
Analysis of Variance or ANOVA [12]. ANOVA is a statistical tool used 
to compare the variances of the different sources of error considered 
as significant in the total variance. The variance of each source of 
error considered must be compared with the residual variance by 
means of an F-test. In the present case, the two main sources of error 
are the two analysts and the day. The expressions used to calculate 
the F-values are summarized in Table 2. 
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Total SST n
d-1=t   
a p is the number of analysts (2); b q is the number of days (3); c r is calculated 
as t-[(p-1)+(q-1)-(p-1)(q-1)]; d n is the total number of analyses performed 
(40) 
 
 A previous graphical examination of the experimental data may 
help to detect possible outlier measurements. The peak areas for the 

























 Figure 5. Peak areas obtained during the four-day period. The red dots 
 correspond to analyst 1 and the black ones correspond to analyst 2. 
 
 The response values are clearly higher on day three. The Q Dixon 
statistical test uses the mean values of the days to calculate a Q-
value of 0.93. For n equal to 4 at a significance level of 5%, the 
tabulated Q-value is 0.83. In addition to this, it is found in the 
laboratory register notebook that the conditions of analysis were 
rather different from the standard conditions. Therefore, the 
responses obtained on day three are removed from the data set. 
 
 Provided that a) outlier data have been examined; b) the variances 
studied (i. e. variance caused by the day and variance caused by the 
analyst) a priori do not differ significantly; and c) the data follow a 
normal probability distribution function, the ANOVA table is 
constructed. The F-values shown in Table 3 are compared to the 
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corresponding tabulated F-values at a 5 % significance level and 
corresponding degrees of freedom. The tabulated F-values for the 
analyst, for the day and for the interaction are 4.3, 3.4 and 3.4. So it 
can be concluded that the sources of variation and how they interact 
make the same contribution to the final variance as the experimental 
error. 
 










Analyst 0.66 1 0.66 2.0 
Day 0.043 2 0.021 0.065 
Interaction 1.1 2 0.53 1.6 
Residual 7.9 24 0.33  
     
Total 9.7 29   
 
 The calibration line is studied by preparing duplicate calibration 
standards in a range of concentrations between 0.40 and 5.0 ng/g. The 
calibration standards are prepared following the procedure described 
above but taking into account the final concentration of the analyte. 
The same vial of 0.4 µl/ml is used to prepare the necessary standards 
for a single calibration line. The measurements are also performed 
under the conditions described above. The resulting calibration line 
has a slope of 17.8, an intercept of -0.8793 and a determination 
coefficient of 0.9959. The plot of the residuals in Figure 6 shows that 
no point is near the so-called Warning Limits (i. e. twice the standard 





In addition to this the residual distribution throughout the 
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 Figure 6. Residual values for the calibration standards measured 
 
 The statistical tool ANOVA is used again but to validate the linear 
model chosen to fit the data. Regression ANOVA (Table 4) compares 
the variance of the lack of fit with the variance of the experimental 
error. The calculated F-value is compared with the corresponding 
tabulated F-value. The linear model is appropriate whenever both 
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Regression SSREG 1 REGMS   
Residual SSR n-2 RMS   
Lack of fit SSLOF k-2 2−k









−   
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 In the present case, the data are obtained in repeatability 
conditions. Provided that a) the series probability distribution function 
is approximately normal; and b) the variances of the series are 
homogeneous, the ANOVA Table 5 shows that the linear model is 
suitable for the data obtained in repeatability conditions, because the 
calculated F-value is 3.53 and the tabulated F-value is 7.76 at a 5% 
significance level. 
 
 Table 5. ANOVA table computed for the calibration standards measured 








Regression 9256.40 1 9256.40  
Residual 38.09 8 4.76  
Lack of fit 25.89 3 8.63  
Experimental error 12.20 5 2.44 3.53 
     






 The detection limit has been calculated from the calibration line 
data. Taking into account the standard error of the residuals (2.18), 
the number of concentration levels used (5) and the number of 
measurements on the future sample (usually 1), and for a significance 
level of 5%, the detection limit is 0.52 ng/g. This value is acceptable 
as long as the samples with less than 2.0 ng/g of aflatoxin B1 are 
considered not to be contaminated.
 
 The following stage is to analyse spiked samples using a real 
blank matrix. The use of spiked samples involves calculating a value 
of recovery which will we considered in subsequent analyses. A 
Certified Reference Material is also analysed in order to assess the 
traceability of the method when analysing real samples. Next, we 
describe the preparation and validation of the calibration line used for 
quantification and the preparation of the spiked samples for estimating 
the value of the recovery. 
 
 The calibration line used for quantification is in the concentration 
range from 0.80 to 2.4 ng/g. The calibration standards are prepared in 
duplicate. The plots in Figure 7 and Figure 8 show that there are no 
outlier and that the residual values are rather homoscedastic. The 
ANOVA table (Table 6) confirms that the linear method is suitable 
because the tabulated F-value (4.15) is higher than the calculated F-
value (0.09). The detection limit is computed in the same way as for 
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 Table 6. ANOVA table obtained when measuring the duplicate calibration 
 standards twice 








Regression 2176.48 1 2176.48  
Residual 36.72 18 2.04  
Lack of fit 0.69 3 0.23  
Experimental error 36.03 15 2.40 0.09 
     
Total 2213.21 19   
 
 The preparation of the spiked samples is more complicated than 
the preparation of the standards because it requires a clean-up step. 
However, some of the stages are the same for both standards and 
spiked samples (e. g. the enrichment and derivatization steps). 
 The weight of the frozen vial containing 0.40 µl/ml of aflatoxin B1 
standard should also be taken into account when spiking a sample. 
Then, the corresponding volume of 0.40 µl/ml aflatoxin B1 standard is 
added to 40 g of the same sample matrix used to validate the test kit 
(ready salted peanut butter), described in the previous paper, and 
which also contains 5 g of sodium chloride. A total of 40 g is used 
because of the intended parallel analysis with the test kit. The results 
obtained with 50 g were presented in the previous paper. 
 After a few minutes to favour the contact between the analyte and 
the matrix, 25 ml n-hexane and 100 ml of a methanol/water (80:20) 
solution are added. The homogenization is performed according to the 
process described in the previous article: 2 minutes at 13000 rpm. If 
the filtrate is not transparent when a Whatman 2V double filter is 
used, it is exchanged for a glass microfibre filter. 
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 The clean-up stage is critical. Immunoaffinity columns contain a 
sorbent with the monoclonal antibody for the specific retention of 200 
ng of aflatoxins B1, G1, B2 and G2 that are adsorbed on it [13]. A 10% 
Tween 20 solution is used to dilute 2 ml of the methanol/water filtrate 
(80:20) up to 10 ml. This solution is then passed through the 
immunoaffinity column drop-wise. Air must not be allowed to form so 
that the uniformity of the analyte retention can be assessed. Once the 
10 ml have nearly passed through the column, 20 ml of Millipore water 
are used to wash the 10-ml Erlenmeyer. This volume is also passed 
through the immunoaffinity column. Finally, it is dried with air. 
 The elution of the analyte is also decisive. After the 
immunoaffinity column has been dried with air, 1 ml methanol is left in 
contact for 1 minute. Then the analyte is eluted by back flushing the 
methanol rapidly and repeatedly. The methanol is evaporated under a 
nitrogen stream. The derivatization process is now the same as for 
the standards. Instead of adding 10 ml of the acetonitrile/water 
solution (10:90), the volume added is 950 µl. After a few minutes of 
waiting time, Millex HV must be used to carry out a filtration before 
the injection. If the analysis is not performed immediately, the samples 
must be frozen. The chromatograms obtained (see Figure 9) are very 
similar to the chromatograms of the standards, with two peaks 
corresponding to the excess of trifluoroacetic acid and to the 
derivatized aflatoxin B1. The emission spectrum of the second peak 




































 Figure 9. Chromatogram and emission spectrum at an excitation 
 wavelength of 365 nm of a spiked sample with 2.0 ng/g of aflatoxin B1
 
 The procedure described above consists of several stages, which 
involve diluting the sample (i. e. the concentration of the analyte at 
the end of the sample preparation process is lower than the 
concentration at the beginning). Therefore, this dilution must be taken 
into account when the recovery of the method. Equation /1/ shows the 
concentration of the analyte at the end of the preparation process 
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 Although the range of concentration levels is wider, the spiked 
samples quantified contain 1.2, 2.0 and 2.2 ng/g of aflatoxin B1. Table 
7 shows the analyte concentration added, the concentration at the end 
of the sample preparation, the mean value of the calculated 
concentration after three analyses, the corresponding standard 
deviation and the recovery. 
 


















M23G2(2) 39.98 2.00 1.60 1.65 0.01 103.20 
M24G2(1) 39.9 2.00 1.60 1.44 0.00 90.35 
M24G2(2) 39.98 2.00 1.60 1.51 0.01 94.42 
M28G22(1) 39.68 2.20 1.75 1.4 0.04 80.70 
M28G22(2) 40 2.20 1.75 1.58 0.03 89.79 
M5F12(1) 40.09 1.20 0.96 0.79 0.03 82.31 
M5F12(2) 39.9 1.20 0.96 0.97 0.01 101.07 
M6F12(1) 40.09 1.20 0.96 0.78 0.01 81.43 
M6F12(2) 39.9 1.20 0.96 0.96 0.01 100.61 
M7F12(1) 39.96 1.20 0.96 0.83 0.02 87.47 
M7F12(2) 39.98 1.20 0.96 0.92 0.01 96.05 
 
 The mean value of these recovery values is 88.7%. The individual 
values and the mean value lie within the interval of values accepted by 
the Official Method of the AOAC recovery values (60-110%). An 
aliquot of these spiked samples was also analysed using the Aflacard 






 To conclude this section on the confirmatory method of analysis, 
the experiments carried out with a Certified Reference Material are 
presented. The aim of these analyses is to assess the traceability of 
both the confirmatory method and the Aflacard B1 test kit. Therefore, 
the experiments use the quantitative and the qualitative method of 
analysis. The material is kindly supplied by the Public Health 
Laboratory although it is purchased at the Central Science Laboratory 
Proficiency Testing Group [14]. It consists of 50 g of ready salted 
peanut butter naturally contaminated with aflatoxin B1. The sample 
has been measured by seventy laboratories and the resulting 
concentrations range between 1.67 and 4.30 ng/g. The concentration 
value of 2.98 ng/g is accepted as the reference value. 
 Therefore, our aim is to analyse an aliquot of the material with a 
concentration of aflatoxin B1 which lies in the unreliability region 
defined in the previous article (between 1.2 and 2.0 ng/g). As the 
concentration value of 2.98 ng/g is too high, some modifications must 
be made if the same sample is to be used for both methods of 
analysis. If the weight of the sample of reference material is 24.16 g, 
the theoretical aflatoxin B1 concentration to be determined is 1.8 ng/g. 
Taking into account the dilution process during the preparation of the 
sample, the final aflatoxin B1 concentration is 1.44 ng/g. Table 8 
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 Table 8. Summary of the results obtained when analysing an aliquot of  
 24.16 g of the Certified Reference Material 
 
Aflacard B1 





Sample 1 inconclusive 1.16 2.40 
Sample 2 inconclusive 1.18 2.43 
Sample 3 negative 1.16 2.37 
Mean value and  
uncertainty (ng/g) 
 1.17±0.133 2.42±0.148 
 
 After three instrumental replicates (Sample 1, Sample 2, Sample 3) 
the analysis with the confirmatory method provides a mean 
concentration of aflatoxin B1 of 1.17 ng/g and an uncertainty value of 
0.133 ng/g. In order to confirm that the method of analysis performs 
appropriately, the relative standard deviation is checked throughout 
the concentration range tested to see that it does not vary 
significantly (i. e. between 1 and 2%). Then, an extrapolation is 
carried out to consider a sample size of 50 g. The concentration is 
2.42 ng/g and the uncertainty associated to this concentration value 
0.148 (see Table 8). 
 
 Since we have not found a statistically significant difference 










Ana ysis using a different matrix: ready salted roasted p stachio butter l i
 
 The Aflacard B1 test kit mainly deals with two different matrix 
types: nuts and spices. The paper presented deals with ready salted 
peanut butter. However, just one matrix might not be sufficient to 
consider that a method of analysis is fully validated for that type of 
sample. Therefore, the same experiments are carried out with another 
nut matrix. As has been stated in the section above, the work with nut 
matrices is directly related to the availability of blank samples. Thus, 
the Laboratory of Public Health also supplied the ready salted roasted 
pistachio butter. Other available matrices were not suitable since they 
were slightly contaminated with the four main aflatoxins or with 
aflatoxin B1. 
 The results of previous analyses of the new matrix are similar to 
the analyses performed with the peanut butter. At a concentration 
level of 1.0 ng/g, one result out of six is negative, four are 
inconclusive and one is positive. At a concentration level of 1.40 ng/g, 
just one result out of twelve is inconclusive. The rest are positive. 
Then, the same modification proposed for the peanut butter matrix is 
made. Although, an in depth study of the raw data may conclude that it 
is also possible to work with 35 g of sample, we decided to work with 
40 g to unify standard operation procedures. 
 
 The reproducibility and linearity studies carried out before on 
aflatoxin B1 standards are not repeated. In order to periodically check 
the instrumental responses, 2.0 ng/g aflatoxin B1 standards are 
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 The spiked samples are also analysed in parallel, using both 
methods of analysis. The results obtained, shown in Table 9, are 
represented in Figure 10 where they are fitted to the sigmoidal curve. 
 
Table 9. Results of the 40-g samples of ready salted roasted pistachio butter 
when using both methods of analysis 
Conc. 
(ng/g) 
Analyst 1 Analyst 2 P(X) N(X) I(X) P(X)+I(X) 
HPLC mean 
recovery 
0.9 −  − −  −  
0.9 −  − NS 0 
83.3 16.6 16.6 79.6 
        
1.1 −  I -  -      
1.1 -  - I  - 0 60 40 40 64.1 
1.1 NS I   I      
        
1.3 -  I I   I      
1.3 +  I +  I 30 10 60 90 79.6 
1.3 I  + NS      
        
1.5 −  Ι +  I      
1.5 −  Ι I   I 30 20 50 80 80.3 
1.5 +  + NS      
        
1.7 +  + +  Ι      
1.7 +  + +  + 70 0 30 100 76.7 
1.7 I   I NS      
        
1.9 +  + +  +      
1.9 +  + +  + 100 0 0 100 77.3 
1.9 +  + +  +      
1.9 +  + +  +      
        
2.1 +  + +  +      
2.1 +  + +  + 100 0 0 100 79.4 
2.1 +  + +  +      
2.1 +  + +  +      
- means a negative result  I means an inconclusive result 







































 Figure 10. Performance characteristic curves for 40 g of pistachio butter 
 samples 
 
 The final results show that the sensitivity rate at 1.9 ng/g is equal 
to 95% and at this concentration level there are no false negative 
responses. The specificity rate at 0.75 ng/g is equal to 95% and there 
are no false positive responses at this concentration level. The cut-
off and the detection limit are placed at this concentration level as 
well. The unreliability region, then, lies in the concentration interval 
between 0.75 and 1.9 ng/g. 
 
 At the time of this experimentation, no Certified Reference 
Material with the suitable characteristics was available. Therefore, 
traceability could not be assessed at this level. 
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 The final conclusions are very similar to those in the article. The 
validation process has confirmed the bias to false positive responses. 
In general, manufacturers are conservative as far as false negative 
results are concerned. In applications dealing with food contaminants, 
for example, a high false negative rate must be avoided because 
harmful consequences would affect public health. 
 
 
 The first commercial test kit chosen for validation has been 
characterised. Performance characteristic curves are a very useful 
and informative tool whenever a visual detection test kit needs to be 
validated. Although the main drawback might be the considerable 
number of experiments to be made, the information gathered permits a 
detailed characterisation. In any case, the number of experiments 
proposed in several validation documents referenced in the article is 




4.3 VZV IgG: A BINARY RESULT TEST KIT THAT PROVIDES 
AN INSTRUMENTAL RESPONSE 
 
 Among the great variety of commercial test kits, those that use an 
instrumental response to provide a final binary result are of special 
interest. These methods of analysis record a response value for a 
reference, and is a crucial step in the subsequent comparison with the 
response of the test sample. Depending on this comparison, the final 
binary result is YES or NO. 
 These methods have several advantages. If the decision about the 
sample is taken just by comparing the responses of the test sample 
and the reference, there will be no need for a quantification with a 
fitting model. So a considerable amount of experimental work and its 
associated costs are avoided. In addition, they are also quick and easy 
to handle. 
 Our study is made in close collaboration with the Immunology 
Department of the Laboratorio de Análisis Dr. Echevarne in Barcelona. 
The aim of this cooperation is to validate a commercial test kit with 
the characteristics mentioned above. The test kit studied is the VZV 
IgG, which measures the presence of IgG antibodies to Varicella-
Zoster Virus (VZV) in human serum. This assay is just one of a wide 
range of clinical analyses performed in the Immunology Department, 
such as the determination of IgG and IgM antibodies to Helicobacter 
pylori or to Dengue virus in human serum. 
 The commercial test kit is an indirect Enzyme Linked 
Immunosorbent Assay with Varicella-Zoster Virus antigen coating the 
96-well microtiter plate. It is used as a routine method in the 
laboratory according to the habitual standard procedures in clinical 
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analysis. The application does not use a confirmation technique 
because the standard operational procedure of the Varicella-Zoster 
Virus does not require one. Therefore, independently of the result 
obtained, serum samples are not re-analyzed in the laboratory with a 
different method of analysis. Only in a few extreme situations (i. e. 
inconclusive results that in a second analysis provide the same results 
or test samples that first provide a clear positive response and, in a 
replicate, a clear negative response), is further analysis required, 
usually with another commercial test kit. In the exceptional case that 
the new commercial test kit does not clarify the final result, the test 
for Varicella-Zoster Virus fluorescent antibody to membrane antigen 




4.3.1 Varicella-Zoster Virus 
 
 Varicella-Zoster Virus is a human alphaherpesvirus that belongs 
to the Herpesvirus family. Herpesviruses get their name from the 
Greek ‘ herpein’ , which means ‘ to creep’ , and they can cause 
chronic, latent and/or recurrent infections. Approximately 100 
Herpesviruses have been isolated, at least one for most of the animal 
species studied. However, to date, just eight human Herpesviruses are 
known [16]. Infection to humans is nearly universal. That is to say, 
most adults have the virus in a latent stage and various cell types can 
be infected (e. g. nerve cells, lymphocytes) 
 The International Committee on Taxonomy of Viruses (ICTV) 




according to their biological properties [17]. Alfaherpesvirinae, which 
can affect several host cells, have a relatively short reproductive 
cycle, and are rather efficient at both destroying host cells and 
establishing latency in the cells of the dorsal root and sensory ganglia. 
Betaherpesvirinae, which are made up of a narrower range of host 
cells, have a longer reproductive cycle and establish latency in 
lymphocytes and kidney tissues, among other possibilities. Finally, 
gammaherpesvirinae affect lymphoblasts and sometimes cause the 
lysis of fibroblast or epithelial cells. 
 
 Table 10. Summary of the eight human Herpesviruses 
SUBFAMILY GENRE NAME 
ALPHAHERPESVIRUS 
human herpesvirus 1, 2
human herpesvirus 3 
Simplexvirus 1, 2 (HSV-1, HSV-2) 
Varicella-Zoster virus (VZV) 
BETAHERPESVIRUS 
human herpesvirus 5 
human herpesvirus 6, 7
Cytomegalovirus (CMV) 




human herpesvirus 4 





 Varicella and herpes zoster are caused by the VZV which is a 
virus transmitted by the respiratory route [18]. The result of primary 
VZV infection is varicella, also known as chicken pox, which shows 
symptoms such as fever and pruritic rashes. Although it is a typical 
childhood illness prevalent in temperate climates [19] it can be found 
worldwide. However, herpes zoster or shingles can only be caused by 
a VZV reactivation. The symptoms are a localized, and usually painful, 
vesicular rash which involves dermatomes. The occurrence of herpes 
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zoster increases with age or immunosuppression, and is particularly 
prevalent in patients being treated with immunosuppressive drugs for 
malignant diseases or to prevent the rejection of bone marrow or 
organ transplants, and in individuals with antibodies against human 
immunodeficiency virus (HIV). 
 Primary VZV infection produces IgG, IgM and IgA antibodies that 
bind to many classes of viral proteins. Antibody production is 
detectable within three days of the first symptoms. The first 
antibodies to be produced are IgM, followed immediately by IgG. 
However, the number of IgM antibodies decreases after a month, 
while IgG antibodies to many viral proteins remain at acceptable 
levels for years as part of the long-term immune response to VZV. 
 The presence of VZV can be detected in two ways depending on 
the problem at hand. Virological methods based on 
immunofluorescence with monoclonal or polyclonal antibodies, which 
are rapid and sensitive [20], can be used to assess VZV infection. 
Also DNA isolation of the vesicles helps to detect virus infection. 
These methods are used in quite specific circumstances (i. e. to 
assess if there is viral infection in the fetus during pregnancy or to 
check the viral origin of some lesions because the symptoms of 
Herpes Zoster are not so evident). These analyses can lead to an 
antiviral therapy being prescribed, which is of outstanding importance 
for high-risk (that is to say, immunocompromised) patients. 
 However, if it is the immune status of the individual that needs to 
be determined, then serological methods are required. Commercial 
enzyme linked immunosorbent assays are useful in this case for 
screening purposes. The antibodies used in these methods of analysis 




are often inconclusive. In these cases, the sample is reanalysed and if 
the final result is not conclusive or does not agree with the clinical 
history, another commercial test kit is used. The confirmatory testing 
(FAMA or latex agglutination [21]) is seldom necessary. 
 Both the virological and serological methods of analysis are based 
on procedures that use monoclonal or, more commonly, polyclonal 
antibodies to the specific VZV antigens. The strength of this bond is a 
reversible interaction in which non-covalent inter-molecular forces (i. 
e. hydrogen bonding, electrostatic, van der Waals and hydrophobic) 
take part. The most important factor is the complementarity between 
the antigen and the antibody: if they are complementary enough, the 
reactive parts of the antigen (antigenic determinant) and of the 
antibody draw closer together because the water molecules in 
between are removed. The affinity of the antibody for the antigen is 
the sum of all non-covalent intermolecular binding forces of a single 
antigenic determinant to an antibody. So, antibody affinity is an 
expression of the attraction between the molecules of the antibody 
and the antigen. 
 Due to the multivalent nature of antigens, the immunological 
system can produce different types of antibodies (i.e. a single 
antigenic determinant generates multiple antibodies and a single 
natural antigen has multiple antigenic determinants). The binding 
strength of antibodies to multiple antigenic determinants on natural 
antigens is known as avidity [22]. It is a measure of the multivalent 
antigen-multivalent antibody stability complex and it depends on the 
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 An infection with VZV is treated with antiviral agents such as 
acyclovir, famcyclovir and valacyclovir, which are all licensed. The 
usual concentrations required to inhibit the virus are about 1.0 to 2.0 
mg/ml and the dose is usually 10 mg/kg. However, the virus is not 
eliminated from the host, so it may reactivate when the treatment is 
stopped. Prevention is carried out by means of passive immunization 
with VZV IgG antibodies: that is to say, a preparation of high-titer 
VZV IgG antibodies is given to susceptible high-risk individuals (i.e. 
immunocompromised children and pregnant women who have been in 
contact with VZV), by means of a live attenuated varicella vaccine, 




 The prevalence of an illness is the ratio, for a given time period, 
of the number of occurrences of this illness to the number of units at 
risk in the population. Varicella and Herpes Zoster are well-known for 
their rather high prevalence and, considering the negative 
consequences of infection (either primary [23] or reactivation [24]), 
it is important for rapid and reliable methods of analysis to be 
available. 
 In order to contribute to this task, we describe below the 
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Qualitative analytical methods are nowadays being widely used as 
screening methods. The detection of analytes in samples above 
certain concentration levels is important before their quantification 
with the routine method. In order to achieve the best quality also in 
clinical analysis results, all methods must be validated. A relevant 
issue is to define and to assess the quality parameters, considering 
the actual sample matrix (urine, serum, etc). A strategy to validate an 
ELISA that assesses the presence or absence of the IgG antibodies 
against Varicella-Zoster Virus (VZV) analysing a serum sample is 
presented. The absorbance is transformed into an index that links the 
test sample values to those obtained daily by analysing the control 
samples provided with the test kit. The data obtained during two 
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months from the control samples are examined in detail. The 
calculated indexes are distributed following normal distributions. 
Then, performance parameters (traceability, sensitivity and 
specificity, the unreliability region and the false response rates) are 
calculated easily. 
 
Keywords: clinical test kits, binary results, control samples, quality 






Qualitative methods of analysis are becoming increasingly valuable, 
among other purposes, as screening methods. They are used in 
different contexts, such as environmental, clinical or food-quality 
control, but all are related to analytical chemistry. Depending on the 
application, a positive result should be accompanied by a confirmatory 
analysis as is the case of environmental or food analysis [1, 2]. 
However, clinical chemistry is a rather particular case. Confirmatory 
methods are only used if concrete determinations (e.g. HIV or 
Hepatitis C) require the corroboration of a positive result. Other cases 
are those in which inconclusive results are obtained in duplicate, 
though such cases are even fewer. In all these situations, time and 
cost are considerably reduced. Like any other method of analysis, 
those used in the clinical context must be validated. Most 
determinations in clinical analysis are performed with commercial test 
kits, so confirmation of the quality parameters claimed by the 
manufacturer is very important for the quality of the results. 
 
 Validation must always be considered at the end of the method 
development process. Method validation was described some time ago 
by ISO [3] and, from the practical point of view, it can be considered 
as the definition and estimation of the performance parameters 
necessary to fit the analytical requirements. The validation procedure 
must be carefully defined in order to properly assess the performance 
characteristics of the analytical method. Validation of quantitative 
methods has been widely developed and it is a well established 
process, as is shown by the existence of several validation documents 
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and guidelines addressed to practitioners [4, 5]. In the field of 
qualitative analytical methods, some regulatory bodies provide 
validation documents and guidelines, although they are still not 
generally accepted [6, 7]. Following this trend, several research 
teams are attempting to establish qualitative validation procedures as 
shown by recent papers [8-10]. 
 
 The validation procedure depends not only on the external 
analytical requirements, but also on the intrinsic characteristics of the 
qualitative method. The detection system, either sensorial or 
instrumental, is one of these internal characteristics. And whether or 
not the method is based on the measurements of control samples 
should also be taken into account. In all cases, as we are dealing with 
qualitative methods, the final result is binary (yes/no or 
positive/negative). Therefore, the validation strategy should be 
adapted to and consistent with each particular methodology [11, 12]. 
 
 This paper reports the validation procedure of a test kit based on 
instrumental detection (absorbance measurement) and control samples 
measurement. This test kit is used in laboratories that perform clinical 
analyses and does not require confirmation of positive results. The 
technique is an Enzyme Linked Immunosorbent Assay (ELISA) [13] 
based on the antigen-antibody reaction. The control samples must be 
measured to establish a cut-off value which is a key point in the 
classification of the test samples. Traceability, and estimate values for 
the sensitivity and specificity, the unreliability region and the 





 As we record absorbance values for both the test and the control 
samples, a statistical characterization of the distributions of the 
control samples, always in the response domain, is useful to validate 
the method. The main performance parameters of the test kit are 
estimated from the positive and negative control samples distribution 
and also from the information associated to the cut-off value obtained 
during its estimation. Sample compliance is assessed by means of 
prediction intervals defined around the cut-off value. Although these 
intervals have already been used to estimate the uncertainty of a 
qualitative method of analysis, involving control samples is a novelty. 
First, the characteristics of the test kit are described, and then the 
performance parameters and how to estimate them are defined. As a 
case study, the validation of a specific ELISA test kit that detects IgG 
antibodies against VZV in human serum is reported. 
 
 
Materials and methods 
 
Basis of the test kit 
 
The test kit VZV IgG [14] is an indirect Enzyme-Linked 
Immunosorbent Assay for detecting the presence or absence of IgG 
antibodies against VZV in human serum. The microtiter wells are 
coated with VZV antigen from a cellular culture. If the sample 
analysed contains IgG antibodies to this virus, they link to the antigen 
coating the microtiter well. Adding the enzyme-labelled anti-antibody 
provides the coloured solution after a chromophore is added. The 
colour intensity, which is directly related to the amount of antibodies 
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in the sample, is measured by means of a spectrophotometer at 450 
nm. Since an instrumental response is recorded, it is compared to the 
cut-off value in terms of raw absorbance though, as is shown later, a 
comparison in terms of index is usual. So the final result is YES, if the 
test sample response is higher than the cut-off value, meaning that 
the serum sample contains IgG antibodies to the virus. And it is NO, if 
it is lower than the cut-off value, meaning that there are no IgG 
antibodies or that they cannot be detected. 
 The cut-off value is a key value during the assay as every test 
sample response has to be compared to it before the final result can 
be given. In this particular kit, it is obtained by combining the 
response values of the negative and the positive control samples 
provided with the kit. The mathematical expression that calculates the 
cut-off value (COV) is defined by the manufacturer as a combination 
of the duplicated absorbance values of both control samples (Equation 
1): 
 
+− ×+= AACOV 1.0        /1/ 
 
Where,  
−A  is the mean absorbance value of the negative control 
+A  is the mean absorbance value of the positive control 
 
 The manufacturer also supplies information about the range of 
variation of this cut-off value. This range refers to inconclusive 




testing of internal and external quality controls. However, nothing is 
said about how it is estimated or the units in which it is expressed. 
 Our own results suggest that this range is derived from the 
coefficient of variation associated to the COV. In this particular test 
kit the range of variation of the cut-off value provided by the 
manufacturer is 15%, so the test samples responses must be 
compared in the following terms: 
 1) If the absorbance of the test sample measured at 450 nm is 
higher than the COV  plus 15%, the sample is given as positive. That 
it is to say, the serum sample is considered to have IgG antibodies to 
VZV 
 2) If the absorbance is lower than the COV minus 15%, the sample 
is given as negative. In this case, the sample is considered not to have 
enough IgG antibodies to VZV 
 3) Finally, if the absorbance lies between the COV plus and minus 
15%, the sample is given as inconclusive.
 
 Though the manufacturer does not suggest that a mathematical 
transformation be used for the COV, practitioners usually like to 
standardise the COV value, and therefore assign it a value of 1. 
Subsequently, the raw test sample responses are also divided by the 
COV value giving rise to the index of the cut-off value. Equation /2/ 
shows how these indexes are obtained. The indexes are compared in 
the response domain as well. Therefore, though it exists, a 
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COV
absorbanceSampleIndex =       /2/ 
 
 Following the same reasoning as in the previous paragraph, the 
decision about the test sample also takes into account the lack of 
precision of the cut-off value. So, 1) the result is positive if its index 
is higher than 1.15; 2) the result is negative if its index is lower than 





Two types of samples are distinguished: positive and negative control 
samples and reference material. All tests are performed using test kits 
from the same batch. 
 
 The negative control sample is a pool of different human sera that 
is proven to be free of VZV IgG antibodies. Similarly, the positive 
control sample is a pool of human sera that has an activity level of 20 
milliInternational Units per millilitre (mIU/ml) of IgG antibodies against 
the VZV. Both control samples are provided by the manufacturer and 
are ready to use. The positive control sample is also diluted at two 
different dilution factors to obtain two samples that provide responses 
in the region close to the cut-off value. The dilution is made following 
the manufacturer’ s instructions using the dilution buffer provided in 





 As traceability is a key performance parameter, a reference 
material is also used [15]. This reference material consists of an 
ampoule with lyophilised VZV IgG antibodies, which provide an 
activity level of 4 International Units per millilitre when they are 





The samples are measured in a 96-microtiter well plate so 96 
analyses can be performed simultaneously. Though the negative and 
the positive control samples are ready to use, the samples resulting 
from the dilution of the positive control sample are not. They are 
obtained by using the correct dilution factor to reach responses close 
to the cut-off value (inconclusive and low positive responses). After 
testing several dilution factors it is proven that the relation between 
the index value and the dilution factor follows a quadratic function 
[16] and that the best dilution factors are 1/8 and 1/12 as they 






































 Fig. 1. Quadratic relation (solid line) of the indexes ( ) obtained when the 
 positive control sample is diluted by several dilution factors. 
 
 To verify traceability, the reference material should have an 
activity level equivalent to that of the positive control sample, so in 
the present case it must be diluted. The activity of the reference 
material is 200 times that of the positive control sample since the kit 
insert states that the activity of the latter is 20 mUI per millilitre. So a 
two-step dilution is performed according to the standard procedures 
in the laboratory: first, a dilution factor of 1/20 and second, a dilution 
factor of 1/10. As in the case of the positive control sample, the 
dilution is made using the buffer provided with the test kit.  
 
 The analyses are performed according to the manufacturer’ s 
instructions: 100 microliters of the sample are added to the microtiter 




minutes, the microtiter plate is washed four times with 400 microliters 
of the wash solution provided with the test kit. Then, 100 microliters 
of the conjugate (enzyme-labelled anti-antibody) are added to the 
microtiter well and after 30 minutes of incubation time and being 
washed 5 times with 500 microliters, 100 microliters of the substrate 
(3, 3’ , 5, 5’ -Tetramethylbenzidine) are added. The reaction finishes 
when, after 15 minutes of incubation time, 100 microliters of stop 
solution are added. The absorbance of the yellow coloration shown by 
the microtiter plate is measured in a spectrophotometer at 450 nm 





The validation methodology does not depend only on the analytical 
requirements: it is also closely related to the intrinsic characteristics 
of the analytical method. Pulido et al. describe a validation strategy 
for qualitative analytical methods that provide an instrumental 
response [17]. But for the particular case in which control samples 
are used, no validation procedure has been published. This procedure 
is based on estimating the cut-off value and its statistical distribution, 
which, in turn, depends on the statistical distributions of both control 
samples. The methodology also characterises the statistical 







J. Pharm. Biomed. Anal. Submitted 
Characterisation of the statistical distributions 
 
First of all, the type of probability distribution function that the test kit 
responses follow must be checked. If the distribution is to be 
estimated properly, the experiments must follow a predefined 
experimental design (Figure 2). The analyses are performed for thirty 
days, which should be long enough to be able to estimate the 
theoretical errors. Every day two replicates of each sample (positive 
and negative control sample, the reference material and the diluted 
positive control sample) are measured by the same analyst under the 
same conditions, and according to the instructions provided with the 
test kit. The analyst is not considered a source of variation because 
the routine analyses are always performed by the same operator. 







X2,1 X2,2 X30,1 X30,2…
sample
 
Fig. 2. Experimental design used to analyse the samples (control samples and 
reference material) 
 
Performance parameters estimation 
 
The validation of an analytical methodology with either a quantitative 
or a qualitative method must fulfil some requirements [18, 19] related 
to the quality of the analysis, and time and cost constraints. According 




parameters for our test kit depending on these requirements are 
identified and estimated. 
 As has been stated, traceability is assessed [21] by using a 
reference material, although other possibilities do exist (reference or 
alternative methods). In addition to the ‘ British Standard varicella-
zoster antibodies’  reference material [15], it is assumed that the 
control samples submitted by the test kit are secondary references 
since they have been compared to an in-house serum preparation and 
that the whole test kit performance has been compared to another 
commercially available ELISA [22]. The control samples are 
measured twice daily to establish the cut-off value. Also, as is stated 
in the test kit instructions, the analysis will be valid if: a) the 
absorbance value for the blank sample (i. e. the microtiter well that 
undergoes the analysis without the control or test sample) is lower 
than 0.150; b) the mean absorbance value of the negative control 
sample is lower than or equal to 0.250; and c) the mean absorbance 
value for the positive control is equal to or higher than 0.750. 
Therefore, traceability is established daily by reference to these 
control samples. 
 In the context of clinical analyses, performance parameters such 
as sensitivity and specificity are also used. On the one hand, clinical 
assays may refer to analytical sensitivity and analytical specificity, 
both of which are classical concepts in analytical chemistry [13]. On 
the other hand, they may also refer to diagnosis sensitivity and 
diagnosis specificity. Though these latter terms generally agree with 
those considered for sensitivity and specificity in qualitative methods 
of analysis [12, 13, 23], some fine distinctions should be highlighted. 
Diagnosis sensitivity is a measure of the probability of correctly 
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diagnosing a diseased condition. In the present case study, it is the 
probability of correctly assessing the presence of VZV IgG antibodies. 
Diagnosis specificity measures the probability of correctly identifying 
a non-diseased condition. In this case study, it is the probability of 
correctly assessing the absence of VZV IgG antibodies. The lower 
these probabilities are, the better the test kit performs. 
 These two parameters are very important because they show the 
ability of the test kit to correctly classify positive and negative 
samples. They are evaluated with the positive and the negative 
control samples. Sensitivity is also estimated with a sample at another 
level of activity. This corresponds to the sample obtained by diluting 
the positive control by a factor of 1/8. Moreover, from their 
measurement results and subsequent probability distributions, the 
probability of misclassification is also estimated. 
 
 Selectivity is an intrinsic characteristic of ligand-receptor systems 
such as antigen-antibody. However, unspecific reactions often occur. 
In this case study, rheumatoid factor may interfere with the binding of 
IgG-specific conjugates, producing a lower or false reaction in the 
test kit. It is assumed that the manufacturer has checked and 
confirmed the absence of these reactions [22]. Also, cross reactivity 
with Herpes Simplex Virus and Epstein-Barr Virus may be expected. 
It is necessary, therefore, to rule out such infections before 
interpreting the results of the test kit. As a first stage, and according 
to the standard protocol and experience of the laboratory, it is 
assumed that these two infections are absent. However, sound studies 





 In qualitative analysis and particularly when dealing with binary 
responses, the unreliability region is where inconclusive results are 
obtained [12, 24]. In the test kit this region of inconclusive responses 
is placed around the cut-off value. 
 It is therefore in the range of absorbance or index values where 
the test kit wrongly determines the presence or absence of IgG 
antibodies against VZV. This performance parameter is estimated 
using the definition of the two-sided upper prediction bound [17, 25] 
and the precision associated to the cut-off value. As will be shown 
below, the precision of the cut-off value is estimated by means of the 
propagation error law. 
 
 As can be seen in Figure 3, the limits of the unreliability region 
around the COV (index equal to 1) provide very valuable information 
because 1) they define when the positive, negative and inconclusive 
results are obtained; and 2) together with the probability density 
function, they make it possible to estimate the probability of obtaining 
false responses (positive and negative). It should be pointed out that if 
both limits are to be defined a predefined probability of error (α and β 
probabilities of error) must be considered. 
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 Fig. 3. Information provided when the unreliability region is defined. The 
 dotted vertical lines are the lower and upper unreliability region limits. 
 The solid line corresponds to the distribution function of a hypothetical 
 positive sample. The dotted line corresponds to the distribution function 
 of a hypothetical negative sample. 
 
 The probabilities of giving false results are the false results rates. 
False results can be either false positive (when the test kit classifies a 
true negative sample as positive, i. e. the presence of IgG antibodies 
is wrongly assessed) or false negative (when the test kit classifies a 
true positive sample as negative, i. e. the absence of IgG antibodies is 
wrongly assessed) [6]. They are closely related to the sensitivity and 
specificity of the diagnosis and they also give an idea of how good the 
test kit classifies. Inconclusive results slightly modify this reasoning 
because, on the one hand, the lower limit of the unreliability region 




inconclusive result; and on the other hand, the upper limit of the 
unreliability region gives the percentage of real positive samples 
providing an inconclusive result. Figure 3 shows that the area of a 
negative control sample above the index value 0.85 is the probability 
of providing an inconclusive result, i. e. the false inconclusive rate. 
The area of the same distribution function above the index value of 
1.15 would be the false positive rate. Regarding the distribution 
function of a positive control sample, the area below the index value 
of 1.15 is the probability of providing an inconclusive result, i. e. a 
false inconclusive rate of a positive sample, and the area below the 
index value of 0.85 would be the false negative rate. 
 
 
Results and discussion 
 
In theory, the data obtained when the control samples and reference 
material are analysed in duplicate every day for thirty days should 
follow a Gaussian distribution. Therefore, once this hypothesis is 
assessed, we propose a validation procedure based on the properties 
of the t-Student distribution function, which is a particular case of the 
normal probability distribution function. First, the expected 
distribution function of the data must be checked. Figure 4 shows the 
normal plot of the experimental data. The data of the negative control 
sample clearly show a normal probability distribution function as the 
data points fit the straight line. Some data points of the positive 
control sample and of the reference material slightly deviate from 
normality. The deviations shown could be due to the occurrence of 
unspecific reactions. However, it is assumed that the data of the 
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positive control sample and the data of the reference material follow a 
normal probability distribution function. These assumptions have been 
assessed by means of the Chi-square normality test [26]. Before 
estimating the performance parameters, it is systematically checked 
the presence of abnormal data and/or outliers. The different sources 
of variation by means of the Analysis of Variance (ANOVA) are also 
studied. 
a)






































































































 Fig. 4. Normal probability plot for a) negative control sample data, b) 




The measurements are performed in accordance with a specific 
experimental design (Figure 2). Therefore, information about the 
sources of variation (day and replicates) that affect the data 
dispersion can be obtained. Table 1 shows the results of performing 
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 Table 1. Calculated and tabulated F-values for both control samples, for 
 the reference material and for both diluted samples from the positive 











Pos. control  
sample: dil. 
factor 1/12 
S2 day 0.00053 0.053 0.57 0.016 0.0098 
S2 replicate 0.00037 0.025 0.068 0.0025 0.0070 
Calculated F-value 1.5 2.1 8.3 6.4 1.4 
Tabulated F-value 1.8 1.8 1.8 1.8 1.8 
Significant differences? NO YES YES YES NO 
 
 There is no significant difference between the within-days 
(replicates) and between-days variance of the negative control 
sample. On the other hand, there are significant differences between 
these two variances for the positive control sample and the reference 
material. With regard to the normality of the positive control sample 
and the reference material sample, the higher level of activity 
probably increases the unspecific reactions. The differences between 
the variances for the reference material are considerable. In this case, 
two factors must be considered: first, the dilution (200 fold) that 
decreases the initial activity of 4 IU/ml; and second, the final 
reference material solution, which is prepared every day as has been 
described above. This dilution process negatively affects the data 
dispersion. 
 
Estimation of the quality parameters 
 
Traceability is assessed by statistically comparing the measurement 




response of the reference material, both at the same level of activity. 
In the case under study, the positive control sample has a mean index 
value of 5.8 and a standard deviation of 0.20, while for the reference 
material the mean value and standard deviation are 5.9 and 0.50, 
respectively. The t-value calculated to compare mean values is 1.4 
and the tabulated t-value is 2.0 for 74 degrees of freedom and a 
significance level of 5%. Therefore, it is concluded that the mean 
values do not statistically differ at the level of significance chosen. 
Consequently, the results obtained with the test kit are traceable to 
the reference material. 
 
 Sensitivity and specificity are estimated from control samples 
measurements. As it is shown, all negative samples provided negative 
results as they are below the range of values that the manufacturer 
considers to be inconclusive (0.85-1.15) so, the specificity of the 
diagnosis given by the test kit is 100%; and all the positive results are 
above the previously mentioned range of values, so sensitivity of the 
diagnosis given by the test kit is also 100%. Moreover, for the 1/8 
factor diluted positive control sample, 59 measurements out of 60 
provided a positive result: that is to say 98.3 % sensitivity at that 
level of activity.  
 
 The unreliability region is the range of instrumental responses 
around the cut-off value that gives rise to inconclusive results. As it 
has been stated in the section Performance Parameters Estimation, 
this region can be defined using the two-sided prediction bounds 
[25]. The cut-off values are derived from absorbance values that 
follow a t-Student’ s probability distribution function and therefore 
 
192 
J. Pharm. Biomed. Anal. Submitted 
follow the same type of distribution. Because of this, the limits of the 
unreliability region provided by the manufacturer are checked. To 
achieve this, a prediction interval around the COV (Equation /3/) is 
established. The sample is positive or negative if its absorbance value 
is above or below the limits of this interval (Equation /3/). 
 
Prediction interval = ( ) pstCOV ×± να ,      /3/ 
 
Ps  is the standard deviation associated to the prediction interval and 
it is estimated by taking into account the standard deviation of the 
cut-off value and the number of replicates measured of the test 
sample (Equation /4/): 
COV
COV










11        /4/ 
And 
m is the number of replicates carried out on the future unknown 
sample. It is usually 1. 
nCOV is the number of independent analyses performed to calculate the 
cut-off value. In our case, this is 30 measurements. 
sCOV is the standard deviation of the cut-off value. 
 
 A key point in estimating of the unreliability region is the precision 
associated to the cut-off value. To experimentally assess its size, the 
error propagation law to the COV expression (Equation /1/) is applied. 
As can be observed, it depends on two variables: the mean value of 
the absorbance for the negative control sample, −A , and the mean 




precision associated to the COV is calculated therefore as a function 
of the precisions associated to the control samples in terms of 
variance, 2
−A
s  and 2
+A




























COV      /5/ 
 




×+=×+×= AAAACOV sssss     /6/ 
 
 As the absorbance mean values and standard deviations are 0.11 
and 0.015 for the negative control sample, and 1.5 and 0.21 for the 
positive control sample, the sCOV value is equal to 0.026. Expressed in 
terms of relative standard deviation, this corresponds to 10% of the 
mean value of the cut-off value, which is 0.25. This value of 10% is 
not so different from the variability value provided by the 
manufacturer (15%), although it is slightly lower. 
 













 is 1.016. Therefore, in accordance with 
Equation /3/, the new unreliability region lies between the absorbance 
values 0.30 and 0.21 considering the tabulated t-value at a 5% level 
of significance, or in terms of indexes between 0.83 and 1.17. That it 
is to say, a sample will be positive when its index is above 1.17, with 
an error probability of 5%. The same occurs with negative samples 
whose index is below 0.83. This unreliability region coincides with the 
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15% of variability provided by the manufacturer (0.85 –  1.15). It 
should be emphasized that the unreliability region strongly depends on 
the previously set probability of error. For instance, if an error 
probability of 1% is considered, then the new unreliability region lies 
between the absorbance values of 0.19 and 0.32, or in terms of 
indexes between 0.75 and 1.25. 
 
 The advantage of this approach is that the properties of the 
normal probability distribution function are perfectly established. The 
analyst has to set a probability of error when setting the confidence 
intervals, which means that he already knows how many samples will 
provide an inconclusive result. In addition to this, the probability of 
error can be adapted to the problem in hand: the smaller the 
probability is, the larger the confidence interval will be and vice-
versa. 
 
 The data for the dilution factors 1/8 and 1/12 of the positive 
control sample are used to estimate the false rates at activity levels 
close to the COV. Though they do not seem so important, there are 
some differences between the two data sets. The reason is that the 
higher the activity level is, the higher probability for unspecific 
reactions to occur is. So, the probability of having measurements out 
of range is also higher when using the dilution factor 1/8. As it has 
been stated before, the same experimental design shown in Figure 2 











































 Fig. 5. Index distribution obtained for the positive control sample diluted 
 at 1/8. It is computed following the theoretical t-distribution function. The 
 unreliability region is also plotted. 
 
 The false negative rate or probability of committing a β  type 
error is calculated using the data from the 1/8 dilution factor 
distribution function. The experimental probability of committing error 
is zero because no samples out of the sixty tested provide an index 
equal to or lower than 0.83. That is to say that no sample provides a 
false negative result. However, in this case false inconclusive results 
arise because samples belonging to the low positive distribution 
function (1/8 dilution factor) provide inconclusive results instead of 
positive ones. All samples whose indexes are lower than 1.17 belong 
to this category. From 60 measurements, 3 provided an inconclusive 
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 Similarly, using the distribution function corresponding to the 
dilution factor 1/12 the false negative rate from an inconclusive 
sample is estimated. Therefore, this rate is computed by considering 
negative results: that is to say indexes below 0.83 from among all the 
replicated measurement samples belonging to the inconclusive 
distribution function. Of the 60 analyses, 9 were negative, so the 
probability is calculated as 9/60x100=15 %. No false positive results 
were obtained from this sample. Since this sample should provide 
inconclusive results, it makes no sense to determine the sensitivity 
rate at this activity level. 
 
 Finally, the probability of committing a false positive (the 
probability of committing an α  error) from a negative sample is 
visualized from the distribution function for a sample that provides 
indexes that are almost below the lower limit of the unreliability 
region. As this sample is not available, it is indicated how this rate 
should be computed. Using this distribution function, the positive 
results obtained should be computed, which means indexes above 
1.17. False inconclusive results from a negative sample can also be 





In the framework of the recent development of the validation of 
qualitative methods and of clinical analysis, a methodology for test kit 
validation that is adapted to the characteristics of the present assay 




measurement and on the use of control samples to estimate the cut-
off, a methodology that characterizes the statistical distributions of 
the positive and negative control sample measurements is provided. 
 
 The validated immunoassay-based test kit, which is used in some 
laboratories as a routine method, measures immunoglobulin G 
antibodies of VZV in human serum. Traceability, sensitivity and 
specificity of the diagnosis, the unreliability region and the 
probabilities of giving false results (positive and negative false rates) 
are estimated. The value of the specificity, agrees with the 
manufacturer’ s specifications of 100%, but the sensitivity differs 
slightly from the value provided of 92.68%. This difference could arise 
from the differences in the levels of activity tested in both validation 
studies. 
 
 In spite of the lack of any formal statement, the manufacturer 
indirectly sets the probability of committing false results at nearly 
zero because the unreliability region proposed is very wide. The price 
to be paid is that there are more inconclusive results. In the validation 
process, this region is re-estimated experimentally by taking into 
account the precision associated to the cut-off value and a pre-set 
probability of committing both types of error. Considering this new 
unreliability region, the probability of obtaining false results is 
estimated. In this particular case, not only the false negative rate but 
also the false inconclusive rate is calculated. 
 The validation methodology presented in this paper has been 
chosen according to the intrinsic characteristics of the test kit, i. e. 
the instrumental response and the measurement of control samples to 
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calculate the cut-off value. The statistical intervals derived are used 
to estimate the performance parameters by taking into account the 
variability associated with the cut-off value. The analyst can either 
adopt the usual 5% probability of committing an error or select a 
certain value for probability of error that suits the problem at hand. 
Depending on the availability of an appropriate antigen-antibody 
system, this methodology could be used to validate other ELISA 
formats, such as direct and sandwich, as well as other analytes in 
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4.4 A HOMEMADE AUTOANALYZER THAT PROVIDES 
GLOBAL INDEXES 
 
 The last part of this chapter describes the validation of a 
homemade autoanalyzer that is used to determine whether two 
analytes in the same solution are simultaneously above or below a 
certain concentration level. 
 Like the two previous practical applications, this one is carried out 
in collaboration with the Department of Analytical Chemistry of the 
University of Córdoba. 
 This method of analysis is like the new automated methods of 
analysis that are to be used as screening sample systems, and which 
are being developed by the Department of Analytical Chemistry of the 
University of Córdoba. Other configurations are used for the direct 
screening of lyophilised fluids for bile acids [25], for the sequential 
determination of total sugars in soft drinks [26] or for the screening 
and confirmation of sulphonamide residues in milk [27]. 
 This particular application aims to determine the total content of 
mineral oil and surfactant in degreasing baths, which are commonly 
used in the automotive industry. The characteristics of the method of 
analysis depend on the requirements of the external client, and it is 
designed and built with these in mind. It is, therefore, a homemade 
method of analysis unlike the previous practical applications which are 
commercially available and whose performance parameters have 
already been defined by the corresponding manufacturer. 
 Another difference between this application and the ones that have 
been described so far is its environmental approach. Degreasing baths 




replaced, and their waste managed with care. Therefore, external 
clients require a method of analysis which determines when the 
degreasing bath must be replaced. Our method is quicker and more 
reliable than current methods, which are rather tedious, involve 
several steps and take 24 hours to provide the final results. 
 
 
4.4.1 Degreasing baths 
 
 Various finishing processes are carried out in all industries that 
produce metal parts that must comply with specific conditions before 
they are subject to any other changes 
 Production and mechanization (i. e. modification of the physical 
structure of the metal pieces to give them particular characteristics or 
specifications) is usually performed with tools which have cutting 
edges. The friction and deformation have several undesirable effects 
on both metal surfaces (e. g. local cold welding, swarf, chipping). To 
minimize these effects, cooling lubricants or cutting fluids are widely 
used. Cutting fluids dissipate heat, reduce friction and remove swarf 
during the mechanization. They are responsible for the lubrication that 
prevents breakage and wear of the cutting tool and protects metal 
surfaces from oxidation and corrosion [28]. 
 Cutting fluids are essentially of two different types. On the one 
hand, oil-based systems are composed of either mineral or synthetic 
oils with some additives which, depending on the subsequent 
application, can be either organic or inorganic compounds [29]. Due 
to the oil-based formulation, they considerably reduce friction. On the 
other hand, water-based emulsions (i. e. 2-10% oils and additives) 
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have a higher cooling efficiency. In the present application, the fluids 
used basically contain mineral oils. 
 Once the metal piece has the required physical conformation, the 
oil and grease must be completely removed because the subsequent 
processes (i. e. galvanization, painting, passivation, etc.) need the 
surface to be absolutely free from oil and grease. Therefore, 
degreasing baths are an essential part of the productive process. 
 Traditionally, metal components have been degreased with 
halogenated organic solvents such as trichloroethylene or 
tetrachloroethylene [30]. Because the volatile organic compounds 
emitted represent both an environmental hazard (i. e. ozone damage, 
air and ground water contamination) and a health risk (i. e. damage to 
the hormonal system and neurotoxicity) [31], they are gradually being 
substituted by other degreasing modalities. More modern techniques 
use aqueous cleaners which, in combination with a mechanical action, 
make cleaning efficient [32]. However, not all aqueous cleaners can 
be used to degrease all metal components. Such factors as the 
chemical and physical properties of the metal component or the 
finishing operation required, as well as the amount of oil to be 
removed must be considered before it is submitted to a proper 
degreasing process. 
 
 To achieve the best performance, the mechanical action is also 
very important [33]. Immersion systems (i. e. tanks in which the parts 
are immersed in the degreasing solution for a certain time) can 
combine both temperature and ultrasound to improve the separation of 
the dirt from the substrate. Sprinkling systems are also widely used. 




mechanical effect of the high pressure of the flow, and give good 
results. 
 The three main types of aqueous degreasers are acid, neutral and 
alkaline. Acidic solutions are composed of mineral acids (hydrochloric, 
sulphuric and nitric), chromic acid, carboxylic acids, and other organic 
acids. They are useful for removing metal oxides before pre-
treatment or painting. However, such cleaning solutions generally 
require more attention due to the aggressive action of the acid on the 
metal parts. Increased dirt loading and neutralization are common 
problems that require the cleaning solution to be changed frequently. 
Acidic cleaners are generally not the best choice as degreasing 
agents. 
 Cleaning solutions with a pH from six to eight are considered 
neutral. They generally include surfactants, which act as wetting and 
emulsifying agents. Other ingredients, such as corrosion inhibitors and 
dispersants, are also generally added. These formulations are best 
suited for removing organic residues (e. g. oil and grease) and many 
inorganic residues. The key point for best performance is to select 
the solution that is most appropriate for the targeted dirt; also 
important is the type of mechanical agitation chosen for the process. 
 Alkaline cleaning solutions are formulated by adding such 
materials as sodium or potassium hydroxide, carbonate, bicarbonate, 
phosphate, silicate, or other similar materials. It is important to keep 
in mind that sodium hydroxide, like other alkaline metal hydroxides, is 
very corrosive. 
 A solution at a pH of 13.5 will remove carbonaceous soils. pHs 
ranging from 8 to 13 are generally used to remove oils and greases. 
As a rule, alkaline degreasing solutions do not need the same level of 
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attention as acidic ones. Nonetheless, they must be periodically 
monitored and adjusted for concentration and soil loading. 
 Alkaline degreasing solutions use both physical and chemical 
means to clean the substrate surface. Chemical action can occur via 
the saponification of certain contaminants. In the saponification 
process, water-soluble soaps are produced by neutralizing fatty acid 
soils. Physical cleaning occurs via the wetting and emulsification 
caused by the addition of surfactants. These are the degreasing baths 
that are used in the present application. 
 The surfactants found in alkaline degreasing baths can have 
different hydrophilic parts and therefore different natures. Anionic 
surfactants have been the most common because of their optimal 
detergency properties. However, non-ionic surfactants also provide 
good detergency but at lower pH values. Amphoteric surfactants, 
which are used in personal care products and in neutral cleaning 
solutions, are added to improve the properties of other surfactants. 



































 Figure 11. Three examples of non-ionic, anionic and amphoteric 
 surfactants 
 
 In addition to the wetting and emulsifying effects of the 
surfactants, other components are also added to alkaline degreasing 
baths. The so-called builders or alkaline agents (e. g. sodium and 
potassium hydroxides, carbonates and phosphates) [34] help to 
disperse dirt and to enhance the properties of the surfactants. Anti-
corrosive and chelating agents also have a key role in the degreasing 
process. 
 Decreasing baths cause a variety of environmental problems 
because they contain oil and grease residues, the management of is 
strictly legislated [35] and the effluents are alkaline. Therefore, 
appropriate waste management is required. However, some proposals 
have been made to prolong the lifetime of aqueous degreasing baths. 
Ultrafiltration has become an extensively used technique for 
separating oil and grease from the solid particles which may be in 
suspension. The separation is performed using a selective membrane 
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which is renewed periodically. Oil skimmers collect the oil and grease 
accumulated on the surface when the emulsion formed is not highly 
stable. The filtered residue is then submitted to suitable waste 
management. A more recent technique uses microorganisms that 
degrade complex molecules such as oils and greases. The resulting 
main product is carbon dioxide. These aerobic bacteria need special 
conditions, which involve relatively low temperatures (40-50°C) 
(compared to the temperatures used in the subsequent processes), 
and a pH range between 8.5 and 9.5 to enhance the consumption of 
the emulsified oil. In these conditions, the degreasing bath achieves 
optimal performance [33]. 
 The prolongation of the bath’ s lifetime is limited; i. e. the oil and 
grease content and the concentration of surfactant must be controlled. 
In the application below, the client uses a 24-hour method of analysis 
which is based on the EPA official method [36]. This involves 
extracting the analytes with n-hexane to determine the total content 
of both families of analytes and, then, treatment with silica gel to 
remove the polar compounds and determine the total content of 
grease. Therefore, there is a need for a rapid and reliable method of 
analysis. 
 The configuration designed for our method is a continuous flow 
system that can sequentially determine the surfactant and the mineral 
oil content in a run time of less than ten minutes. The two families of 
compounds are separated with a silica sorbent column so that the 
surfactant can be retained [37]. The detection system is an 
evaporative light scattering detector which has been proven to 





 The new method of analysis, which determines both the surfactant 
and grease content, is submitted to a suitable validation procedure 
that takes into account its particular characteristics. The validation 
process and the results are presented in the following section. 
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4.4.2 STATISTICAL INTERVALS TO VALIDATE AN 
AUTOANALYZER FOR MONITORING THE EXHAUSTION OF 
ALKALINE DEGREASING BATHS 
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We describe how to use the statistical intervals for validating a 
qualitative method for determining the alkaline degreasing baths 
exhaustion. A homemade autoanalyzer based on flow injection-
evaporative light scattering detector (FI-ELSD) coupling measures 
two instrumental responses related to the contents of surfactant and 
mineral oil. These two responses are necessary to decide whether the 
degreasing bath is exhausted. The instrumental responses  are 
compared to their corresponding decision values i.e. cut-off response 
( ) and screening response ( ). These decision values are 






specification limit (SL) of both analytes. The prediction bound of each 
analyte must be defined differently according to their corresponding 
specification limit. Performance parameters, such as sensitivity, 
specificity, false response rates and the unreliability region, are 
established. The performance of this qualitative method of analysis is 
checked by analyzing a set of 10 real samples. Our results show that 
the method is accurate as far as mineral oil content is concerned. 
 
Keywords: statistical intervals; flow-injection-evaporative light 
scattering detector coupling; degreasing baths; validation 
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Introduction 
 
The correct performance of an analytical method is important because 
it implies that it satisfies the requirements for which it was designed. 
This is part of the validation process, which is carried out at the end 
of the method development stage. This process must be carefully 
defined if the method’ s performance characteristics are to be 
accurately assessed. According to the ISO definition [1, 2], validating 
an analytical method means defining and estimating the performance 
parameters needed to satisfy the analytical requirements. In a similar 
way, the EURACHEM defines validation as the confirmation of the 
method performance capabilities consistency with the requirements of 
the application [3]. 
 
 The validation of qualitative analytical methods has not been 
within the scope of the main regulatory bodies, although some 
documents and guidelines, which are not generally accepted but 
valuable nonetheless, can be found in the bibliography [4-6]. Some 
validation proposals have been published addressing to specific 
applications. The methodologies used in those cases are different 
depending on the intrinsic characteristics of the method of analysis. 
The main approaches are the Performance Characteristic Curves, 
Bayes’  theorem, the Contingency Tables and the Statistical Intervals. 
As far as the methodology that uses Performance Characteristic 
Curves [7] is concerned, it is suitable for methods providing sensorial 
(i.e. visual) detection [8]. They allow the estimation of several 
performance parameters of the method such as sensitivity and 




allows the calculation of conditional probabilities referred to just one 
sample. However, it has been used as an approach to quantify 
uncertainty [9]. Contingency tables also permit the calculation of 
predictive values of the method of analysis and they have been widely 
used in clinical analysis. Recently, statistical intervals, and concretely 
prediction intervals, have been used to validate a qualitative method 
providing an instrumental response [10, 11]. 
 
 Following the last presented approach, in this paper we report the 
validation procedure for a qualitative method that assesses if an 
alkaline degreasing bath is to be replaced. The analytical method is 
not a test kit but a homemade autoanalyzer that uses a high-pressure 
pump, an injection valve, a silica sorbent column and an evaporative 
light-scattering detector [12]. It measures simultaneously two 
analytes and compares their response with the response of their 
corresponding specification limit (SL), i. e. the concentration of the 
mineral oil and of the surfactant at which the bath is exhausted. The 
decision about the sample is done considering simultaneously the two 
target analytes. Therefore, statistical intervals are defined around the 
specification limit of each analyte. New decision values such as cut-
off and screening limits are also defined to take into account the 
different types of error. 
In addition to the establishment of the new decision values, 
performance parameters such as sensitivity and specificity, the 
unreliability region and false results rates, are also estimated from the 
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 Degreasing baths are often used as a necessary step before the 
final processing of some metallic components because a perfectly 
clean and active surface is required. Previous steps in the 
manufacturing or processing of these components involve using 
greases and oils, usually mineral, with cooling and lubricant 
properties. These are usually removed from the metallic components 
using an alkaline degreasing bath by simply dipping them or sprinkling 
them with the cleaning solution. Other possibilities involve electrolytic 
techniques or ultrasounds. A wide range of alkaline degreasing baths 
exist because the composition of the bath must suit the problem at 
hand: e.g. dirt, the cleaning system, the composition of the metallic 
component or the subsequent process. They all have a similar 
formulation, which is based on the following main components [10]: 
surfactants (used as humectants), alkaline salts (used for the 
saponification of the oil and greases) and chelating agents (used to 
avoid the precipitation of metallic hydroxides). 
 
 As the amount of mineral oil in the degreasing bath increases, the 
bath becomes less and less efficient until a new one is required. The 
exhausted bath must then be submitted to proper waste management, 
which involves both economic and environmental costs. The 
exhaustion of the degreasing bath must therefore be correctly 
assessed in order to remove any still usable bath. Exhaustion is 
defined by the client or by the end user of the metallic components 
and measured in terms of different indicators—basically, the amount 
of mineral oil collected and the content of alkaline salts, though the 









 The autoanalyzer [9] used as the screening system is shown in 
Figure 1. It consisted of a Hewlett-Packard 1050 high-pressure 
quaternary gradient pump, a Rheodyne (Cotati, Ca, USA) 7725 
injection valve fitted with a 250 µl PTFE sample loop, a laboratory-
made silica column constructed by packing 40 mg of silica sorbent into 
a 3 cm x 4 mm i.d. PTFE tube using small cotton beads to prevent 
material losses, and a DDL 31 evaporative light-scattering detector 
(Eurosep, Cergy- Pontoise, France). The detector used air as 
nebulizing gas at 1.5 bar, the temperature of the nebulizing chamber 
was set at 75 ºC and the photomultiplier gain was set at 350V for the 
mineral oil and at 550V for the surfactant. Signals were acquired using 
an HPChem software connected to the detector via an HP 35900C 
(Agilent, Palo Alto, CA) multichannel interface. Peak height was 
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 Fig. 1. The autoanalyzer used as the screening method 
 
Reagents and samples 
 
 The validation standards contained both surfactant (0.39 g/l) and 
mineral oil (1g/l). In addition to these, 20 g/l alkaline salts solution 
was also added. The surfactant was a commercial product called 
Ridosol®. This, and the alkaline salts solution (Ridoline® 1565/1), were 
kindly supplied by Henkel Surface Technologies. Ridosol® is a mixture 
of 4 surfactants (Triton DF-11 (11%), Genapol PN-70 (3%), Lutensol 
DN-70 (11%), Plurafac LF-431 (5%) in 70% deionised water). 
Ridoline® is a solution of 48% potassium hydroxide (61.30%), 50% 
sodium hydroxide (3.20%), 75% phosphoric acid (6%) and boric acid 
(24.50%) in 5% deionised water. Ethanol 96% and n-hexane were 
obtained from Sharlau (Barcelona, Spain), sulphuric acid, sodium 








Sample preparation and analysis by the screening method   
 
 The validation standards were prepared by measuring 830 µl of a 
standard solution of 9.05 g/l surfactant in deionised water and 
measuring 830 µl of a standard solution of 30.1 g/l mineral oil in n-
hexane. Also, 0.5 g of Ridoline® was added to the 25 ml round flask. 
The organic phase was left to evaporate overnight and the 
corresponding amount of water was then added. The 25 ml aqueous 
solution was mixed in a separation funnel with 5 g sodium sulphate 
and 2 ml concentrated sulphuric acid. It was then extracted with 15 ml 
n-hexane and the final volume of the organic solution was 25 ml. 250 
µl of the extract was injected into the screening system carried by an 
n-hexane stream at a flow rate of 0.5 ml/min, passed through the 
silica column for quantitative surfactant fraction retention while the 
grease was directly driven to the detector and quantified. The flow 
rate of the n-hexane was raised to 0.8 ml/min (3.5 min) for column 
clean-up. The surfactant fraction was eluted using an ethanol stream 
at a flow rate of 1.0 ml/min (4 min). A post-time of 5 min with 0.8 
ml/min n-hexane was required as washing step. 
 
 The signal recorded was the light scattered by the analyte 
particles via previous nebulisation and evaporation of the mobile 
phase. The response is mass dependent [11], so the peak height of 
both analytes (mV) depends on the concentration of the analyte. The 
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Validation methodology 
 
According to the requirements of the end user, the degreasing bath 
must be replaced when the mineral oil content is above the 
specification limit, and when the alkaline salts content or the 
surfactant content are below their corresponding specification limit, 
both in terms of concentration. Not complying with these values will 
negatively affect the final quality of the metallic components. Then, 
just by measuring the response of the mineral oil and of the 
surfactant, the decision on the bath lifetime can be taken. 
 
 In the present case, the final YES/NO result comes from the 
instrumental signal measured. This means that the decision about the 
sample, i. e. bath lifetime, is made by comparing the surfactant 
response and the mineral oil response obtained for a specific bath 
with the corresponding one-sided prediction bound [12] of the 
specification limit response ( SLr ) obtained when recording several 
times, in intermediate precision conditions, the response at the 
concentration specification limit defined for a given standard. The 
three main steps in this process are: 
1) set the specification limit response for each analyte; 
2) if error probabilities are considered, estimate new response values 
(  or ) where the right final decision about the sample will 
be taken; and 
offcutr − screeningr
3) estimate the performance parameters of the analytical method 





Cut-off and screening responses 
 
 We have introduced the concept of specification limit responses as 
the responses at the concentration value of the mineral oil and at the 
concentration value of the surfactant, given by the client, at which we 
consider that the bath is no longer usable. However, taking the 
decision at the specification limit level is risky because, due to the 
associated imprecision of the measurements, the probability of 
committing an error is 50 %. Therefore, it is useful to take the 
decision at the cut-off response ( ) which is the response value 
beyond which the sample is positive with a certain probability of 
committing a type I error. This probability of committing the type I 
error is defined by taking into account the consequences of having 
false positive responses. The  strongly depends on the 
variability in the response values at the specification limit 




 Although the type I error is taken into account, this may not be 
sufficient to make the decision at the  because the probability of 
committing a type II error is rather high. The decision is therefore 
made at the screening response ( ) to also take into account the 
type II error. This probability of committing a type II error is set 
considering the consequences of having false negative results. It is 
therefore also a response value beyond which the sample is positive 
with certain probabilities of committing type I and type II errors. 
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both analytes at their corresponding specification limit concentration 
level. 
 
 Both limits (  and ) are defined from the statistical 
distribution of the specification limit. Then, the starting point in the 
definition of the prediction boundary is the response values 
corresponding to this limit. In the current application, both 
specification limits are set by the client at 0.39 g/l surfactant and 1 g/l 
mineral oil.  
offcutr − screeningr
 
 As the content of the mineral oil increases and the content of the 
surfactant decreases, their prediction boundary must be defined 
differently (Figure 2). This definition is done according to the 
following hypotheses: 
 
1) Surfactant: H0: ri≥ rSL (SL=0.39 g/l)  H1: ri < rSL
 A type I error means accepting H1 when actually H0 is true. This 
means affirming that the content of the surfactant is less than 0.39 g/l 
(the bath is exhausted) when it is not. The probability of making this 
type of error should, for several reasons, be as low as possible. An 
exhausted degreasing bath is subjected to a waste management 
process, which involves both economical and environmental costs. For 
those involved in waste management, therefore, it is more attractive 
to replace a truly exhausted degreasing bath that has perhaps been 
used longer than its shelf-life than to replace a falsely exhausted 
degreasing bath. 
 A type II error means accepting H0 when actually H1 is true. This 




than 0.39 g/l, i.e. the bath is not exhausted when in fact it is. Since the 
consequences of this wrong decision are relatively unimportant, it is 
not necessary to set the probability of this type of error very low. 
 The prediction boundary is therefore defined as in Equation (1 a): 
 
( ) SLSLoffcut strr ×−=− να ,      (1 a) 
 
 To establish the cut-off response value we need to set the 
probability of committing a type-I error (false positive) as low as 
possible. Also, though in the present case, it is not so important, 
defining the β -type probability error would avoid a considerable 
number of false negative results. Therefore, if we take into account 
the probabilities of committing both types of error, we obtain the so-
called screening response value, which depends on α , β  and the bias 
Δ , which is defined as the difference between the screening response 
and the response at the specification limit (Δ = ( SLscreening rr − )). From 
Figure 2 we can see that α , β  and Δ  are closely related. The 
previous definitions of α  and Δ  involve a particular β . Similarly, 
therefore, from pre-defined α  and β , the bias is automatically set. 
 
 This new decision value is expressed as shown in Equation (1 b), 
which takes into account the specification limit response of the 
surfactant: 
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2) Mineral oil: H0: ri≤ rSL (SL=1 g/l)  H1: ri> rSL
 A type I error means affirming that the content of mineral oil is 
higher than 1 g/l (the bath is exhausted) when it is not. For the 
mineral oil, the probability of a type-I error should be as low as 
possible. 
 A type II error means incorrectly stating that the content of 
mineral oil is equal to or lower than 1 g/l, i.e. the bath is not 
exhausted when in fact it is. Again, it is not necessary to set this 
probability of error as low as possible. 
 The prediction interval is defined as in Equation (2 a): 
 
( ) SLSLoffcut strr ×+=− να ,      (2 a) 
 
 The same occurs if we consider the probability of committing a 
type II error (see Equation (2 b)) and take into account the 
specification limit response of the mineral oil: 
 




















 Fig. 2. Specification limit, cut-off and screening response for a) the 




The variability of the measured responses needs to be reliably 
evaluated. The experimental design is crucial to achieving this aim. 
 
 A key value in the estimation of the screening response is the 
standard deviation of the specific limit response sSL. This value must 
be conveniently calculated using the following experimental design. 
To calculate the major sources of variability, the experimental design 
is therefore a 4-factor fully-nested design in which, for 22 days, two 
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operators twice analysed two new and different validation standards 
(Figure 3). 
 
operator= 1, 2 2
day=1, …, 22 1           ...          22 1           ...          22
sample=1, 2 1 2 1 2 1 2 1 2
instrumental replicate= 1, 2
1
 
 Fig. 3. Experimental design 
 
 The variance estimated in intermediate precision conditions 
contains the variability from the operator, day and sample. It is the 
estimated variance of an individual measurement made by an arbitrary 
operator on an arbitrary day. The intermediate precision can easily be 
estimated [13] by applying ANOVA to the results of this experimental 
design. However, the ANOVA table for the 4-factor fully-nested 
design is quite rare and a simpler design can be used if we consider 
the factors we vary within a run, which in the present case are the 
operator, the day and the sample. The design therefore becomes a 
two-factor fully-nested design with two instrumental replicates per 










Table 1. ANOVA for a two-factor fully-nested design 





























Total  (pn)-1 
 
Table 2. Variances for a two-factor fully-nested design 
Variance Expression Degrees of freedom 
Repeatability variance, S2r EMS  (pn)-1 
Between-run variance, S2run
n
MSMS Erun −  
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 As nr and pr are the number of replicates and the number of runs 
performed over the unknown sample, both are usually equal to 1. n 
and p are the number of replicates and runs used in the experimental 
























1111 22       (4) 
 
 The value obtained is substituted in equations (1) and (2) for each 
analyte. The effective number of degrees of freedom of the Student-t 
test must be computed using the Satterthwaite [14] approach. 
 
Results and discussion 
 
Following the experimental design shown in Figure 3, two operators 
twice analysed two different validation standards for 22 days, thus 
leading to 88 runs. From these analyses performed at the specification 
limits of the surfactant and mineral oil, both responses were recorded 
and, from the standard deviations in intermediate precision conditions, 
the cut-off and screening responses were calculated (Table 3). 
 
 Table 3. Variances, effective degrees of freedom, and for the 
 surfactant and the mineral oil. All values are calculated in response 
 terms. 
 Surfactant Mineral oil 
Mean response at the specification limit, SLr  (mV) 2.6 0.53 
Repeatability variance, S2r 4.5x10-4 1.3x10-4 
Between-run variance, S2run 3.8x10-2 1.4x10-3 
Run-different intermediate variance for the  




3.9 x10-2 1.5 x10-3 
Effective degrees of freedom, ν eff 89 103 
rcut-off (α=1%) (mV) 2.1 0.62 




 We can estimate the performance parameters by taking into 
account the decision values shown in table 3. Sensitivity was assessed 
by measuring 20 times a sample with a concentration of surfactant 
below 0.39 g/l (0.099 g/l). All 20 responses recorded were below 
 (i.e. 1.89 mV), so the sensitivity rate at this concentration 
level was 100%. Similarly, specificity was estimated from a sample 
with a surfactant concentration above 0.39 g/l (0.619 g/l) and a 
mineral oil concentration below 1g/l (0.707 g/l). All of the 20 
responses recorded showed a response value for the surfactant above 
 (i.e. 1.89 mV) and a response value below  (i.e. 0.67 
mV) for the mineral oil. This implies a specificity rate of 100% at both 




 The unreliability region is the interval of responses or 
concentrations where the probability of obtaining false responses or 
results obtained is higher [6]. In the present case, this region is 
placed between the specification limit response and the screening 
response of the analyte because is where these probabilities of 
committing false responses are higher. Once calculated these two 
response values, (i. e. specification limit response and screening 
response), the unreliability region is estimated easily. For the 
surfactant, the unreliability region lies between the response values of 
2.61 mV (specification limit) and 1.89 mV (screening response). For 
the mineral oil content, the unreliability region lies between response 
values of 0.53 mV (specification limit) and 0.67 mV (screening 
response). In both cases, within the unreliability region the probability 
of a type I error is the most important. 
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 False positive and false negative rates are interesting in the 
present application because the decisions depend on them. For the 
mineral oil, the false positive rate is assessed using a sample that 
contains 0.707 g/l of mineral oil. None of the 20 responses recorded 
provided a value above = 0.67 mV, which is a false positive 
rate of 0% at this concentration level. In this case, there is just one 
analyte to provide the false response rate. If we consider both 
analytes, several situations arise: 
screeningr
a) a false positive result for the mineral oil content but a true negative 
result for the surfactant content, which means that the bath can still 
be used since there is enough surfactant, 
b) a false positive result for the surfactant but a true negative result 
for the mineral oil, which means that the bath can still be used if a 
small amount of surfactant is added, 
c) both results are false positives, which means that the degreasing 
bath must be replaced. This situation will not happen often because 
the probability of a type I error has been set at 1%, 
d) both results are true negative, which means that the bath can still 
be used. 
 
 A similar situation occurs with regard to the false negative rate 
since it is assessed by measuring a sample with 1.246 g/l mineral oil 
but a rather low concentration of surfactant. Twenty samples were 
measured but no response recorded was below  =0.62 mV, 
which means that the false negative rate was 0%. Again, if we 






a) a false negative result for the mineral oil but true positive result for 
the surfactant, which means that, even though it is falsely assumed 
that there is not enough mineral oil, the bath can still be used if a 
small amount of surfactant is added. 
b) a false negative result for the surfactant but true positive result for 
the mineral oil. We can decide to longer use the bath if removing a 
small part of the mineral oil on the surface. 
c) a true positive result for both analytes, which means that the 
degreasing bath must be replaced. 
d) a false negative result for both, which means that we can continue 
to use the bath if we add more surfactant. This situation will not 
happen often because the probability of a type II error is set at 10%. 
 
 To properly validate this method, we analyzed ten samples 
provided by a specialized industry. These samples were collected for 
5 days and every 12 hours from a degreasing bath with a lifetime of 
one week. 
 
 Table 4 shows the results for mineral oil content measured with 
the reference method of analysis [15] and with the qualitative method. 
We can see that, with the reference method, all the results except one 
were clearly negative. Note that the mineral oil concentration of the 
sample with the positive result was close to the one corresponding to 
. When we analyse the samples with the qualitative method, a 
sample is positive if the instrumental response  is higher than the 
. On the other hand, a sample is negative whenever the 
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corresponding . As we can see, all the samples analysed— 
including the one that was positive with the reference method—
provided negative results. This is therefore a false negative result and 
is acceptable if we consider that its mineral oil concentration (1.31 
g/l) is extremely close to the corresponding concentration of the 
 (1.246 g/l). The method of analysis therefore performed 




 Table 4. Results of the analysis of the real samples using the 
 reference method and the qualitative method. 
Mineral oil 
(reference method) 
Mineral oil ri 
(qualitative method of analysis) 
Final result 
Negative 0.25 Negative 
Negative 0.22 Negative 
Negative 0.37 Negative 
Negative 0.40 Negative 
Negative 0.52 Negative 
Positive 0.61 Negative 
Negative 0.51 Negative 
Negative 0.46 Negative 
No information 0.50 Negative 





We have described how to use the statistical intervals in the validation 




screening method we have validated determines the exhaustion of a 
degreasing bath, which is used in the automobile industry. Two 
components were considered (the content of mineral oil and the 
content of surfactant) in order to decide whether the bath should be 
replaced. 
 
 The statistical intervals are defined in response terms and for both 
measurands simultaneously. As the specification limit is considered in 
terms of response, the one-sided prediction bounds are defined 
around the corresponding responses at the specification limit 
concentration because the probabilities of committing a type I error 
and a type II error are considered. On the basis of the  
responses for the two analytes, the sample is considered positive or 
negative. When the two responses are combined, however, the 
considerations may be different. 
screeningr
 
 Our results, obtained with a set of ten real samples, show that the 
method classified correctly at low concentrations of mineral oil and 
close to the concentration value for the specification limit. In the 
region near the concentration of the , however, one false 
negative result was obtained. No information is available on the 
surfactant content, so this cannot be checked. 
screeningr
 
 Although the validation procedure considered only two 
components of the degreasing baths, it can be extended to the content 
of alkaline salts provided the method of analysis is suitable for these 
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analytes. These salts are another valid indicator for the replacement 
of the degreasing bath. 
 
 Future proposals are to perform the validation study at other 
concentrations of these analytes and to determine robustness and 
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 The practical applications presented in the previous chapter have 
shown how to estimate some of the most common performance 
parameters of three particular methods of qualitative analysis. 
Although the general definition of method validation may involve 
assessing several performance parameters, the fact is that only a few 
are evaluated in a first approach to the validation process (e. g. 
sensitivity, specificity and false response rates, the unreliability 
region and, in some cases, the detection limit. Thus, parameters that 
may be important in some cases are left undetermined in others. This 
is what often happens as far as robustness and ruggedness are 
concerned. 
 Theoretically, no method of analysis should show important 
differences in its results when small changes are made to the 
experimental conditions. This property, known as robustness, is often 
confused or used indistinctly with ruggedness, which has a very 
similar meaning. Ruggedness refers to the changes that are observed 
in the response, but when external operation conditions are changed 
(i. e. operator, laboratory or equipment) [1-5]. 
 Robustness and ruggedness are usually studied with quantitative 
methods of analysis. Practitioners have several helpful documents 
which discuss how to perform robustness and ruggedness studies. 
These documents are not only practical descriptions [6-12], but also 
references from institutions involved in method validation [13]. 
 The AOAC INTERNATIONAL does not consider ruggedness as a 
formal part of the validation process, as is stated in the Methods 





Food Microbiological Official Methods of Analysis” [14]. Although it is 
not compulsory, submitting the method of analysis to the AOAC® 
Official MethodsSM Program (OMA) may provide valuable information. 
 An example of an indistinct use of the terms robustness and 
ruggedness is provided in the EURACHEM Guide “Fitness for Purpose 
of Analytical Methods” [15]. They are both used to refer to the 
performance characteristic related to the comparability of results 
within one method of analysis in different conditions. 
 The European Commission, when describing the performance of 
analytical methods and the interpretation of results [16], only uses 
the term ruggedness. It is defined as “the susceptibility of the method 
to changes in the experimental conditions” and it is evaluated in the 
validation procedure, which is presented as a two-stage process. In 
the first stage, a particular set of performance parameters should be 
unequivocally determined. These parameters are specificity, trueness, 
stability and calibration curves. Ruggedness is included in this first 
stage and it is also called applicability in this particular situation. It is 
evaluated by introducing reasonable minor variations, which should 
match usual deviations, in factors such as sample pre-treatment, 
clean-up and analysis. It seems that the term robustness, which is 
defined in the second paragraph, would fit this idea, i.e robustness to 
minor changes. Then, the results should be interpreted. The second 
stage of the validation procedure depemds on the intrinsic 
characteristics of the method of analysis. Other performance 
parameters such as recovery, repeatability or reproducibility, among 
others, should be determined. In this stage, ruggedness to the so-
called major changes (i. e. different species, matrices or sampling 




the second paragraph as ruggedness. The Youden approach is the 
statistical tool frequently used to determine the corresponding effects. 
 In this sense, qualitative methods of analysis should also be 
evaluated for robustness and ruggedness. However, so far validation 
guidelines have neglected this parameter. The aim of this chapter is to 
present a procedure that assesses the robustness of a qualitative 
method of analysis that provides a YES/NO instrumental response. 
 
 As a starting point, studies of the robustness of quantitative 
methods of analysis are very valuable. However, the data will then be 
analysed differently because of the peculiar characteristics of the 
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The growing importance of qualitative information as output in 
nowadays analytical laboratories in response to client’s demands is 
unquestionable. Therefore, the number of reliable, validated 
qualitative methods available for their implementation in routine 
laboratories is increasing in the same way. Unfortunately, no 
metrological support for this type of measurement process is yet 
available. In this paper, a practical approach about the assessment of 
the robustness of a qualitative method is presented. The proposed 
procedure is based on the selection of the critical variables and the 
estimation of the reliability and false positives and false negatives 
rates. The qualitative procedure selected is an automated 
configuration developed for monitoring the degree of exhaustion of 
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alkaline degreasing baths based on the total oil/grease and surfactant 
contents. The study was carried out at two concentration levels for 
each family of compounds. 
 





1. Analytical properties of qualitative analysis 
 
The quality indicators of an analytical process are the so-called 
analytical properties. They have been mainly used to characterize a 
quantitative result and therefore the associate (bio) chemical 
measurement process. As it is the case with other facets of qualitative 
analysis, few approaches to define/adapt the analytical properties to 
qualitative test methods have been systematically carried out [1]. The 
analytical properties in qualitative analysis can also be ranked into 
three categories (capital, basic and productivity related) existing, as in 
quantitative analysis, basic, contradictory and complementary 
relationship among them. Some adaptations of the quantitative 
analytical features are required taking into account the peculiarity of 
the qualitative binary response and the test methods. Therefore, 
reliability defined as a combination of accuracy and precision, is used 
in qualitative analysis [2] as capital analytical property (together with 
representativeness) and characterized the yes/no binary response. 
Reliability depends on sensitivity, selectivity and robustness of the 
method. The dependence on sensitivity and specificity is not a 
mathematical function but a conceptual one. Reliability includes the 
information regarding the results which are proved to be true. 
Therefore, there are included both the results truly given as positive, 
i.e. sensitivity; and the results truly given as negative, i.e. specificity. 
Then, it is expressed as a rate. Also, the classical concept of 
uncertainty should be replaced by unreliability in this context. This 
analytical property defines an interval around the cut-off or threshold 
limits where qualitative errors (false positives and false negatives) are 
produced. Finally, the analytical properties are different depending on 
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the type of qualitative analysis being under consideration, viz. analyte 
identification or sample qualification/classification. Fig. 1 shows a 
general procedure for the determination of the suitability of a 
qualitative method to the chemical information needs posed by the 
clients through the estimation/determination of the analytical features. 
In a first step it is necessary to establish the fitness-for-purpose of 
the qualitative method through a rough estimation of capital and basic 
properties. As can bee seen, one of the properties to be estimated 










DETERMINATION OF RECOVERY 
(if applicable)
STUDY OF INTERFERENCES
DETERMINATION OF RELIABILITY: FALSE 
POSITIVES AND FALSE NEGATIVES RATE
ROBUSTNESS
SAMPLING RATE
DETERMINATION OF SELECTIVITY 
(confirmation of identity)
DETERMINATION OF RELIABILITY: FALSE 
POSITIVES AND FALSE NEGATIVES RATE
ROBUSTNESS
SAMPLING RATE
ESTIMATION OF RECOVERY (if applicable)
ESTIMATION OF THE SELECTIVITY
ESTIMATION OF THE DETECTION LIMIT
ESTIMATION OF % OF RELIABILITY
ESTIMATION OF THE SELECTIVITY
ESTIMATION OF RECOVERY (if applicable)
ESTIMATION OF % OF RELIABILITY
PRESENCE OF ANALYTES








 Figure 1. Proposal of a general, flexible action list to determine the 








2. Robustness versus ruggedness 
 
The robustness of an analytical method is an estimation of its 
capability to remain unaffected by small but deliberated changes in 
method variables. It provides a qualitative estimation of its reliability 
when it performs analyses in standard conditions [3]. Through an 
experimental design, it is possible to define allowable limits for 
critical parameters. There is another term with a similar meaning that 
is often used when referring to robustness. Ruggedness is defined as 
‘the degree of reproducibility when the procedure is subjected to 
changes in external conditions such as different laboratories, analysts, 
instruments [4]. Although the difference may be slight, both terms 
must be employed in the right situation. Then, if the variables 
considered belong to the method of analysis, the study will check 
robustness. On the contrary, if the variables studied are of 
environment nature (e.g., laboratory temperature, analyst, brand of 
the reagents), ruggedness will be examined [5-7]. 
 It is necessary to use both terms correctly because they represent 
such different features of the method of analysis: robustness is 
related to the practicability and to the stability of the method of 
analysis using as a starting point the intrinsic variables; and 
ruggedness is related to the inter-laboratory method transferability 
[6, 7]. 
 Robustness and ruggedness testing should be carried out during or 
nearly at the end of method development stage [8, 9]. The reason is 
that they can help in evaluating the precision of the analytical method 
[10]: they identify critical factors or variables, which may have 
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influence in the performance of the analytical method. Then, they are 
crucial for the subsequent validation of the analytical method. 
 The distinction made between robustness and ruggedness hardly 
affects the design of a robustness and/or ruggedness study. In any 
case, it involves the selection of the suspected sources of variation, 
the experimentation, the estimation of the effects and the statement of 
the conclusions. The experimental domain should include the values of 
the variables when any change in the experimental conditions of the 
analysis (e.g., different equipment, different analyst, and different 
value of an inherent variable of the method of analysis) occurs. So the 
most common values for the variables under study are included in this 
experimental domain. Once the results are obtained, the adequate 
conclusions are inferred i.e. whether any change in the equipment, the 
analyst or any particular condition of the method of analysis will affect 
the final result or not. 
 Robustness in qualitative analysis is an analytical property of the 
qualitative test method, as in quantitative methods of analysis, rather 
than of the binary response, whose ultimate purpose is to define the 
experimental weakness of the qualitative method by defining what 
variables are critical to ensure the reliability of the responses. This 
property is very relevant as test methods are usually handled by 
unskilled and even different personnel, being therefore crucial to 
guarantee that the response obtained does not depend on external 
factors; but also on intrinsic ones, such as the stability of biochemical 
and immunoassay reagents, widely used for this purpose. Robustness 
also depends on the concentration of the analytes as experiments 
performed within the unreliability region will show higher influence of 





 A practical approach of these theoretical considerations is the 
subject matter of this article. 
 
 
3. Robustness studies in qualitative analysis. A case study 
 
Robustness and ruggedness are analytical features which should be 
evaluated whenever it is necessary. However, these studies have 
been carried out commonly over quantitative methods of analysis due 
to their more extensive development. The growing importance of 
qualitative methods of analysis suggests the evaluation of these 
performance parameters in addition to the capital ones. Nonetheless, 
the main problem is that this process has not been systematized 
enough. As a starting point, the difference between the type of result 
provided by a quantitative method of analysis (i.e., a numerical value) 
and a qualitative method of analysis (i.e., binary outcome, YES/NO) 
should be considered. Then, this binary nature of the result is crucial 
in the subsequent data treatment and conclusions statement about the 
different factors or variables examined. The data evaluated are not 
the changes in the final numerical results but in two capital 
performance parameters such as reliability and false response rates 
[1]. These performance parameters, which are closely related, are 
very important because they reveal how good the method of analysis 
classifies the samples. Robustness and ruggedness move on the same 
direction as reliability: the closer to the decision value of the method 
the study is performed (i.e., lower reliability and higher false response 
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3.1. Robustness of an autoana yzer for monitoring the exhaustion of 
alkaline degreasing baths 
l
The qualitative method selected for this study has been previously 
described by our research group [11]. It consists of a manual liquid-
liquid extraction of the total surfactant and oil/grease contents in n-
hexane followed by the injection of a 250 µl aliquot of the extract in a 
continuous flow manifold. The sample passes through a silica column 
carried by a stream of n-hexane where the surfactant is retained 
while the oil/grease is driven to the evaporative light scattering 
detector. Surfactants are afterwards eluted by means of an ethanol 
stream. It was optimized and validated for monitoring the degree of 
exhaustion of industrial degreasing baths considering the global level 
of two families of compounds. If the amount of surfactant is high 
enough and/or the concentration of oil/grease is not so high, the 
degreasing bath can be keep on using whereas for a low surfactant 
concentration and/or high amount of oil, the bath should not be used 
any longer. The decision is made according to a threshold 
concentration fixed by the clients (in this case a surface technology 
industry): 0.39 g/l for the surfactant and 1 g/l for the mineral oil. The 
four possibilities derived from the combination of these two 
parameters are depicted in Fig. 2. The study will consider the change 
in the reliability and false response rates when different experimental 
conditions inherent to the method of analysis are varied. Therefore, it 
is a robustness study. Reliability and false response rates are checked 
for the two families of compounds individually at two different 














BATH  EXHAUSTED 







OIL -  
 Figure 2. Control plot for internal quality control of the ageing 
 process of an alkaline degreasing bath as regards the surfactant and oil 
 contents 
 
 In general terms, the study will include: a selection of the 
variables (or factors), a selection of the number of levels for each 
variable (usually 2), selection of the best experimental design, 
establishment of the response value that evaluate the changes in the 
factors and experimentation, calculation of the effects, i.e. individual 
and interaction between factors, and statement of the conclusions. 
 The automated configuration used for global indices determination 
consists of a high pressure pump, a six-port injection valve, a silica 
sorbent column and an evaporative light scattering detector. The 
signal measured is the light scattered by the analyte particles, after 
solvent evaporation which provides peak height (mV) as a response 
which depends on the analyte concentration [12]. Concerning sample 
preparation, it includes a liquid-liquid extraction, which entails several 
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critical factors that affect the recoveries of the analytes. This effect is 
minimised by performing several sample preparations consecutively 
and by mixing extracts. Doing so, the probable difference in the 
values of every sample recovery is minimised. In addition to this, the 
automated system involves several intrinsic variables which can 
influence the final result, such as the flow rate of the eluents, the 
pressure of the nebulizing gas in the detector, the photomultiplier 
gain, the temperature of the nebulizing chamber or the post-time 
required for system conditioning between runs. 
 To achieve the objective proposed, it is necessary to consider the 
previous information gathered during the optimization [11] and during 
the validation [13] of the method of analysis. These two stages which 
involve a considerable experimental part allow the identification of the 
main variables which directly affect the performance of the method of 
analysis. The variables to be included are the detector gain, the 
temperature of the nebulizing chamber and the post-time between 
analyses. As it has been described elsewhere [11], the detector gain 
is different depending on the analyte measured, being 350 mV and 550 
mV the optimum values for oil/grease and surfactant, respectively. 
This parameter is changed during analyses and thus, it may lead to 
photomultiplier gain values slightly different from the right ones. A 
variation of 5 mV above and below each value is considered as 
suitable. Although the temperature is constant during the analysis, 
some fluctuations have been observed. The analyses are performed at 
a nebulizing chamber temperature of 75 ºC and the variations 
observed usually do not exceed 3 ºC. Therefore this interval is 
considered for the robustness study. Similarly, some variations 





programmed and a variation of 4 min is considered for this variable in 
this study. The definitive levels (optimum and tolerated interval) for 
each factor are summarized in Table 1. 
 
 Table 1. Levels of the factors chosen for the robustness study 
Variable Optimum level value Tolerated interval 
Photomultiplier gain 
(mV) 
350 mineral oil 
550 surfactant 





POST-TIME (min) 5 3-7 
 
 
3.2. Experimental design 
In order to cover the experimental domain defined in Table 1, the 
experiments should be carried out following a pre-set experimental 
design. Due to the information exposed in the previous section, a full 
factorial design is the best option because there are not so many 
variables and the number of levels is two for each variable. 
Considering the 3 factors under study and two levels for each one, the 
total number of experiments is 8 and they are summarized in Table 2. 
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 Table 2. Matrix of experiments following a 2-factor fully factorial 
 experimental design. A is the photomultiplier gain, B is the nebulizing 
 chamber temperature and C is post-time. 
Experiment A B C AB AC BC ABC 
1 - - - + + + - 
2 + - - - - + + 
3 - + - - + - + 
4 + + - + - - - 
5 - - + + - - + 
6 + - + - + - - 
7 - + + - - + - 
8 + + + + + + + 
 
 The results obtained from these experiments will be decisive for 
the subsequent decision about their influence in the quality 
parameters chosen, i.e. reliability and false response rates. As they 
are rates, their calculation involves a considerable number of 
experiments and results. This feature must be also considered before 
performing the experimental part, so each experiment will be carried 
out 20 times. Doing so, any change of 5% in any rate will be noticed. 
The experiments are performed according to the experimental 
conditions specified in Table 2. The analyses are carried out during 
eight days. In order to avoid any possible systematic error, a fraction 
of 5 analyses for 4 different experiments is performed daily. Then, 
each day, 20 analyses are carried out but every 5 analyses the 
experimental conditions are changed. 
 The samples are chosen according to different degrees of 





used contain different concentration levels of mineral oil and 
surfactant: the first sample contains: 0.099 g/l surfactant and 1.246 g/l 
mineral oil and the second sample contains 0.619 g/l surfactant and 
0.707 g/l mineral oil. 
 
3 3  Definition of the initial conditions . .
The method of analysis provides an instrumental response which is 
converted into a binary final result: YES the bath is exhausted and 
therefore, must be replaced; or NO the bath is not exhausted and 
replacement is not required yet. The decision of YES or NO is taken 
according to the instrumental response obtained for each analyte. A 
first approach, proposes a comparison of the response obtained with 
the response value corresponding to the threshold concentrations. 
However, in the present application the probabilities of error (type I 
and type II) are considered and then a new response value arises. 
This is the screening response or rscreening [13]. According to this, the 
comparison is performed between the response of the sample and the 
screening response. 
 As it has been previously described, the two analytes measured 
correspond to two different families of compounds. Although it is 
more interesting to consider both families simultaneously, they will be 
examined separately on account of their different behaviour in the 
analytical (or detection) system. The oil fraction is not retained on the 
silica sorbent while the signal for the surfactant fraction appears 
between 4.75 and 5 min after the automated system starts as the 
likely result of its interaction with the sorbent column. Then, the 
variables of the method of analysis may affect in a different manner 
these two global indexes. Bearing this in mind, the experiments are 
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performed with the two samples and the responses are examined for 
each analyte. The screening responses considered for each analyte 
are summarized in Table 3. 
 
 Table 3. Mean responses and screening responses for the surfactant and 
 the mineral oil [13] 
 Mean response at the specification limit, SLr rscreening (β=10%) 
Surfactant 2.6 0.53 
Mineral oil 1.9 0.67 
 
 The reliability is defined as the ‘proportion of right answers 
provided by the qualitative method of analysis carried out 
independently on aliquots of the same sample [1]. It is calculated 
according to Equation /1/: 
Reliability (%) = 100 %-FP (%)-FN (%)    /1/ 
 
Then, false responses should be defined previously: 
1) A false positive result (FP) is to state that the degreasing bath is 
exhausted, provided it is not exhausted yet and it must be replaced. 
Then: 
Surfactant: ri < rscreening (1.9 mV) and mineral oil: ri > rscreening (0.67 mV) 
 
2) A false negative result (FN) is to state that the degreasing bath is 
not exhausted when indeed it is. Then: 







3.4. Robustness study using a real sample obtained from an exhausted 
bath 
For sample 1 due to the concentration levels of the analytes: a) 
surfactant (0.099 g/l) and b) mineral oil (1.246 g/l), the surfactant 
measurements should provide a response below its rscreening (1.9 mV) 
and the mineral oil should provide a response value above its rscreening 
(0.67 mV). 
 The results regarding the reliability of both the surfactant and the 
mineral oil are summarized in Table 4. The experiments performed 
with the optimal conditions show a reliability of 100% for both families 
of compounds. The false positive rate is 0% for the surfactant and the 
false negative rate is also 0% for the mineral oil. 
 
 Table 4. Plan of experimentation carried out with the first sample. The 
 reliability and the false response rates are calculated for the surfactant 
 and the mineral oil. 
Experiment A (mV) B (ºC) C (min) aRel. (%) bRel. (%) 
cF. positive  
rate (%) 
dF. negative  
rate (%) 
1 345-545 72 3 100 80 0 20 
2 355-555 72 3 100 100 0 0 
3 345-545 78 3 100 55 0 45 
4 355-555 78 3 100 100 0 0 
5 345-545 72 7 100 80 0 20 
6 355-555 72 7 100 100 0 0 
7 345-545 78 7 100 65 0 35 
8 355-555 78 7 100 100 0 0 
a, c Reliability and false positive rate for the surfactant and b, d Reliability and 
false negative rate for the mineral oil. 
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 As it can be seen, reliability is 100 % for the surfactant. Then the 
method is robust as far as this family of compounds is concerned. 
 
 According to the reliability obtained for the mineral oil, the factors 
studied have an effect (DF) on the responses. This effect must be 
estimated (Equation /2/) 
 




∑ ∑ −−+=       /2/ 
( )+Y  is the reliability at the upper level of factor F, i.e. all the 
experiments with (+) in Table 2. ( )−Y  is the lower level of factor F, 
i.e. all the experiments with (-) in Table 2, and n is the number of 
experiments performed at each level of the factor under study. 
 Then, it is calculated for the three factors under study, i.e. 
photomultiplier gain, temperature, post-time and for the interaction 
between two and three factors (Table 5). 
 
 Table 5. Effects on the reliability for the three factors studied. 
Interactions  between two and three factors are also showed. 
Factor or interaction between factors Effect (DF) 
Photomultiplier gain 30% = 0.3 
Nebulizing chamber temperature 10% = 0.1 
Post-time 2.5% = 0.025 
Photomultiplier gain and nebulizing chamber temperature 10% = 0.1 
Photomultiplier gain and post-time -2.5% = -0.025 
Nebulizing chamber temperature and post-time 2.5% = 0.025 
Photomultiplier gain nebulizing chamber temperature  
and post-time 






 Once the effect (DF) of each factor is calculated, a t-test (Equation 









t        /3/ 
 
where sI is the standard deviation computed in intermediate precision 
conditions. This value is 0.0388 for the mineral oil. DF should not be 
used as a percentage but as the corresponding value between 0 and 1. 
 The calculated t-value is compared with the corresponding 
tabulated value for a specific level of significance (e.g., 95%) and 
degrees of freedom. The degrees of freedom are these associated to 
sI and are computed using Satterthwaite [14] approach. For the 
mineral oil, this value is 103. The comparison between both t-values 
is summarized in Table 6. 
 Regarding the surfactant as Table 4 shows, reliability is 100%. 
Then, the changes in the experimental conditions have not affected 
the final results. Therefore, the calculations performed with the 
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 Table 6. Calculated and tabulated t-values related to the effects of the 
 three factors studied and their interactions for the mineral oil. 





Photomultiplier gain 10.92 1.66 
Nebulizing chamber temperature 3.64 1.66 
Post-time 0.911 1.66 
Photomultiplier gain and nebulizing chamber temperature 3.64 1.66 
Photomultiplier gain and post-time 0.911 1.66 
Nebulizing chamber temperature and post-time 0.911 1.66 




 The main conclusion is that both the photomultiplier gain and the 
temperature of the nebulizing chamber affect the reliability at this 
concentration level of mineral oil. In addition to these effects, the one 
corresponding to the interaction between both factors is also relevant. 
The effect of the post-time as well as the effect of the interactions 
between post-time and the other two factors is not significant. As it 
was expected, the interaction between the three factors is also not 
relevant. On the contrary, the system is robust at this concentration 
level of surfactant. 
 The effect on false response rates can be easily inferred, once the 
reliability has been studied. The results of false response rates for the 
first sample are also summarized in Table 4. 
 The effects calculated for the false negative response rate are the 
same as for the reliability as far as the mineral oil is concerned. 
Therefore, the same factors are relevant at this concentration level 





3.5. Robustness study using a real sample obtained from a non-
exhausted bath 
For sample 2 due to the concentration levels of the analytes: a) 
surfactant (0.619 g/l) and b) mineral oil (0.707 g/l), the surfactant 
measurements should be above its rscreening (2.6 mV) because higher 
responses are provided by true negative samples. Similarly, the 
mineral oil should provide a response value below its rscreening (0.53 
mV) because lower responses are given by true positive samples 
(Table 3). Table 7 summarizes the results obtained. As reliability is 
100 %, false response rates are 0% and therefore not listed in the 
table. As for the first sample, the experiments performed under the 
optimal conditions show a reliability of 100% for the surfactant and 
the mineral oil. The false positive rate is 0% for the surfactant and the 
false negative rate is also 0% but for the mineral oil. 
 
 Table 7. Plan of experimentation carried out with the second sample. The 
 reliability is calculated for the surfactant and the mineral oil. 
Experiment A (mV) B (ºC) C (min) aReliability (%) bReliability (%) 
1 345-545 72 3 100 100 
2 355-555 72 3 100 100 
3 345-545 78 3 100 100 
4 355-555 78 3 100 100 
5 345-545 72 7 100 100 
6 355-555 72 7 100 100 
7 345-545 78 7 100 100 
8 355-555 78 7 100 100 
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 If reliability is 100% at this concentration level for both analytes, 
the false response rates are 0%. Then, it is not necessary to study the 
effect of the factors. The conclusion is that the method is robust at 





The need of reliable information provided by qualitative methods of 
analysis has been crucial in the apparition of validation guidelines. 
However, not all quality parameters are considered in the proposed 
guidelines. One of these parameters is the robustness which is not 
very often considered when validating this particular group of 
methods of analysis. In this paper, we have presented an approach of 
how robustness studies could be performed as far as methods of 
analysis providing binary type responses is concerned. An automated 
configuration that measures the degree of exhaustion of alkaline 
degreasing baths based on two families of compounds has been 
chosen as the case study. 
 The particular characteristics of the binary type response have 
defined how to design the robustness study. As for the case of 
quantitative methods of analysis, the robustness study proposed also 
involves an experimental design to evaluate the different factors or 
variables previously chosen. However, several concentration levels 
should be tested and the effects are calculated considering one or 
more performance parameters and not the numerical value of the 





 The robustness study is performed with the automated 
configuration at two different concentration levels of analytes. The 
effects of the variables photomultiplier gain, nebulizing chamber 
temperature and of their interaction are rather relevant at one 
concentration level of one family of compounds. Nonetheless, the 
method of analysis is robust for the other family of compounds at both 
concentration levels tested. 
 As robustness depends on the concentration level of the analyte 
studied, i.e. family of compounds, the two samples tested show 
significantly different results. The first sample comes from a bath 
containing oil/grease within the unreliability region. Then, the effect 
of the factors needs to be considered. However, the surfactant 
content is not within the unreliability region so the effect of the 
factors is not relevant. The second sample is from a clearly non-
exhausted degreasing bath as long as the concentration of both 
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 The main contributions of this doctoral thesis are the theoretical 
approach to the validation of qualitative methods of analysis and the 
three practical applications. The conclusions drawn from these 
applications are presented in this chapter. Some suggestions for 





1.  The bibliographic review in the third chapter provided an overview 
of validation in qualitative analysis. 
 1.1  The values of the different operational performance 
characteristics (such as rapidity, ease of handling or economy), as 
well as the statistical values (such as the unreliability region, 
sensitivity or selectivity) favour the growing acceptance of qualitative 
methods of analysis. 
 1.2  However, the main problem is still the lack of harmony as far 
as terminology is concerned. Some terms are used rather imprecisely 
to refer to these methods and to designate their performance 
characteristics. Classifications are often made with different criteria.  
 1.3  Written standards are needed in the field of validation of 
qualitative methods: to help choose the best validation procedure, to 
standardise the nomenclature and to unambiguously define the 
performance parameters. Although some institutions participate in 
defining the main quality parameters, few of them have proposed 





schemes are usually addressed to manufacturers of commercial test 
kits, who require a quality assessment before marketing their 
products. However, the end user should also be able to carry out the 
validation processes proposed. In this respect, specific validation 
guidelines endorsed by renowned institutions would provide valuable 
support to this task. 
 1.4  The validation of a method of analysis should provide 
information about what the method must do for a particular analytical 
problem. In chemical analysis, in addition to the analytical problem, 
the intrinsic characteristics of the method of analysis chosen define 
the validation methodology to be followed. This situation is very 
common in qualitative methods of analysis; therefore, different 
protocols should be developed depending on the specific target.
 
2.  Performance characteristic curves are useful for validating 
Aflacard B1 because it provides a binary type result. 
 2.1  The plot of the probabilities of positive, negative or 
inconclusive results in the range of concentration levels of interest 
leads to the estimation of the performance parameters. 
 2.2  Although the qualitative method performs well in comparison 
with the confirmatory method, a bias towards false positive results is 
detected. This bias has been set by the manufacturer to avoid false 
negative results, and it can be either accepted or corrected. The 
correction, which means changing the experimental conditions, 
involves moving the unreliability region to higher concentration levels. 
 
3.  Statistical intervals are very useful tools for validating the 




binary type final result. However, statistical intervals can be used in 
different ways depending on the intrinsic characteristics of the 
method. 
 3.1  In those situations in which control samples are used, their 
probability distribution function must first be characterised. Two 
performance parameters (i. e. sensitivity and specificity rates) are 
estimated using the data obtained when measuring the control 
samples. The performance parameters related to false response rates 
are estimated using two particular samples because the response of 
the control samples is not near the unreliability region around the cut-
off value. 
 3.2  The need to measure the responses of two analytes with a 
home-made autoanalyzer has also been overcome with statistical 
intervals. These intervals have been used because the method of 
analysis provides an instrumental response but the final result is 
binary. The statistical intervals are used differently from the case of 
the VZV IgG because no control samples are measured. The screening 
response value and the assessment of the quality parameters come 
after the response associated to the corresponding specification limit 
has been set and the one-sided prediction boundary has been defined. 
 
4.  As far as the intrinsic characteristics of the method of analysis and 
the information required by the end user are concerned, neither the 
contingency tables nor Bayes’  Theorem are as good as the 
performance characteristic curves and the statistical intervals at 
validating the three qualitative methods studied. 
 4.1  Although the information extracted from the contingency 





characteristic curves, the unreliability region around the chosen 
decision value cannot be estimated.  
 4.2  The information that can be obtained from Bayes’  Theorem is 
not complete enough. Its well-consolidated theory provides outcomes 
for both the conditional probabilities and the likelihood ratio, but for 
only one sample at a time (e. g. the probability of a true positive being 
a false negative or vice-versa). To calculate these conditional 
probabilities the performance parameters of the method (e.g. 
sensitivity and specificity rates) need to be known. 
 
5.  Robustness can also be evaluated in qualitative methods of 
analysis. Although the procedures for evaluating robustness in 
qualitative and quantitative methods of analysis are apparently similar, 
the difference between them lies in how they treat data. In the field of 
qualitative methods of analysis, the different experimental conditions 
affect the performance parameters and not the experimental response. 
The procedure for evaluating robustness in qualitative methods of 




6.3 FUTURE RESEARCH 
 
 The results presented in this doctoral thesis are just a small part 
of what needs to be done in the field of qualitative methods of 
analysis. Validation guidelines are a good starting point. Nonetheless, 
there are several issues that have not been dealt with here and which 





1) Laboratories often use methods of analysis based on simple 
chemical determination and the sensorial examination of the 
samples that provide the corresponding visual, olfactory or tactile 
outcomes is a rather extended practice. Validation guidelines 
should also be provided for these cases. 
 
2) Methods of analysis that are part of routine quality control should 
have an internal quality system that includes control charts. In the 
particular case of qualitative methods that use control samples, 
measurements should also be used to determine if any undesirable 
variation occurs. Systematization is required in this area. 
 
3) Performance characteristic curves also require further study. This 
model depends on two parameters (the so-called a and b 
parameters). How these two parameters affect the model should 
be examined. As for the linear model, it is known how the 
uncertainty varies, and a similar approximation could be done for 
the sigmoidal model. There is a proposal [1] that likens the central 
region of the performance characteristic curves to a straight line 
model. Although the authors have made the initial, important study, 
the issue should be studied in greater depth so that all the 










6.4 PROFESSIONAL SKILLS ACQUIRED DURING THIS 
DOCTORAL THESIS 
 
 The process of attaining the degree of doctor has involved several 
stages in which I have acquired a variety of skills. 
 
 To start with, I have made an in-depth study of several areas of 
chemistry. Then, I carried out some bibliographic research which was 
presented orally and evaluated on the occasion of the Diploma of 
Advanced Studies This stage was a very important one as it was the 
first contact I had with the research topic of this thesis. As a result: 
• I had a competitive advantage over other students in the first 
years of the doctorate because I had greater scientific 
knowledge. 
However, although scientific knowledge was important I have also 
progressively acquired other skills:  
• To position research in the most appropriate framework. 
• To choose the best bibliographic source. 
• To make the most of the information found. 
• To regularly use bibliography in daily work. 
 
 During the final stages of the doctoral thesis which have led to the 
degree, my scientific knowledge of the research topic has increased 
considerably. However, I also acquired new skills which should be 
added to the ones I have mentioned in the paragraph above: 
• I feel confident about my ability to design, participate in and 




different areas of analytical chemistry as environment and 
food contamination, drug compliance or quality control.  
• I have learned to express myself and the research results 
correctly and clearly, orally and in writing, both in my own 
language and in English. Additionally, I have learnt to 
systematise what is to be said and to make it understandable.  
 
 The fact that other people have made contributions to this thesis 
has shown me how to: 
• Collaborate with other scientists who have different opinions 
and to reach a consensus. 
• Adapt to different groups of people with their own operational 
procedures. I am particularly grateful to the Laboratory of 
Public Health in Tarragona, to the Immunology Department at 
the Laboratorios de Análisis Dr. Echevarne and Prof. 








[1] A. Ríos, D. Barceló, L. Buydens, S. Cárdenas, K. Heydorn, B. 
Karlberg, K. Klemm, B. Lendl, B. Milman, B. Neidhardt, R.W. 
Stephany, A. Townshend, A. Zschunke, M. Valcárcel, Accred. 
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